Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
56 "Hypothyroidism"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Articles
Thyroid
Prevalence of Subclinical Hypothyroidism in a Non-Diabetic Young Female Population and Its Impact on Diabetes and Cardiometabolic Risk
Nawoda Hewage, Udaya Wijesekara, Rasika Perera
Endocrinol Metab. 2024;39(6):864-876.   Published online November 5, 2024
DOI: https://doi.org/10.3803/EnM.2024.2015
  • 3,665 View
  • 95 Download
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
We evaluated the influence of subclinical hypothyroidism (SCH) on insulin resistance (IR), cardiometabolic risk, and obesity in childbearing-age women without diabetes.
Methods
This cross-sectional investigation included 282 women, aged 18 to 35 years, from rural and suburban Sri Lanka. Anthropometric and biochemical parameters, including IR and lipid/thyroid profiles, were recorded. Data were compared between SCH and euthyroidism (EU) for controls (normal weight) and cases (overweight/obese).
Results
The overall rates of SCH, EU, IR, and metabolic syndrome (MetS) were 40.42%, 59.57%, 73.40%, and 24.46%, respectively. Both controls and cases included individuals with SCH; overall, 168 participants (59.57%) had EU, while 114 (40.42%) exhibited SCH. IR was significantly associated with SCH in both weight groups (P<0.05). Among those with SCH, the odds ratios (ORs) for IR were >2 (95% confidence interval [CI], 0.45 to 3.87) in controls and >6 (95% CI, 3.52 to 8.41) in cases. Similarly, the ORs for MetS were >1 (95% CI, 0.38 to 4.16) in controls and >11 (95% CI, 8.73 to 15.01) in cases. Dyslipidemia and hypertriglyceridemia were significantly more prevalent in the SCH group (P<0.05). Women with SCH exhibited higher mean values for all obesity indices compared to their EU counterparts, surpassing normal thresholds (P<0.05). Among obesity measures, visceral adiposity index (VAI) demonstrated the highest area under the curve and sensitivity for assessing SCH and cardiovascular disease (CVD) risk.
Conclusion
SCH must be identified and managed in young women to help prevent diabetes and cardiometabolic disorders. VAI may aid in precisely detecting SCH and CVD.

Citations

Citations to this article as recorded by  
  • Increased Serum Lipopolysaccharide Levels are Related to a Higher Prevalent Risk of Subclinical Hypothyroidism
    Xuan An, Xiaoyi Wang, Jin Zhang, Mingtong Xu, Muchao Wu, Suraiya Saleem
    International Journal of Endocrinology.2025;[Epub]     CrossRef
  • Incidence of Subclinical Hypothyroidism in Obese Adults and Its Metabolic Implications: A Prospective Cohort Study
    Umer Jameel, Obaidullah Durrani, Ahmad Munib, Amanullah Khan
    Cureus.2025;[Epub]     CrossRef
Close layer
Thyroid
Big Data Articles (National Health Insurance Service Database)
Rising Incidence and Comorbidities of Endogenous Hypothyroidism in Republic of Korea from 2004 to 2018: A Nationwide Population Study
Chae Won Chung, Hwa Young Ahn, Sun Wook Cho, Ka Hee Yi
Endocrinol Metab. 2024;39(6):891-898.   Published online September 23, 2024
DOI: https://doi.org/10.3803/EnM.2024.1996
  • 4,334 View
  • 85 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Hypothyroidism, a prevalent endocrine disorder, results from insufficient thyroid hormone production or release, affecting metabolism. However, disparities in comorbidities and treatment trajectories may exist between endogenous and exogenous hypothyroidism.
Methods
Data from the Korean National Health Insurance Service from 2004 to 2018. Endogenous hypothyroidism was defined as cases with two or more diagnostic codes for hypothyroidism coupled with a history of thyroid hormone intake exceeding 60 days. To eliminate iatrogenic hypothyroidism, individuals with diagnosis codes for thyroid cancer, treatment codes for thyroid surgery, or radiotherapy were excluded. Hypothyroidism-related comorbidities were defined as new occurrences of the corresponding diagnosis code after the diagnosis of hypothyroidism during the entire study period.
Results
The age-standardized incidence of endogenous hypothyroidism among men was 0.2 per 1,000 person-years in 2004, increasing to 0.8 in 2018. Among women, the incidence increased from 1.6 per 1,000 person-years in 2004 to 3.7 in 2018. When comparing age groups of 20s–50s and 60s–90s, both sexes in the 60s–90s demonstrated a more rapid increase in incidence than those in the 20s–50s age range. Patients with endogenous hypothyroidism demonstrated a higher incidence of mood disorders across all age groups and cerebrovascular disease in individuals ≥60 years old, regardless of sex.
Conclusion
In Republic of Korea, endogenous hypothyroidism incidence has been increased in recent years. The incidence of endogenous hypothyroidism is increasing more rapidly in men than in women, especially in the elderly. Patients with endogenous hypothyroidism seem to have a heightened risk for cerebrovascular disease and mood disorders.

Citations

Citations to this article as recorded by  
  • Comorbidities of hypothyroidism
    Gabriela Brenta, Ulrike Gottwald-Hostalek
    Current Medical Research and Opinion.2025; 41(3): 421.     CrossRef
Close layer
Review Articles
Thyroid
Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines
Eu Jeong Ku, Won Sang Yoo, Hyun Kyung Chung
Endocrinol Metab. 2023;38(4):381-391.   Published online August 8, 2023
DOI: https://doi.org/10.3803/EnM.2023.1778
  • 14,389 View
  • 742 Download
  • 7 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
Subclinical hypothyroidism (SCH) is characterized by elevated thyroid-stimulating hormone (TSH) and normal free thyroxine levels. The Korean Thyroid Association recently issued a guideline for managing SCH, which emphasizes Korean-specific TSH diagnostic criteria and highlights the health benefits of levothyroxine (LT4) treatment. A serum TSH level of 6.8 mIU/L is presented as the reference value for diagnosing SCH. SCH can be classified as mild (TSH 6.8 to 10.0 mIU/L) or severe (TSH >10.0 mIU/L), and patients can be categorized as adults (age <70 years) or elderly (age ≥70 years), depending on the health effects of LT4 treatment. An initial increase in serum TSH levels should be reassessed with a subsequent measurement, including a thyroid peroxidase antibody test, preferably 2 to 3 months after the initial assessment. While LT4 treatment is not generally recommended for mild SCH in adults, it is necessary for severe SCH in patients with underlying coronary artery disease or heart failure and it may be considered for those with concurrent dyslipidemia. Conversely, LT4 treatment is generally not recommended for elderly patients, regardless of SCH severity. For those SCH patients who are prescribed LT4 treatment, the dosage should be personalized, and serum TSH levels should be regularly monitored to maintain the optimal LT4 regimen.

Citations

Citations to this article as recorded by  
  • Sex differences in prevalence of subclinical hypothyroidism and its clinical correlates in overweight or obese, first-episode drug-naïve Chinese patients with major depressive disorder
    Qiyue Qiu, Wan Yin Tew, Chenxi Liu, Jie Zhang, Bo Liu, Mun Fei Yam, Shichang Yang, Xiang-Yang Zhang
    Journal of Affective Disorders.2026; 398: 121068.     CrossRef
  • Evaluation of the add on effect of Majoone Sarkhas with levothyroxine in primary hypothyroidism: a randomized standard control adjuvant clinical study
    Md Anzar Alam, Mohd Aleemuddin Quamri, Ghulamuddin Sofi, Nafis Haider
    Drug Metabolism and Personalized Therapy.2025; 40(2): 121.     CrossRef
  • Macro-Thyrotropin Syndrome: Prevalence and Clinical Profile of an Under-Recognised Rare Entity in Thyroidology
    Maitri M. Patel, Dhara K. Patel, Lalitkumar B. Patel, Chetan B. Dharaiya, Dhruvkumar M. Patel, Ravi M. Vasani, Mukundkumar V. Patel
    Indian Journal of Endocrinology and Metabolism.2025; 29(1): 95.     CrossRef
  • Long-term forecasting and evaluation of medicine consumption for the ATC class H with a focus on thyroid hormones in OECD countries using ARIMA models
    Lilly Josephine Bindel, Roland Seifert
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(8): 10691.     CrossRef
  • Incidence and risk factors for early thyroxin supplementation therapy after hemithyroidectomy for benign conditions in Europe. A Eurocrine® registry-based study
    Jesús M. Villar-del-Moral, Juan I. Arcelus-Martínez, Antonio Becerra-Massare, Nuria Muñoz-Pérez, María C. Olvera-Porcel, Cristina Martínez-Santos
    Updates in Surgery.2025; 77(5): 1593.     CrossRef
  • DIAGNÓSTICO E MANEJO DO HIPOTIREOIDISMO SUBCLÍNICO: UMA REVISÃO DE LITERATURA
    Dayane Beserra Costa Felício, Mariana Barbosa Silva, Mileide Beatriz de Lima Santos, Yasmin Cabral Menezes de Oliveira, Vinícius de Lima Paes, Ana Paula Simadon, Cleyciane Camila de Souza Belo Nogueira, Giulia Costa Moura
    REVISTA FOCO.2025; 18(4): e8209.     CrossRef
  • Subclinical Hypothyroidism after a Three-Month Course of Low-Dose Amiodarone.
    Rano Kirkimbayeva, Telman Seisembekov, Bakyt Iskakova, Nauryzbay Bekishuly, Assel Chinybayeva, Galiya Smailova, Diana Aibulova, Aya Aitpayeva, Aidana Butabayeva, Zhansaya Yerkhanova, Olzhas Yesseneyev, Ayan Abdrakhmanov
    Journal of Clinical Medicine of Kazakhstan.2025; 22(2): 54.     CrossRef
  • Impact of subclinical hypothyroidism on glycemic markers and insulin resistance in nondiabetic Iraqi patients: a cross-sectional study
    Maysam Riyadh Mohammed Hussein Alaasam, Raffat Hilal Abboodi, Hayder Nadhim Mohsin Al-Khayyat
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 21(6): 583.     CrossRef
  • Clinical Implications of Different Thyroid-Stimulating Hormone (TSH) Reference Intervals between TSH Kits for the Management of Subclinical Hypothyroidism
    Won Sang Yoo
    Endocrinology and Metabolism.2024; 39(1): 188.     CrossRef
  • Serum Vitamin B12 and Holotranscobalamin Levels in Subclinical Hypothyroid Patients in Relation to Thyroid-Stimulating Hormone (TSH) Levels and the Positivity of Anti-thyroid Peroxidase Antibodies: A Case-Control Study
    Muqdad Al-Mousawi, Sherwan Salih, Ameer Ahmed, Barhav Abdullah
    Cureus.2024;[Epub]     CrossRef
  • Severe Symptomatic Anemia as a Rare Initial Manifestation of Type 3 Polyglandular Autoimmune Syndrome: A Case Report
    Hugo Goncalves, Francisco De Oliveira Simões, Rosa Sá, Bárbara Fraga Campos, Rui M Domingues, Narciso Oliveira, Teresa Pimentel
    Cureus.2024;[Epub]     CrossRef
  • Evaluation of the effects of thyroid functions on frailty in geriatric patients using the Edmonton, SOF and FRAIL Scales
    Galip Can Uyar, Mustafa Kemal Kılıç
    BMC Geriatrics.2024;[Epub]     CrossRef
Close layer
Thyroid
Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum: 2023 Revised Korean Thyroid Association Guidelines
Hwa Young Ahn, Ka Hee Yi
Endocrinol Metab. 2023;38(3):289-294.   Published online June 9, 2023
DOI: https://doi.org/10.3803/EnM.2023.1696
  • 45,649 View
  • 1,277 Download
  • 7 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   ePub   
Thyroid hormone plays a critical role in fetal growth and development, and thyroid dysfunction during pregnancy is associated with several adverse outcomes, such as miscarriage and preterm birth. In this review, we introduce and explain three major changes in the revised Korean Thyroid Association (KTA) guidelines for the diagnosis and management of thyroid disease during pregnancy: first, the normal range of thyroid-stimulating hormone (TSH) during pregnancy; second, the treatment of subclinical hypothyroidism; and third, the management of euthyroid pregnant women with positive thyroid autoantibodies. The revised KTA guidelines adopt 4.0 mIU/L as the upper limit of TSH in the first trimester. A TSH level between 4.0 and 10.0 mIU/L, combined with free thyroxine (T4) within the normal range, is defined as subclinical hypothyroidism, and a TSH level over 10 mIU/L is defined as overt hypothyroidism regardless of the free T4 level. Levothyroxine treatment is recommended when the TSH level is higher than 4 mIU/L in subclinical hypothyroidism, regardless of thyroid peroxidase antibody positivity. However, thyroid hormone therapy to prevent miscarriage is not recommended in thyroid autoantibody-positive women with normal thyroid function.

Citations

Citations to this article as recorded by  
  • Management of Thyroid Disorders during Pregnancy: A Survey of Physicians from the Middle East and North Africa
    Salem A. Beshyah, Mohammed Bashir, Aly B. Khalil, Bashir Salih
    Journal of Diabetes and Endocrine Practice.2025; 08(01): 045.     CrossRef
  • Association of coexposure to per- and polyfluoroalkyl substances and heavy metals with thyroid function across varied age pregnant women and the potential role of hemoglobin
    Fang Wang, Xinyu Zhang, Yuxin Hu, Gang Wang, Jingbo Pi, Tingyu Wang, Haina Guo, Mingqi Zhang, Lijuan Zhang, Yuanyuan Xu
    International Journal of Hygiene and Environmental Health.2025; 266: 114574.     CrossRef
  • DIAGNÓSTICO E MANEJO DO HIPOTIREOIDISMO SUBCLÍNICO: UMA REVISÃO DE LITERATURA
    Dayane Beserra Costa Felício, Mariana Barbosa Silva, Mileide Beatriz de Lima Santos, Yasmin Cabral Menezes de Oliveira, Vinícius de Lima Paes, Ana Paula Simadon, Cleyciane Camila de Souza Belo Nogueira, Giulia Costa Moura
    REVISTA FOCO.2025; 18(4): e8209.     CrossRef
  • The Relationship between Thyroid Serum Indexes in Early Pregnancy and Diabetes in Pregnancy
    敏 谢
    Advances in Clinical Medicine.2025; 15(05): 2119.     CrossRef
  • Investigating Birth and Thyroid Outcomes of Maternal-Fetal Environmental Exposures (IBM-E): A Cohort Protocol for Dietary Iodine and Endocrine Disruptors
    Yun Ji Jung, Jeong Eun Shin, Ju-hee Yoon, Suhra Kim, Hayan Kwon, Sungbo Shim, Dong Yeob Shin, Minseo Gim, Younglim Kho, JoonHo Lee
    Endocrinology and Metabolism.2025; 40(6): 940.     CrossRef
  • Use of thyroid hormones in hypothyroid and euthyroid patients: A survey of members of the Endocrine Society of Australia
    Nicole Lafontaine, Suzanne J. Brown, Petros Perros, Enrico Papini, Endre V. Nagy, Roberto Attanasio, Laszlo Hegedüs, John P. Walsh
    Clinical Endocrinology.2024; 100(5): 477.     CrossRef
  • A Prospective Clinical Trial of Radiofrequency Ablation in Patients with Low-Risk Unifocal Papillary Thyroid Microcarcinoma Favoring Active Surveillance Over Surgery
    Ji Ye Lee, Dong Gyu Na, Jung Suk Sim, Jin Yong Sung, Sun Wook Cho, Do Joon Park, Young Joo Park, Ji-hoon Kim
    Thyroid®.2024; 34(9): 1126.     CrossRef
  • Association between antinuclear antibodies status and preterm birth in Japanese pregnant women: a prospective cohort study from Adjunct Study of the Japan Environment and Children’s Study
    Mami Fukushige, Xi Lu, Minoru Satoh, Masako Oda, Takashi Ohba, Takahiko Katoh
    BMC Pregnancy and Childbirth.2024;[Epub]     CrossRef
  • Differentiation Between Clinical and Subclinical Hypothyroidism in Pathophysiology, Symptoms, Diagnosis and Treatment – A Narrative Review
    Mustafa Mohammed Albassam, Noor Mohammed Obaid, Yasser Kadhim Hashem Al-Zwaini
    Baghdad Journal of Biochemistry and Applied Biological Sciences.2024; 5(3): 144.     CrossRef
  • Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines
    Eu Jeong Ku, Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2023; 38(4): 381.     CrossRef
  • Maternal isolated hypothyroxinemia in the first trimester is not associated with adverse pregnancy outcomes, except for macrosomia: a prospective cohort study in China
    Jing Du, Linong Ji, Xiaomei Zhang, Ning Yuan, Jianbin Sun, Dan Zhao
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
Close layer
Thyroid
Thyroid Function across the Lifespan: Do Age-Related Changes Matter?
John P. Walsh
Endocrinol Metab. 2022;37(2):208-219.   Published online April 14, 2022
DOI: https://doi.org/10.3803/EnM.2022.1463
  • 23,234 View
  • 547 Download
  • 28 Web of Science
  • 34 Crossref
AbstractAbstract PDFPubReader   ePub   
Circulating concentrations of thyrotropin (TSH) and thyroxine (T4) are tightly regulated. Each individual has setpoints for TSH and free T4 which are genetically determined, and subject to environmental and epigenetic influence. Pituitary-thyroid axis setpoints are probably established in utero, with maturation of thyroid function continuing until late gestation. From neonatal life (characterized by a surge of TSH and T4 secretion) through childhood and adolescence (when free triiodothyronine levels are higher than in adults), thyroid function tests display complex, dynamic patterns which are sexually dimorphic. In later life, TSH increases with age in healthy older adults without an accompanying fall in free T4, indicating alteration in TSH setpoint. In view of this, and evidence that mild subclinical hypothyroidism in older people has no health impact, a strong case can be made for implementation of age-related TSH reference ranges in adults, as is routine in children.

Citations

Citations to this article as recorded by  
  • Cross-sectional association of arsenic exposure with thyroid function in Bangladeshi children aged 5 to 7 years
    Yingyue Ni, Prathiba Balakumar, Tariqul Islam, Syed Emdadul Haque, Mohammad H. Shahriar, Golam Sarwar, Alauddin Ahmed, Chunyu Liu, Brandon L. Pierce, Robert M. Sargis, Brian Jackson, Farzana Jasmine, Muhammad G. Kibriya, Habibul Ahsan, Maria Argos
    Environmental Health.2026;[Epub]     CrossRef
  • Circulating thyroid hormones and metabolites in children with autism spectrum disorder
    Michael Hancock, Rui Zhang, Suzanne J. Brown, Conchita Boyder, Shelby Mullin, Purdey J. Campbell, Scott G. Wilson, Ee Mun Lim, Andrew J.O. Whitehouse, John P. Walsh
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Assessment of transthyretin and key biomarkers for lung cancer diagnosis
    Talib Dabshee Al-Tmimee, Moones Rahmandoust, Fatin Fadhel Al-Kazazz, Leili Sharif Bakhtiar
    Comparative Clinical Pathology.2026;[Epub]     CrossRef
  • Longitudinal PFAS exposure and thyroid function trajectories in Taiwanese youth: a 10-year prospective cohort study
    Chien-Yu Lin, Hui-Ling Lee, Ta-Chen Su
    Environment International.2026; 208: 110106.     CrossRef
  • Early postnatal changes in thyroid-stimulating hormone and subsequent neurodevelopment in preterm infants
    Myoung-Jin Yoo, Yong Hun Jang, Gang-Yi Lee, Habyeong Kang, Dong Hye Ye, Woochang Hwang, Seung Yang, Hyun Ju Lee
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • The role of vitamin D in slipped capital femoral epiphysis in children and adolescents: a retrospective case-control study
    Peng Ning, Shuting Lin, Huiyu Geng, Tianjing Liu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Enhancing thyroid disease prediction and comorbidity management through advanced machine learning frameworks
    P. Sanju, N. Syed Siraj Ahmed, P. Ramachandran, P. Mohamed Sajid, R. Jayanthi
    Clinical eHealth.2025; 8: 7.     CrossRef
  • Precision medicine in hypothyroidism: an engineering approach to individualized levothyroxine dosing
    Davide Manca
    Physical Sciences Reviews.2025; 10(4): 407.     CrossRef
  • Long-term health outcomes of preterm birth: a narrative review
    Faith Gette, Sumera Aziz Ali, Matthew S. P. Ho, Lindsay L. Richter, Edmond S. Chan, Connie L. Yang, Emily Kieran, Cherry Mammen, Ashley Roberts, Kristopher T. Kang, Jonathan Wong, Shahrad R. Rassekh, Michael Castaldo, Kevin C. Harris, James Lee, Carol K.
    Frontiers in Pediatrics.2025;[Epub]     CrossRef
  • Thyrotoxic effects of organophosphate insecticides in adults: a bibliometric and meta-analysis
    Massira Ousseni Diawara, Gaoju Pan, Xu Yang, Mohammed Alqudaimi, Mahamadou Fofana, Solim Essomandan Clémence Bafei, Di Wu, Hein Min Tun, Qianqi Liu, Mingzhi Zhang, Yankai Xia
    International Archives of Occupational and Environmental Health.2025; 98(7): 631.     CrossRef
  • Multivariate Assessment of Thyroid, Lipid, and Inflammatory Profiles by HBV Status and Viral Load: Age- and Sex-Specific Findings
    Hyeokjun Yun, Jong Wan Kim, Jae Kyung Kim
    Viruses.2025; 17(9): 1208.     CrossRef
  • Hormonal changes during aging and their effects on quality of life
    Carter Coggins, Shaan Patel, Sankalp Nigam, Vikrant Rai
    Exploration of Endocrine and Metabolic Diseases.2025;[Epub]     CrossRef
  • Thyroid–Microbiome Allostasis and Mitochondrial Performance: An Integrative Perspective in Exercise Physiology
    Adrian Odriozola, Adriana González, Iñaki Odriozola, Francesc Corbi, Jesús Álvarez-Herms
    Nutrients.2025; 18(1): 59.     CrossRef
  • TSH LEVELS AND BODY COMPOSITION IN OBESITY
    Fatma Zehra Ağan, Çiğdem Cindoğlu, Derya Abuşka
    Kırıkkale Üniversitesi Tıp Fakültesi Dergisi.2025; 27(3): 386.     CrossRef
  • The ageing thyroid: implications for longevity and patient care
    Diana van Heemst
    Nature Reviews Endocrinology.2024; 20(1): 5.     CrossRef
  • Incidence and Determinants of Spontaneous Normalization of Subclinical Hypothyroidism in Older Adults
    Evie van der Spoel, Nicolien A van Vliet, Rosalinde K E Poortvliet, Robert S Du Puy, Wendy P J den Elzen, Terence J Quinn, David J Stott, Naveed Sattar, Patricia M Kearney, Manuel R Blum, Heba Alwan, Nicolas Rodondi, Tinh-Hai Collet, Rudi G J Westendorp,
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1167.     CrossRef
  • Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications
    Rosalie B. T. M. Sterenborg, Inga Steinbrenner, Yong Li, Melissa N. Bujnis, Tatsuhiko Naito, Eirini Marouli, Tessel E. Galesloot, Oladapo Babajide, Laura Andreasen, Arne Astrup, Bjørn Olav Åsvold, Stefania Bandinelli, Marian Beekman, John P. Beilby, Jette
    Nature Communications.2024;[Epub]     CrossRef
  • Evaluation of multiple organophosphate insecticide exposure in relation to altered thyroid hormones in NHANES 2007‐2008 adult population
    Massira Ousseni Diawara, Songtao Li, Mingzhi Zhang, Francis Manyori Bigambo, Xu Yang, Xu Wang, Tianyu Dong, Di Wu, Chenghao Yan, Yankai Xia
    Ecotoxicology and Environmental Safety.2024; 273: 116139.     CrossRef
  • Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults
    Salman Razvi
    Nature Reviews Endocrinology.2024; 20(5): 253.     CrossRef
  • Association between exposure to chemical mixtures and epigenetic ageing biomarkers: Modifying effects of thyroid hormones and physical activity
    Wanying Shi, Jianlong Fang, Huimin Ren, Peijie Sun, Juan Liu, Fuchang Deng, Shuyi Zhang, Qiong Wang, Jiaonan Wang, Shilu Tong, Song Tang, Xiaoming Shi
    Journal of Hazardous Materials.2024; 469: 134009.     CrossRef
  • Biochemical pattern and prevalence of thyroid disorders among adults in a tertiary hospital in North-East Nigeria
    Bawa Ibrahim Abubkar, Longwap Abdulazis Saleh, Dauda E. Suleiman, Sanni Musa, Bosede Oluwasayo Adegoke, Ibrahim Naziru, Abbas Hamisu, Harisu Salisu, Rabi’atu Ahmad Bichi, Mansur Ramalan Aliyu, Christian Isichei
    Annals of African Medical Research.2024;[Epub]     CrossRef
  • Analysis of Inflammatory and Thyroid Hormone Levels Based on Hepatitis A and B Virus Immunity Status: Age and Sex Stratification
    Hyeokjun Yun, Jae-Sik Jeon, Jae Kyung Kim
    Viruses.2024; 16(8): 1329.     CrossRef
  • Hypothyroidism
    Peter N Taylor, Marco M Medici, Alicja Hubalewska-Dydejczyk, Kristien Boelaert
    The Lancet.2024; 404(10460): 1347.     CrossRef
  • Thyroid dysfunction among patients assessed by thyroid function tests at a tertiary care hospital: a retrospective study
    Emmanuel Donkoh Aidoo, Grace Korkor Ababio, Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, Nii Ayite Aryee
    The Pan African Medical Journal.2024;[Epub]     CrossRef
  • The relationship between serum thyroid hormone levels and symptoms severity in young children with autism
    Maria Kopcikova, Barbara Raskova, Ivan Belica, Jan Bakos, Hana Celusakova, Zuzana Chladna, Jana Zibolenova, Daniela Ostatnikova
    Endocrine Regulations.2024;[Epub]     CrossRef
  • DNA Methylation in Autoimmune Thyroid Disease
    Nicole Lafontaine, Scott G Wilson, John P Walsh
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(3): 604.     CrossRef
  • A Causality between Thyroid Function and Bone Mineral Density in Childhood: Abnormal Thyrotropin May Be Another Pediatric Predictor of Bone Fragility
    Dongjin Lee, Moon Ahn
    Metabolites.2023; 13(3): 372.     CrossRef
  • Serum Lipidomic Analysis Reveals Biomarkers and Metabolic Pathways of Thyroid Dysfunction
    Hua Dong, Wenjie Zhou, Xingxu Yan, Huan Zhao, Honggang Zhao, Yan Jiao, Guijiang Sun, Yubo Li, Zuncheng Zhang
    ACS Omega.2023; 8(11): 10355.     CrossRef
  • Developmental and environmental modulation of fecal thyroid hormone levels in wild Assamese macaques (Macaca assamensis)
    Verena Behringer, Michael Heistermann, Suchinda Malaivijitnond, Oliver Schülke, Julia Ostner
    American Journal of Primatology.2023;[Epub]     CrossRef
  • Prevalence of Functional Alterations and the Effects of Thyroid Autoimmunity on the Levels of TSH in an Urban Population of Colombia: A Population-Based Study
    Hernando Vargas-Uricoechea, Valentina Agredo-Delgado, Hernando David Vargas-Sierra, María V. Pinzón-Fernández
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2023; 23(6): 857.     CrossRef
  • Genetic determinants of thyroid function in children
    Tessa A Mulder, Purdey J Campbell, Peter N Taylor, Robin P Peeters, Scott G Wilson, Marco Medici, Colin Dayan, Vincent V W Jaddoe, John P Walsh, Nicholas G Martin, Henning Tiemeier, Tim I M Korevaar
    European Journal of Endocrinology.2023; 189(2): 164.     CrossRef
  • Relationship between Thyroid CT Density, Volume, and Future TSH Elevation: A 5-Year Follow-Up Study
    Tomohiro Kikuchi, Shouhei Hanaoka, Takahiro Nakao, Yukihiro Nomura, Takeharu Yoshikawa, Md Ashraful Alam, Harushi Mori, Naoto Hayashi
    Life.2023; 13(12): 2303.     CrossRef
  • Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status
    Katleen Van Uytfanghe, Joel Ehrenkranz, David Halsall, Kelly Hoff, Tze Ping Loh, Carole A. Spencer, Josef Köhrle
    Thyroid®.2023; 33(9): 1013.     CrossRef
  • Blood hormones and suicidal behaviour: A systematic review and meta-analysis
    Xue-Lei Fu, Xia Li, Jia-Mei Ji, Hua Wu, Hong-Lin Chen
    Neuroscience & Biobehavioral Reviews.2022; 139: 104725.     CrossRef
Close layer
Original Articles
Thyroid
Developmental Hypothyroidism Influences the Development of the Entorhinal-Dentate Gyrus Pathway of Rat Offspring
Ting Jin, Ranran Wang, Shiqiao Peng, Xin Liu, Hanyi Zhang, Xue He, Weiping Teng, Xiaochun Teng
Endocrinol Metab. 2022;37(2):290-302.   Published online April 8, 2022
DOI: https://doi.org/10.3803/EnM.2021.1343
  • 6,198 View
  • 113 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Developmental hypothyroidism impairs learning and memory in offspring, which depend on extensive neuronal circuits in the entorhinal cortex, together with the hippocampus and neocortex. The entorhinal-dentate gyrus pathway is the main entrance of memory circuits. We investigated whether developmental hypothyroidism impaired the morphological development of the entorhinal-dentate gyrus pathway.
Methods
We examined the structure and function of the entorhinal-dentate gyrus pathway in response to developmental hypothyroidism induced using 2-mercapto-1-methylimidazole.
Results
1,1´-Dioctadecyl-3,3,3´,3´-tetramethylindocarbocyanine perchlorate tract tracing indicated that entorhinal axons showed delayed growth in reaching the outer molecular layer of the dentate gyrus at postnatal days 2 and 4 in hypothyroid conditions. The proportion of fibers in the outer molecular layer was significantly smaller in the hypothyroid group than in the euthyroid group at postnatal day 4. At postnatal day 10, the pathway showed a layer-specific distribution in the outer molecular layer, similar to the euthyroid group. However, the projected area of entorhinal axons was smaller in the hypothyroid group than in the euthyroid group. An electrophysiological examination showed that hypothyroidism impaired the long-term potentiation of the perforant and the cornu ammonis 3–cornu ammonis 1 pathways. Many repulsive axon guidance molecules were involved in the formation of the entorhinaldentate gyrus pathway. The hypothyroid group had higher levels of erythropoietin-producing hepatocyte ligand A3 and semaphorin 3A than the euthyroid group.
Conclusion
We demonstrated that developmental hypothyroidism might influence the development of the entorhinal-dentate gyrus pathway, contributing to impaired long-term potentiation. These findings improve our understanding of neural mechanisms for memory function.

Citations

Citations to this article as recorded by  
  • Aberrant Development of Hippocampal GABAergic Neurons Arising from Hypothyroidism Contributes to Memory Deficits in Mice Through Maf Suppressing Mef2c
    Mengyan Wu, Xingdong Zeng, Yongle Cai, Haonan Chen, Hao Yang
    Biomedicines.2025; 13(6): 1436.     CrossRef
  • Semaphorin 3A Increases in the Plasma of Women with Diminished Ovarian Reserve Who Respond Better to Controlled Ovarian Stimulation
    Michela Palese, Gabriella Ferretti, Giuseppe Perruolo, Sara Serafini, Rossana Sirabella, Vincenzo Marrone, Martina De Rosa, Laura Sarno, Ida Strina, Carmela Matrone, Maurizio Guida
    Life.2024; 14(3): 358.     CrossRef
Close layer
Thyroid
Association between Thyroid Function and Heart Rate Monitored by Wearable Devices in Patients with Hypothyroidism
Ki-Hun Kim, Juhui Lee, Chang Ho Ahn, Hyeong Won Yu, June Young Choi, Ho-Young Lee, Won Woo Lee, Jae Hoon Moon
Endocrinol Metab. 2021;36(5):1121-1130.   Published online October 21, 2021
DOI: https://doi.org/10.3803/EnM.2021.1216
  • 12,129 View
  • 206 Download
  • 8 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Heart rate (HR) monitored by a wearable device (WD) has demonstrated its clinical feasibility for thyrotoxicosis subjects. However, the association of HR monitored by wearables with hypothyroidism has not been examined. We assessed the association between serum thyroid hormone concentration and three WD-HR parameters in hypothyroid subjects.
Methods
Forty-four subjects scheduled for radioactive iodine therapy (RAI Tx) after thyroid cancer surgery were included. Thirty subjects were prepared for RAI Tx by thyroid hormone withdrawal (hypothyroidism group) and 14 subjects by recombinant human thyrotropin (control group). Three WD-HR parameters were calculated from the HR data collected during rest, during sleep, and from 2:00 AM to 6:00 AM, respectively. We analyzed the changes in conventionally measured resting HR (On-site rHR) and WDHR parameters relative to thyroid hormone levels.
Results
Serum free thyroxine (T4) levels, On-site rHR, and WD-HR parameters were lower in the hypothyroid group than in the control group at the time of RAI Tx. WD-HR parameters also reflected minute changes in free T4 levels. A decrease in On-site rHR and WD-HR parameters by one standard deviation (On-site rHR, approximately 12 bpm; WD-HR parameters, approximately 8 bpm) was associated with a 0.2 ng/dL decrease in free T4 levels (P<0.01) and a 2-fold increase of the odds ratio of hypothyroidism (P<0.01). WD-HR parameters displayed a better goodness-of-fit measure (lower quasi-information criterion value) than On-site rHR in predicting the hypothyroidism.
Conclusion
This study identified WD-HR parameters as informative and easy-to-measure biomarkers to predict hypothyroidism.

Citations

Citations to this article as recorded by  
  • Cost-effectiveness Analysis Comparing Conventional and Digital Software Supported Management for Hypothyroidism
    Jung Hyun Kim, Jaeyong Shin, Man S Kim, Jae Hoon Moon
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(6): 1596.     CrossRef
  • An explainable non-invasive hybrid machine learning framework for accurate prediction of thyroid-stimulating hormone levels
    Areej Mohammed, Hussam Alshraideh, Munir Abu-Helalah, Abdulrahim Shamayleh
    Computers in Biology and Medicine.2025; 189: 109974.     CrossRef
  • Application progress of artificial intelligence in managing thyroid disease
    Qing Lu, Yu Wu, Jing Chang, Li Zhang, Qing Lv, Hui Sun
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
    Jung Hyun Kim, Jaeyong Shin, Man S Kim, Jae Hoon Moon
    JMIR mHealth and uHealth.2025; 13: e56738.     CrossRef
  • Application of wearables for remote monitoring of oncology patients: A scoping review
    Katharina Cloß, Marlo Verket, Dirk Müller-Wieland, Nikolaus Marx, Katharina Schuett, Edgar Jost, Martina Crysandt, Fabian Beier, Tim H Brümmendorf, Guido Kobbe, Julia Brandts, Malte Jacobsen
    DIGITAL HEALTH.2024;[Epub]     CrossRef
  • Association between resting heart rate and low natural killer cell activity: a cross-sectional study
    Hyoju Oh, A-Ra Cho, Joo-Hwan Jeon, Eunkyung Suh, Junhyung Moon, Baek Hwan Cho, Yun-Kyong Lee
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Thyroid hormone action during GABAergic neuron maturation: The quest for mechanisms
    Sabine Richard, Juan Ren, Frédéric Flamant
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • A machine learning-assisted system to predict thyrotoxicosis using patients’ heart rate monitoring data: a retrospective cohort study
    Kyubo Shin, Jongchan Kim, Jaemin Park, Tae Jung Oh, Sung Hye Kong, Chang Ho Ahn, Joon Ho Moon, Min Joo Kim, Jae Hoon Moon
    Scientific Reports.2023;[Epub]     CrossRef
Close layer
Thyroid
The Positive Association between Subclinical Hypothyroidism and Newly-Diagnosed Hypertension Is More Explicit in Female Individuals Younger than 65
Xichang Wang, Haoyu Wang, Li Yan, Lihui Yang, Yuanming Xue, Jing Yang, Yongli Yao, Xulei Tang, Nanwei Tong, Guixia Wang, Jinan Zhang, Youmin Wang, Jianming Ba, Bing Chen, Jianling Du, Lanjie He, Xiaoyang Lai, Yanbo Li, Zhaoli Yan, Eryuan Liao, Chao Liu, Libin Liu, Guijun Qin, Yingfen Qin, Huibiao Quan, Bingyin Shi, Hui Sun, Zhen Ye, Qiao Zhang, Lihui Zhang, Jun Zhu, Mei Zhu, Yongze Li, Weiping Teng, Zhongyan Shan
Endocrinol Metab. 2021;36(4):778-789.   Published online August 10, 2021
DOI: https://doi.org/10.3803/EnM.2021.1101
  • 11,622 View
  • 178 Download
  • 5 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Subclinical hypothyroidism (SCH) is the most common thyroid dysfunction, and its relationship with blood pressure (BP) has been controversial. The aim of the study was to analyze the association between SCH and newly-diagnosed hypertension.
Methods
Based on data from the Thyroid disease, Iodine nutrition and Diabetes Epidemiology (TIDE) study, 49,433 euthyroid individuals and 7,719 SCH patients aged ≥18 years were enrolled. Patients with a history of hypertension or thyroid disease were excluded. SCH was determined by manufacturer reference range. Overall hypertension and stage 1 and 2 hypertension were diagnosed according to the guidelines issued by the American College of Cardiology/American Heart Association in 2017.
Results
The prevalence of overall hypertension (48.7%), including stage 1 (28.9%) and 2 (19.8%) hypertension, increased significantly in SCH patients compared with euthyroid subjects. With elevated serum thyroid stimulating hormone (TSH) level, the hypertension prevalence also increased significantly from the euthyroid to different SCH subgroups, which was more profound in females or subjects aged <65 years. The age- and sex-specific regression analysis further demonstrated the same trends in the general population and in the 1:1 propensity matched population. Similarly, several BP components (i.e., systolic, diastolic, and mean arterial BP) were positively associated with TSH elevation, and regression analysis also confirmed that all BP components were closely related with SCH in female subjects aged <65 years.
Conclusion
The prevalence of hypertension increases for patients with SCH. SCH tends to be associated with hypertension and BP components in females younger than 65 years.

Citations

Citations to this article as recorded by  
  • Prevalence of thyroid disorders in patients with diabetes and hypertension in India: A systematic review and meta-analysis
    Bhavya Sharma, Vaibhav Chaudhary, Sweta Kumari, Biplab Pal
    Obesity Medicine.2025; 55: 100609.     CrossRef
  • Magnitude and Predictors of Subclinical Hypothyroidism in Individuals With Impaired Glucose Tolerance
    Tejaswita Chourey, Yasmee Khan, Abhijit P Pakhare, Abhishek Singhai, Rachna Parashar, Rajnish Joshi, Mahadev Meena
    Cureus.2025;[Epub]     CrossRef
  • Subclinical hypothyroidism and cardiovascular diseases: Pathogenetic mechanisms and clinical implications
    A. R. Volkova, Yu. Sh. Khalimov, O. D. Dygun, B. G. Lukichev, E. V. Volkova
    Meditsinskiy sovet = Medical Council.2025; (5): 107.     CrossRef
  • Outcomes in Hospitalized Patients With Subclinical Hypothyroidism
    Mayesha Sharaf, Pinak Shah, Andrey Manov, Kartika Shetty, Rakahn Haddadin
    Cureus.2025;[Epub]     CrossRef
  • Physiological Effect of Hypothyroidism on Blood Pressure in Women
    Dalal F. Al-Akabi
    European Journal of Medical and Health Research.2025; 3(5): 188.     CrossRef
  • Systematic review and meta-analysis of levothyroxine effect on blood pressure in patients with subclinical hypothyroidism
    Bahar Darouei, Reza Amani-Beni, Amir Parsa Abhari, Mohammad Fakhrolmobasheri, Davood Shafie, Maryam Heidarpour
    Current Problems in Cardiology.2024; 49(2): 102204.     CrossRef
  • Lipid Profile Pitfalls in Subclinical Hypothyroidism Pathophysiology and Treatment
    Marina Nicolaou, Meropi Toumba
    Lipidology.2024; 1(2): 105.     CrossRef
  • Physical activity affects dysthyreosis by thyroid hormones sensitivity: a population-based study
    Shu-yang Zhang, Xue-qing Hu, Cheng Xiang, Tao Xiang, Song-xue Guo, Fei-hu Zhi, Ping Zhao, Jia-yan Zhu, Chen-yang Zhang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Causal relationship between hypothyroidism and peripheral neuropathy: a Mendelian randomization study of European ancestry
    Xiping Duan, Tianchi Zhang, Ke Wang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Subclinical hypothyroidism and type 2 diabetes mellitus: An update
    Shailendra Kumar Singh, Rina Singh, Sonam Bedi, Arun Kumar Pandey, Alankar Tiwari, Pradeep Kumar Rai
    Thyroid Research and Practice.2024; 20(3): 89.     CrossRef
  • Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study from China
    Fan Zhang, Di Teng, Nanwei Tong, Guixia Wang, Yongze Li, Xiaohui Yu, Zhongyan Shan, Weiping Teng
    Thyroid.2022; 32(5): 571.     CrossRef
  • Effect of Levothyroxine Supplementation on the Cardiac Morphology and Function in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis
    Xichang Wang, Haoyu Wang, Qiuxian Li, Ping Wang, Yumin Xing, Fan Zhang, Jiashu Li, Zhongyan Shan
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(9): 2674.     CrossRef
Close layer
Review Articles
Thyroid
Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape
Won Sang Yoo, Hyun Kyung Chung
Endocrinol Metab. 2021;36(3):500-513.   Published online June 18, 2021
DOI: https://doi.org/10.3803/EnM.2021.1066
  • 31,502 View
  • 900 Download
  • 33 Web of Science
  • 40 Crossref
AbstractAbstract PDFPubReader   ePub   
Subclinical hypothyroidism (sHypo) is defined as normal serum free thyroid hormone levels coexisting with elevated serum thyroid-stimulating hormone (TSH) levels. sHypo is a common condition observed in clinical practice with several unique features. Its diagnosis should be based on an understanding of geographic and demographic differences in biochemical criteria versus a global reference range for TSH that is based on the 95% confidence interval of a healthy population. During the differential diagnosis, it is important to remember that a considerable proportion of sHypo cases are transient and reversible in nature; the focus is better placed on persistent or progressive forms, which mainly result from chronic autoimmune thyroiditis. Despite significant evidence documenting the health impacts of sHypo, the effects of levothyroxine treatment (LT4-Tx) in patients with sHypo remains controversial, especially in patients with grade 1 sHypo and older adults. Existing evidence suggests that it is reasonable to refrain from immediate LT4-Tx in most patients if they are closely monitored, except in women who are pregnant or in progressive cases. Future research is needed to further characterize the risks and benefits of LT4-Tx in different patient cohorts.

Citations

Citations to this article as recorded by  
  • Subclinical hypothyroidism and its clinical relevance in routine practice
    Samar Abed Alharbi, Wisam Abdallah Hassan, Abdulillah Mohammed Al Rashoud, Sakinah Ibrahim Alkhudhair, Omar Jasem Altawash, Faisal Adel Shukr, Ajeed Mohammed Al Rashoud, Rida Saleem, Saleh Ali Alharthi, Abdulrahman Mohammed Mahzara, Tammam Abdulsalam Alma
    International Journal Of Community Medicine And Public Health.2026;[Epub]     CrossRef
  • Efficacy of Jadwar (Delphinium denudatum Wall. ex Hook.f. & Thomson) in subclinical hypothyroid patients: A single-blind, randomized placebo controlled trial
    Saduddin, Mohd Aleemuddin Quamri, Monalisha Samal, Md Anzar Alam
    Phytomedicine.2026; 153: 157925.     CrossRef
  • Decreased vitamin D increase the risk for subclinical hypothyroidism in individuals with T2DM: a cross-sectional study
    Yaling Fang, Xin Wen, Hui You, Yueye Huang, Shen Qu, Xingchun Wang, Le Bu
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Modern therapeutic approaches for hepatic tumors: progress, limitations, and future directions
    Shayan Sadrinasab, Sadaf Saket, Nadia Pourmohammadi, Fatemeh Khosravi, Masoud Saadat Fakhr
    Discover Oncology.2025;[Epub]     CrossRef
  • Subclinical Hypothyroidism in Polycystic Ovary Syndrome: Prevalence and Impact on Metabolic and Cardiovascular risk
    Taieb Ach, Rim Dhaffar, Fatma Ben Abdessalem, Wiem Saafi, Imen Halloul, Hamza ElFekih, Ghada Saad, Yosra Hasni
    Clinical Medicine Insights: Endocrinology and Diabetes.2025;[Epub]     CrossRef
  • Prevalence and Risk Factors of Subclinical and Overt Hypothyroidism in Saudi Arabia: A Systematic Review
    Ali Hadi M Alhajri, Anoud Mubarak Saad Saleh Al Saad, Hoda Idrees, Osama Mohamed Hamednalla Mohamed, Mona Mohammednoor, Ibrahim Obied Ibrahim Ahmed, Fatima Suliman Dawod Faky
    Cureus.2025;[Epub]     CrossRef
  • Hypothyroidism: from diagnosis to therapy success. A review
    Elena V. Biryukova, Arina D. Abramova
    Consilium Medicum.2025; 27(4): 210.     CrossRef
  • Screening and Management of Subclinical Hypothyroidism in Pregnancy: A Nationwide Survey of Physicians in Saudi Arabia
    Raghad Alhejaili, Elsir Mohammed, Beenish Maqsood, Deema Almuhaimel
    Cureus.2025;[Epub]     CrossRef
  • Incidence and Progression of Mental Health Alterations among Middle-Aged Females with Hypothyroidism
    Rabia Aziz, Firdaus Jawed, Sohrab Ahmad Khan
    Journal of Comprehensive Health.2025; 13: 168.     CrossRef
  • Thyroid peroxidase gene variants and autoimmunity in subclinical hypothyroidism: molecular mechanisms and clinical implications
    Larsa Naji Adam, Awat Mustafa Abbas
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Early detection of G2SCH through machine learning analysis of physical examination metrics
    Xiying Huang, Ruizi Lin, Yixin Xiao, Zihan Ma, Hongxia Xu, Yulian Wu, Xiawei Li
    npj Digital Medicine.2025;[Epub]     CrossRef
  • The problem of hypothyroidism today: Current challenges and solutions
    E. V. Biryukova, N. M. Platonova, M. V. Shinkin
    FOCUS. Endocrinology.2025; 6(3): 59.     CrossRef
  • Association between Thyroid-Stimulating Hormone and Tooth Loss Risk in Community-Dwelling Older Adults in Taipei City: A Prospective Cohort Study
    Yi-Chao Zhou, Yi-Chang Chou, Yin-Ling Hung, Yen-Jung Chang
    Gerontology.2025; : 1.     CrossRef
  • THYROID FUNCTION ABNORMALITIES IN PATIENTS WITH CHOLELITHIASIS: A HOSPITAL-BASED CROSS-SECTIONAL STUDY
    AVANISH KUMAR SAXENA, ANAM FATIMA, KUNDRAPU VEERA VENKATA SIVA, ANUSHKA PARIYA, VAYALAPALLI SYAMA CHINMAYI
    Asian Journal of Pharmaceutical and Clinical Research.2024; : 138.     CrossRef
  • Subclinical hypothyroidism and clinical outcomes after cardiac surgery: A systematic review and meta-analysis
    Michele Dell’Aquila, Camilla S. Rossi, Tulio Caldonazo, Gianmarco Cancelli, Lamia Harik, Giovanni J. Soletti, Kevin R. An, Jordan Leith, Hristo Kirov, Mudathir Ibrahim, Michelle Demetres, Arnaldo Dimagli, Mohamed Rahouma, Mario Gaudino
    JTCVS Open.2024; 18: 64.     CrossRef
  • The Relationship between Subclinical Hypothyroidism and Carotid Intima-Media Thickness as a Potential Marker of Cardiovascular Risk: A Systematic Review and a Meta-Analysis
    Oana-Maria Isailă, Victor Eduard Stoian, Iuliu Fulga, Alin-Ionut Piraianu, Sorin Hostiuc
    Journal of Cardiovascular Development and Disease.2024; 11(4): 98.     CrossRef
  • Variability of Thyroid Hormones in Newborns from Mothers with Endemic Goiter
    Turdieva Shokhida Tolkunovna, Ganieva Durdona Kamalovna
    Journal of Nature and Science of Medicine.2024; 7(2): 129.     CrossRef
  • Thyroid dysfunction in the ageing patient
    O.V. Bilookyi, V.L. Vasiuk, O.A. Shupik
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(2): 143.     CrossRef
  • Hormonal influences on cerebral aneurysms: unraveling the complex connections
    Zahra Hasanpour Segherlou, Mahdieh Shakeri-Darzekonani, Armin Khavandegar, Sara Stephenson, Kimberly Ciccone, Forough Masheghati, Mohammad Reza Hosseini Siyanaki, Mac Lyerly, Brandon Lucke-Wold
    Expert Review of Endocrinology & Metabolism.2024; 19(3): 207.     CrossRef
  • Causal validation of the relationship between 35 blood and urine biomarkers and hyperthyroidism: a bidirectional Mendelian randomization study and meta-analysis
    Wanxian Xu, Jiao Wu, Daolei Chen, Rui Zhang, Yue Yang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care
    Nanny Natalia Mulyani Soetedjo, Dessy Agustini, Hikmat Permana
    IJC Heart & Vasculature.2024; 55: 101536.     CrossRef
  • Correlation of Hypothyroidism with Age and Comorbidities Among Women: A Cross-Sectional Study
    Mufida Begum Ifthikhar, Kumudha Dhamotharaswamy
    Journal of Pharmacology and Pharmacotherapeutics.2024; 15(3): 336.     CrossRef
  • EPIDEMIOLOGICAL CHARACTERISTICS OF SUBCLINICAL HYPOTHYROIDISM
    Nigina Inoyatova, Makhina Pirmatova, Shakhnoza Samieva
    AVICENNA BULLETIN.2024; 26(4): 608.     CrossRef
  • Hipotiroidismo subclínico como principal trastorno de la función tiroidea en pacientes ambulatorios atendidos en un laboratorio de primer nivel, Riobamba - Ecuador
    Grace Emperatriz Urgilés Ibarra, Vinicio Estuardo Santillán Rodríguez
    Anatomía Digital.2024; 7(3.2): 142.     CrossRef
  • Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature
    Bogumila Urgatz, Salman Razvi
    Current Medical Research and Opinion.2023; 39(3): 351.     CrossRef
  • Indicator of thyroid hormones in newborns from mothers with diffuse-endemic goiter
    G. T. Makhkamova, Sh. T. Turdieva
    Meditsinskiy sovet = Medical Council.2023; (1): 212.     CrossRef
  • Diagnóstico y tratamiento del hipotiroidismo subclínico en adultos mayores
    Debbie Noelia Tebanta Albán, Gabriel Aníbal Hugo Merino, María Valentina Muñoz Arteaga, Ariana Lisseth Vázquez López
    Ciencia Digital.2023; 7(1): 6.     CrossRef
  • 2023 Korean Thyroid Association Management Guidelines for Patients with Subclinical Hypothyroidism
    Hyun Kyung Chung, Eu Jeong Ku, Won Sang Yoo, Yea Eun Kang, Kyeong Jin Kim, Bo Hyun Kim, Tae-Yong Kim, Young Joo Park, Chang Ho Ahn, Jee Hee Yoon, Eun Kyung Lee, Jong Min Lee, Eui Dal Jung, Jae Hoon Chung, Yun Jae Chung, Won Bae Kim, Ka Hee Yi, Ho-Cheol Ka
    International Journal of Thyroidology.2023; 16(1): 32.     CrossRef
  • Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases
    María José Mendoza-León, Ashutosh K. Mangalam, Alejandro Regaldiz, Enrique González-Madrid, Ma. Andreina Rangel-Ramírez, Oscar Álvarez-Mardonez, Omar P. Vallejos, Constanza Méndez, Susan M. Bueno, Felipe Melo-González, Yorley Duarte, Ma. Cecilia Opazo, Al
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Human amnion-derived mesenchymal stem cells improve subclinical hypothyroidism by immunocompetence mediating apoptosis inhibition on thyroid cells in aged mice
    Chuyu Li, Qiang Rui, Xiaohan Dong, Song Ning, Jing Zhou, Huimin Wu, Chunyan Jiang, Yugui Cui, Jiayin Liu, Jun Jiang, Lianju Qin
    Cell and Tissue Research.2023; 394(2): 309.     CrossRef
  • Is Thyroid Dysfunction Associated with Unruptured Intracranial Aneurysms? A Population-Based, Nested Case–Control Study from Korea
    Hyeree Park, Sun Wook Cho, Sung Ho Lee, Kangmin Kim, Hyun-Seung Kang, Jeong Eun Kim, Aesun Shin, Won-Sang Cho
    Thyroid®.2023; 33(12): 1483.     CrossRef
  • The Role of Global Longitudinal Strain in Subclinical Hypothyroid Patients With Heart Failure
    Nismat Javed, Vibha Hayagreev, Angel DeLaCruz, Muhammad Saad, Amandeep Singh, Timothy Vittorio
    Cureus.2023;[Epub]     CrossRef
  • Association between shift work and the risk of hypothyroidism in adult male workers in Korea: a cohort study
    Seonghyeon Kwon, Yesung Lee, Eunhye Seo, Daehoon Kim, Jaehong Lee, Youshik Jeong, Jihoon Kim, Jinsook Jeong, Woncheol Lee
    Annals of Occupational and Environmental Medicine.2023;[Epub]     CrossRef
  • Estimation of left ventricular functions in patients with subclinical hypothyroidism: a meta-analysis
    Binyi Li, Yong Huang, Zheng Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Comparison of Five Different Criteria for Diagnosis of Subclinical Hypothyroidism in a Large-Scale Chinese Population
    Yan-song Zheng, Sheng-yong Dong, Yan Gong, Jia-hong Wang, Fei Wang, Qiang Zeng
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Subclinical Hypothyroidism and Cognitive Impairment
    Jung-Min Pyun, Young Ho Park, SangYun Kim
    Journal of Alzheimer's Disease.2022; 88(2): 757.     CrossRef
  • Effect of Levothyroxine Supplementation on the Cardiac Morphology and Function in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis
    Xichang Wang, Haoyu Wang, Qiuxian Li, Ping Wang, Yumin Xing, Fan Zhang, Jiashu Li, Zhongyan Shan
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(9): 2674.     CrossRef
  • Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS)
    A. Amouzegar, M. Dehghani, H. Abdi, L. Mehran, S. Masoumi, F. Azizi
    Journal of Endocrinological Investigation.2022; 45(12): 2353.     CrossRef
  • Retrospective cohort analysis comparing changes in blood glucose level and body composition according to changes in thyroid‐stimulating hormone level
    Hyunah Kim, Da Young Jung, Seung‐Hwan Lee, Jae‐Hyoung Cho, Hyeon Woo Yim, Hun‐Sung Kim
    Journal of Diabetes.2022; 14(9): 620.     CrossRef
  • Long working hours and the risk of hypothyroidism in healthy Korean workers: a cohort study
    Yesung Lee, Woncheol Lee, Hyoung-Ryoul Kim
    Epidemiology and Health.2022; 44: e2022104.     CrossRef
Close layer
Miscellaneous
Clinical Characteristics, Management, and Potential Biomarkers of Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors
Shintaro Iwama, Tomoko Kobayashi, Hiroshi Arima
Endocrinol Metab. 2021;36(2):312-321.   Published online April 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.1007
  • 10,678 View
  • 325 Download
  • 28 Web of Science
  • 27 Crossref
AbstractAbstract PDFPubReader   ePub   
Immune-related adverse events (irAEs) affecting the endocrine glands are among the most frequent irAEs induced by immune checkpoint inhibitors (ICIs) and include hypopituitarism, primary adrenal insufficiency, thyrotoxicosis, hypothyroidism, hypoparathyroidism, and type 1 diabetes mellitus. Since the incidence and clinical features of endocrine irAEs vary according to the ICI used, it is important to understand the characteristics of these irAEs and to manage each one appropriately. Since some endocrine irAEs, including adrenal crisis and diabetic ketoacidosis, are potentially life-threatening, predicting the risk of endocrine irAEs before their onset is critical. Several autoantibodies have been detected in patients who develop endocrine irAEs, among which anti-thyroid antibodies may be predictive biomarkers of thyroid dysfunction. In this review, we describe the clinical features of each endocrine irAE induced by ICIs and discuss their potential biomarkers, including autoantibodies.

Citations

Citations to this article as recorded by  
  • Blood glucose variability in early-onset adrenocorticotropic hormone deficiency induced by immune checkpoint inhibitor therapy with continuous blood glucose monitoring: a case report
    Yuta Nanao, Gentaro Egusa, Ryuta Baba, Takaya Kodama, Tsuguka Matsuda, Gaku Nagano, Haruya Ohno
    Diabetology International.2026;[Epub]     CrossRef
  • Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
    Shintaro Iwama, Tomoko Kobayashi, Hiroshi Arima
    Nature Reviews Endocrinology.2025; 21(5): 289.     CrossRef
  • Thyroid Dysfunction After Intensity-Modulated Radiotherapy and PD⁃1 Inhibitor Treatment for Locally Advanced Nasopharyngeal Carcinoma
    Kai Shang, Qianyong He, Xinyu Xu, Xunyan Luo, Chaofen Zhao, Lina Liu, Zhuoling Li, Yuanyuan Li, Feng Jin
    Therapeutics and Clinical Risk Management.2025; Volume 21: 15.     CrossRef
  • Subacute thyroiditis during anti-programmed cell death protein 1 antibody therapy: A case report
    Makiko Ikemoto, Yasufumi Seki, Daisuke Watanabe, Toshio Takagi, Atsuhiro Ichihara
    Thyroid Science.2025; 2(2): 100024.     CrossRef
  • Combined PD-1 and CTLA-4 Blockade Increases the Risks of Multiple Pituitary Hormone Deficiency and Isolated Adrenocorticotropic Deficiency: A Prospective Study
    Shintaro Iwama, Tomoko Kobayashi, Tetsushi Izuchi, Koji Suzuki, Takanori Murase, Masahiko Ando, Tomoko Handa, Takeshi Onoue, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Tetsunari Hase, Shoichiro Mori, Tomoyasu Sano, Sh
    Endocrinology and Metabolism.2025; 40(3): 459.     CrossRef
  • Clinical characteristics and immunotherapy efficacy in advanced lung cancer patients with immune checkpoint inhibitor-related adrenal insufficiency
    Lu Xu, Xinjie Zhang, Wang Yao, Vincent Kam Wai Wong
    Medicine.2025; 104(34): e43983.     CrossRef
  • Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors
    Ling Zhu, Yee-Ming M Cheung, Cherie Chiang, Emily J Gallagher, Ole-Petter R Hamnvik, Jennifer Mammen, Zoe Quandt, Renisha Jones, Jon McDunn, Huda Al-Bahadili, Trevor Angell, Irina Bancos, Allison Betof Warner, Susan Blackwell, Cassandra Calabrese, Tracey
    Journal for ImmunoTherapy of Cancer.2025; 13(10): e011865.     CrossRef
  • Increased risk of hyperthyroidism induced by immune checkpoint inhibitors in patients with existing or prior Graves’ disease: a nested prospective cohort study with propensity score matching
    Koji Suzuki, Tomoko Kobayashi, Tetsushi Izuchi, Takanori Murase, Masahiko Ando, Tomoko Handa, Takeshi Onoue, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Hiroshi Arima, Shintaro Iwama
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events
    Tomoko Kobayashi, Shintaro Iwama, Hiroshi Arima
    Endocrine Journal.2024; 71(1): 23.     CrossRef
  • A case of rapidly progressive insulin-dependent diabetes mellitus without islet autoantibodies developed over two years after the first dose of nivolumab
    Kota Nishihama, Yuko Okano, Chisa Inoue, Kanako Maki, Kazuhito Eguchi, Soichiro Tanaka, Atsuro Takeshita, Mei Uemura, Taro Yasuma, Toshinari Suzuki, Esteban C. Gabazza, Yutaka Yano
    Diabetology International.2024; 15(3): 583.     CrossRef
  • Endocrinopathies Associated With Immune Checkpoint Inhibitor Use
    Anupam Kotwal, Randol Kennedy, Nupur Kikani, Sonali Thosani, Whitney Goldner, Afreen Shariff
    Endocrine Practice.2024; 30(6): 584.     CrossRef
  • Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study
    Tomoko Kobayashi, Shintaro Iwama, Ayana Yamagami, Tetsushi Izuchi, Koji Suzuki, Koki Otake, Yoshinori Yasuda, Masahiko Ando, Takeshi Onoue, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Tetsunari Hase, Naoki Nishio, Shoi
    Cancer Immunology, Immunotherapy.2024;[Epub]     CrossRef
  • Adrenal Insufficiency and Thyrotoxicosis Following Combined Immune Checkpoint Inhibitor Use: A Case Report and Literature Review
    Kaoruko Fukushima, Saori Kitayama, Manami Sazuka, Remi Kodera, Kazuhito Oba, Kenji Toyoshima, Yuko Chiba, Hiroshi Yamamoto, Atsushi Araki, Yoshiaki Tamura
    Cureus.2024;[Epub]     CrossRef
  • Changes in TgAb and TPOAb titers are greater in thyrotoxicosis than isolated hypothyroidism induced by PD-1 blockade
    Ayana Yamagami, Shintaro Iwama, Tomoko Kobayashi, Xin Zhou, Yoshinori Yasuda, Takayuki Okuji, Masaaki Ito, Tetsushi Izuchi, Masahiko Ando, Takeshi Onoue, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Hiroshi Arima
    Endocrine Journal.2024; 71(5): 515.     CrossRef
  • Single-cell RNA sequencing analysis of peripheral blood mononuclear cells in PD-1-induced renal toxicity in patients with lung cancer
    Shusu Liu, Peiyu Lu, Bixia Yang, Yan Yang, Hua Zhou, Min Yang
    BMC Nephrology.2024;[Epub]     CrossRef
  • Development of pituitary dysfunction and destructive thyroiditis is associated with better survival in non-small cell lung cancer patients treated with programmed cell death-1 inhibitors: a prospective study with immortal time bias correction
    Koji Suzuki, Tomoko Kobayashi, Tetsushi Izuchi, Koki Otake, Masahiko Ando, Tomoko Handa, Takashi Miyata, Mariko Sugiyama, Takeshi Onoue, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Tetsunari Hase, Megumi Inoue, Makoto Ishii, Hiroshi Arima, Shintaro Iw
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Recovery from insulin dependence in immune checkpoint inhibitor‐associated diabetes mellitus: A case report
    Marie Okubo, Yuji Hataya, Kanta Fujimoto, Toshio Iwakura, Naoki Matsuoka
    Journal of Diabetes Investigation.2023; 14(1): 147.     CrossRef
  • Case Report: A Rising Cause of New-Onset Endocrinopathies After Immunotherapy
    Charity Tan, Sarah Hendricks, Kristina Hernandez, Martha Benavides, Rupinderjit Samra
    The Journal for Nurse Practitioners.2023; 19(5): 104582.     CrossRef
  • Risk of Thyroid Dysfunction in PD-1 Blockade Is Stratified by the Pattern of TgAb and TPOAb Positivity at Baseline
    Xin Zhou, Shintaro Iwama, Tomoko Kobayashi, Masahiko Ando, Hiroshi Arima
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(10): e1056.     CrossRef
  • Severe thyrotoxicosis induced by tislelizumab: a case report and literature review
    Liman Huo, Chao Wang, Haixia Ding, Xuelian Shi, Bin Shan, Ruoying Zhou, Ping Liang, Juan Hou
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Life-Threatening Endocrinological Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy
    Aleksandra Basek, Grzegorz K. Jakubiak, Grzegorz Cieślar, Agata Stanek
    Cancers.2023; 15(24): 5786.     CrossRef
  • Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at Baseline
    Shintaro Iwama, Tomoko Kobayashi, Yoshinori Yasuda, Takayuki Okuji, Masaaki Ito, Masahiko Ando, Xin Zhou, Ayana Yamagami, Takeshi Onoue, Yohei Kawaguchi, Takashi Miyata, Mariko Sugiyama, Hiroshi Takagi, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Tets
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(4): e1620.     CrossRef
  • Biomarkers and risk factors for the early prediction of immune-related adverse events: a review
    Ying Zhang, Xiaoling Zhang, Weiling Li, Yunyi Du, Wenqing Hu, Jun Zhao
    Human Vaccines & Immunotherapeutics.2022;[Epub]     CrossRef
  • Immune Checkpoint Inhibitors as a Threat to the Hypothalamus–Pituitary Axis: A Completed Puzzle
    Agnese Barnabei, Andrea Corsello, Rosa Maria Paragliola, Giovanni Maria Iannantuono, Luca Falzone, Salvatore Maria Corsello, Francesco Torino
    Cancers.2022; 14(4): 1057.     CrossRef
  • Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade
    Tomoko Kobayashi, Shintaro Iwama, Ayana Yamagami, Yoshinori Yasuda, Takayuki Okuji, Masaaki Ito, Xin Zhou, Masahiko Ando, Takeshi Onoue, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Tetsunari Hase, Masahiro Morise, Taka
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(10): e4115.     CrossRef
  • Preconditioning of the immune system modulates the response of papillary thyroid cancer to immune checkpoint inhibitors
    Fabiana Pani, Yoshinori Yasuda, Sylvie T Rousseau, Kevin C Bermea, Solmaz Roshanmehr, Rulin Wang, Srinivasan Yegnasubramanian, Patrizio Caturegli, Luigi Adamo
    Journal for ImmunoTherapy of Cancer.2022; 10(12): e005538.     CrossRef
  • Survival benefit of endocrine dysfunction following immune checkpoint inhibitors for nonthyroidal cancers
    Anupam Kotwal, Mabel Ryder
    Current Opinion in Endocrinology, Diabetes & Obesity.2021; 28(5): 517.     CrossRef
Close layer
Original Articles
Clinical Study
Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
Jee Hee Yoon, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Endocrinol Metab. 2021;36(2):413-423.   Published online April 6, 2021
DOI: https://doi.org/10.3803/EnM.2020.906
  • 11,394 View
  • 277 Download
  • 41 Web of Science
  • 39 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Thyroid immune-related adverse events (IRAEs) have been reported in patients treated with programmed cell death protein-1 (PD-1) and programmed cell death protein-ligand 1 (PD-L1) inhibitors. We investigated the incidence and clinical course of PD-1/PD-L1 inhibitor-induced thyroid IRAEs, and identified predictable clinical risk factors of thyroid IRAEs, in particular, overt hypothyroidism (OH).
Methods
We retrospectively reviewed the medical records of 325 cancer patients receiving PD-1/PD-L1 inhibitor in a tertiary referral center.
Results
A total of 50.5% (164/325) of patients experienced at least one abnormal thyroid function following PD-1/PD-L1 inhibitor. Eighty-four patients (51.2%) of them recovered to normal thyroid function during follow-up. In overall population, 25 patients (7.7%) required thyroid hormone replacement therapy due to PD-1/PD-L1 inhibitor-induced OH. Patients who progressed to OH showed significantly higher baseline thyroid stimulating hormone level and longer duration of PD-1/PD-L1 inhibitor therapy than those without thyroid dysfunction or OH (both P<0.001). Median time interval to the development of OH was 3 months after the therapy. OH was significantly associated with positive anti-thyroid peroxidase antibody at baseline and anti-thyroglobulin antibody during the therapy than those without thyroid dysfunction or OH (P=0.015 and P=0.005, respectively). We observed no patients with OH who were able to stop levothyroxine replacement after the cessation of PD-1/PD-L1 inhibitor therapy.
Conclusion
PD-1/PD-L1 inhibitor-induced thyroid dysfunctions are considerably reversible; however, OH is irreversible requiring levothyroxine replacement even after stopping the therapy. Positive thyroid autoantibodies may predict the progression to OH.

Citations

Citations to this article as recorded by  
  • Perioperative preparation for head and neck cancer patients receiving immunotherapy
    Shao-Chun Wu, Kuan-Hao Liao, Pi-Chieh Lin, Ching-Hua Hsieh
    Asian Journal of Surgery.2026; 49(2): 652.     CrossRef
  • Risk factors of immune-related endocrine toxicities in non-small cell lung cancer patients treated with pembrolizumab and its impact on patient outcomes: a multicenter retrospective study
    Haoting Zhang, Jing Zheng, Chenyi Ren, Chenlin Ye, Xiaoyu Wu, Xiaodong Lv, Yuping Li, Jianya Zhou, Jianying Zhou
    BMC Pulmonary Medicine.2025;[Epub]     CrossRef
  • Thyroid dysfunction as a predictor of PD- 1/PD-L1 inhibitor efficacy in advanced lung cancer
    Yanling Wang, Xiaoping Ma, Jia Ma, Jing Li, Zhiyi Lin, Wei Gao, Ping Gong, Ping Dai
    BMC Cancer.2025;[Epub]     CrossRef
  • Pembrolizumab-Induced Thyroid Storm in a Patient With Triple-Negative Breast Cancer
    Sobrina S. Mohammed, Eun Young Park, Reda Asad, Shourya Tadisina
    AACE Endocrinology and Diabetes.2025; 12(2): 107.     CrossRef
  • Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-related Hypothyroidism: A Retrospective Study
    Ya Gao, Chunxia Du, Yan Xu, Xinqi Cheng, Haitao Zhao, Fang Jiang, Ninghai Cheng, Yang Xiang, Yuelun Zhang, Yuanmeng Li, He Liu, Xiaofeng Chai, Xiaolan Lian, Weigang Zhao, Naishi Li
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(12): 3342.     CrossRef
  • Complete remission in PD-L1 high expression advanced gastric cancer patient with PD-L1 immunotherapy and chemotherapy integration treatment strategy: a case report
    Xiaopeng Yu, Wenwen Zhao, Qingqing Feng, Jin Tian, Lili Zhao, Jun Xiao, Hongmei Wei
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Changes in thyroid hormone levels indicate immunotherapy efficacy in gastric cancer
    Min Xiao, Lan Qian, Qiu Zhao, Jian Ma, Qianxiao Li, Qian Liu, Zhiyan Bi
    Oncology Letters.2025; 30(1): 1.     CrossRef
  • Development and validation of a nomogram for predicting immune-related thyroid dysfunction during immunotherapy in non-small cell lung cancer: a prospective cohort study in China
    Qianjie Xu, Yuliang Yuan, Xiaosheng Li, Lulu Wang, Wei Zhou, Zuhai Hu, Haike Lei, Yongzhong Wu
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Incidence of thyroid adverse events following immune checkpoint inhibitor treatment in patients with baseline positive thyroid antibodies: a systematic review and meta-analysis
    Hui Yu, Qichao Chen, Wenbing Hu, Yuanhao Chen, Hui Ming
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitors
    Nicola Marrano, Mariangela Caporusso, Carlo Ganini, Andrea Borraccino, Angelo Cignarelli, Sebastio Perrini, Luigi Laviola, Camillo Porta, Francesco Giorgino, Annalisa Natalicchio
    Journal of Endocrinological Investigation.2025;[Epub]     CrossRef
  • Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma
    Young Shin Song, Hannah Yang, Beodeul Kang, Jaekyung Cheon, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Yun Beom Sang, Sanghoon Jung, Ho Yeong Lim, Vincent E. Gaillard, Chan Kim, Hong Jae Chon
    Liver Cancer.2024; 13(1): 89.     CrossRef
  • Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer
    Yanling Wang, Xiaoxuan Yang, Jia Ma, Shenglan Chen, Ping Gong, Ping Dai
    Heliyon.2024; 10(5): e27077.     CrossRef
  • Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors
    Ben Ponvilawan, Abdul Wali Khan, Janakiraman Subramanian, Dhruv Bansal
    Cancers.2024; 16(6): 1225.     CrossRef
  • Changes in TgAb and TPOAb titers are greater in thyrotoxicosis than isolated hypothyroidism induced by PD-1 blockade
    Ayana Yamagami, Shintaro Iwama, Tomoko Kobayashi, Xin Zhou, Yoshinori Yasuda, Takayuki Okuji, Masaaki Ito, Tetsushi Izuchi, Masahiko Ando, Takeshi Onoue, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Hiroshi Arima
    Endocrine Journal.2024; 71(5): 515.     CrossRef
  • Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
    Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, Theo Rispens, Els M E Verdegaal, Dirk J A R Moes, Catharina M Korse, Ellen Kapiteijn, Marij J P Welters, Sjoerd H van der Burg, Winan J van Houdt, Johannes V van Thienen, John B A G Haanen, Dia
    Journal for ImmunoTherapy of Cancer.2024; 12(6): e009215.     CrossRef
  • Development and Validation of a Prediction Model for Thyroid Dysfunction in Patients During Immunotherapy
    Qian Wang, Tingting Wu, Ru Zhao, Yuanqin Li, Xuetao Chen, Shanmei Shen, Xiaowen Zhang
    Endocrine Practice.2024; 30(10): 943.     CrossRef
  • Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial
    Yan Zheng, Guanghui Liang, Dongfeng Yuan, Xianben Liu, Yufeng Ba, Zimin Qin, Sining Shen, Zhenxuan Li, Haibo Sun, Baoxing Liu, Quanli Gao, Peng Li, Zongfei Wang, Shilei Liu, Jianping Zhu, Haoran Wang, Haibo Ma, Zhenzhen Liu, Fei Zhao, Jun Zhang, He Zhang,
    Cancer Communications.2024; 44(10): 1214.     CrossRef
  • Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction
    Jinyu Liu, Mengli Chen, Shu Li, Le Cai, Liang Ma, Qiuliang Yang, Xiaoxuan Zhang, Nan Bai, Xiaodong Wu, Zhihui Tang, Tianlin Wang
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal
    Xinya Li, Zaiwei Song, Yixuan Chen, Jingjing Wu, Dan Jiang, Zhen Zhang, Zeyuan Wang, Rongsheng Zhao
    Cancer Immunology, Immunotherapy.2024;[Epub]     CrossRef
  • Serologic predictors of thyroid immune-related adverse events during immune checkpoint inhibitors therapy: a retrospective cohort study
    Anastasia A. Glibka, Natalia V. Mazurina, Ksenia A. Sarantseva, Galina Y. Kharkevich, Mikhail V. Volkonskii, Alina R. Elfimova, Ekaterina A. Troshina
    Almanac of Clinical Medicine.2024; 52(7): 385.     CrossRef
  • Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy
    David Dora, Syeda Mahak Zahra Bokhari, Kenan Aloss, Peter Takacs, Juliane Zsuzsanna Desnoix, György Szklenárik, Patrick Deniz Hurley, Zoltan Lohinai
    International Journal of Molecular Sciences.2023; 24(3): 2769.     CrossRef
  • Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors
    Xiangxiao Hu, Lina Wang, Bin Shang, Junren Wang, Jian Sun, Bin Liang, Lili Su, Wenjie You, Shujuan Jiang
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Immune-related adverse events induced by programmed death protein-1 inhibitors from the perspective of lymphoma immunotherapy
    Yong-Zhe Hou, Qin Zhang, Hai Bai, Tao Wu, Ya-Jie Chen
    World Journal of Clinical Cases.2023; 11(7): 1458.     CrossRef
  • Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events
    Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, Virginia Arrazubi, Nuria Torrego, Ana Campillo-Calatayud, Iñaki Elejalde, Grazyna Kochan, David Escors
    Cancers.2023; 15(5): 1629.     CrossRef
  • Immune-related thyroid dysfunctions during anti PD-1/PD-L1 inhibitors: new evidence from a single centre experience
    Alice Nervo, Matteo Ferrari, Giovanni Gruosso, Enrica Migliore, Sara Basile, Valentina D’Angelo, Anna Roux, Alessandro Piovesan, Emanuela Arvat
    Clinical and Experimental Medicine.2023; 23(8): 4817.     CrossRef
  • RNA Sequencing Reveals Unique Transcriptomic Signatures of the Thyroid in a Murine Lung Cancer Model Treated with PD-1 and PD-L1 Antibodies
    Rena Pollack, Joshua Stokar, Natan Lishinsky, Irina Gurt, Naomi Kaisar-Iluz, Merav E. Shaul, Zvi G. Fridlender, Rivka Dresner-Pollak
    International Journal of Molecular Sciences.2023; 24(13): 10526.     CrossRef
  • Immune‐related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity
    Namrata Singh, Anne M. Hocking, Jane H. Buckner
    Immunological Reviews.2023; 318(1): 81.     CrossRef
  • Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
    Nicia I. Profili, Roberto Castelli, Antonio Gidaro, Alessandro Merella, Roberto Manetti, Giuseppe Palmieri, Margherita Maioli, Alessandro P. Delitala
    Journal of Clinical Medicine.2023; 12(15): 5161.     CrossRef
  • Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review
    Won Sang Yoo, Eu Jeong Ku, Eun Kyung Lee, Hwa Young Ahn
    Endocrinology and Metabolism.2023; 38(6): 750.     CrossRef
  • PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
    Ke Zhang, Xiangyi Kong, Yuan Li, Zhongzhao Wang, Lin Zhang, Lixue Xuan
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients
    Han-sang Baek, Chaiho Jeong, Kabsoo Shin, Jaejun Lee, Heysun Suh, Dong-Jun Lim, Moo Il Kang, Jeonghoon Ha
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • A Successful Case of Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab with Multisystem Immune-related Adverse Events
    Hidemi Hayashi, Koji Sawada, Takumu Hasebe, Shunsuke Nakajima, Jun Sawada, Yuri Takiyama, Yumi Takiyama, Toshikatsu Okumura, Mikihiro Fujiya
    Internal Medicine.2022; 61(23): 3497.     CrossRef
  • Immune Related Adverse Events of the Thyroid – A Narrative Review
    Christopher A. Muir, Venessa H. M. Tsang, Alexander M. Menzies, Roderick J. Clifton-Bligh
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Thyroid-related adverse events induced by immune checkpoint inhibitors
    Alexandra Chera, Andreea Lucia Stancu, Octavian Bucur
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors
    Adithya Chennamadhavuni, Laith Abushahin, Ning Jin, Carolyn J. Presley, Ashish Manne
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Case 5: A 41-Year-Old Woman With Palpitation
    Jiwon Yang, Kabsoo Shin, Jeongmin Lee, Jeonghoon Ha, Dong-Jun Lim, Han-Sang Baek
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
    Hyemi Kwon, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, Eun Heui Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Jun Sung Moon, Jin Hwa Kim, Mi-kyung Kim
    Endocrinology and Metabolism.2022; 37(6): 839.     CrossRef
  • Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario
    Calogera Claudia Spagnolo, Giuseppe Giuffrida, Salvatore Cannavò, Tindara Franchina, Nicola Silvestris, Rosaria Maddalena Ruggeri, Mariacarmela Santarpia
    Cancers.2022; 15(1): 246.     CrossRef
  • Antineoplastics

    Reactions Weekly.2021; 1874(1): 31.     CrossRef
Close layer
Clinical Study
Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery
Hana Kim, Sung Hye Kong, Jae Hoon Moon, Sang Yoon Kim, Kay-Hyun Park, Jun Sung Kim, Joong Haeng Choh, Young Joo Park, Cheong Lim
Endocrinol Metab. 2020;35(2):308-318.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.308
  • 10,154 View
  • 174 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The aim of this study was to determine the associations between subclinical hypothyroidism (SCH) and long-term cardiovascular outcomes after coronary artery bypass grafting (CABG) or heart valve surgery (HVS).
Methods
We retrospectively reviewed and compared all-cause mortality, cardiovascular mortality, and cardiovascular events in 461 patients who underwent CABG and 104 patients who underwent HVS.
Results
During a mean±standard deviation follow-up duration of 7.6±3.8 years, there were 187 all-cause deaths, 97 cardiovascular deaths, 127 major adverse cardiovascular events (MACE), 11 myocardial infarctions, one unstable angina, 70 strokes, 30 hospitalizations due to heart failure, 101 atrial fibrillation, and 33 coronary revascularizations. The incidence of all-cause mortality after CABG was significantly higher in patients with SCH (n=36, 55.4%) than in euthyroid patients (n=120, 30.3%), with a hazard ratio of 1.70 (95% confidence interval, 1.10 to 2.63; P=0.018) after adjustment for age, sex, current smoking status, body mass index, underlying diseases, left ventricular dysfunction, and emergency operation. Interestingly, low total triiodothyronine (T3) levels in euthyroid patients who underwent CABG were significantly associated with increased risks of all-cause mortality, cardiovascular mortality, and MACE, but those associations were not observed in HVS patients. Both free thyroxine and thyroid-stimulating hormone levels in euthyroid patients were not related with any cardiovascular outcomes in either the CABG or HVS group.
Conclusion
SCH or low total T3 might be associated with a poor prognosis after CABG, but not after HVS, implying that preoperative thyroid hormonal status may be important in ischemic heart disease patients.

Citations

Citations to this article as recorded by  
  • Subclinical Hypothyroidism as a Risk for Coronary Artery Bypass Grafting
    Ricardo Mendes Martins, Felipe José M. Pittella, Beatriz C. de Oliveira, Bernardo G. S. Lima, Caio C. Ferreira, Aline D. Pereira, Wolney A. Martins, Rubens A. C. Filho, Giovanna A. B. Lima, Muhammad Riaz
    Cardiovascular Therapeutics.2026;[Epub]     CrossRef
  • The impact of thyroid function on surgical prognosis in patients undergoing cardiac and major vascular surgeries
    Qi Sun, Wei Wang, Xiaoming Mao, Hao Liu
    Journal of Cardiothoracic Surgery.2025;[Epub]     CrossRef
  • Subclinical hypothyroidism and clinical outcomes after cardiac surgery: A systematic review and meta-analysis
    Michele Dell’Aquila, Camilla S. Rossi, Tulio Caldonazo, Gianmarco Cancelli, Lamia Harik, Giovanni J. Soletti, Kevin R. An, Jordan Leith, Hristo Kirov, Mudathir Ibrahim, Michelle Demetres, Arnaldo Dimagli, Mohamed Rahouma, Mario Gaudino
    JTCVS Open.2024; 18: 64.     CrossRef
  • Impact of subclinical hypothyroidism on outcomes after coronary artery bypass grafting: a systematic review and meta-analysis
    Muhammad O. LARIK, Abdul R. SHAHID, Moeez I. SHIRAZ, Maryam UROOJ
    The Journal of Cardiovascular Surgery.2024;[Epub]     CrossRef
  • The Association Between Hypothyroidism Treatment and Mortality in Patients Hospitalized in Surgical Wards
    Hiba Masri-Iraqi, Yaron Rudman, Carmel Friedrich Dubinchik, Idit Dotan, Talia Diker-Cohen, Liat Sasson, Tzipora Shochat, Ilan Shimon, Eyal Robenshtok, Amit Akirov
    Endocrine Research.2023; 48(2-3): 68.     CrossRef
  • Mid-term outcomes of patients with subclinical hypothyroidism after coronary bypass surgery
    Dong Zhao, Wei Zhao, Chuangshi Wang, Fei Xu, Wei Zhao, Xieraili Tiemuerniyazi, Hao Ma, Wei Feng
    Interdisciplinary CardioVascular and Thoracic Surgery.2023;[Epub]     CrossRef
  • Thyroid Pathology in High-Risk Cardiac Surgery Patients with Coronary Artery Disease
    Olena K. Gogayeva, Anatoliy V. Rudenko, Vasyl V. Lazoryshynets, Serhii A. Rudenko, Tetiana A. Andrushchenko
    Ukrainian Journal of Cardiovascular Surgery.2022; 30(1 (46)): 9.     CrossRef
  • High-TSH Subclinical Hypothyroidism Is Associated With Postoperative Mortality in Acute Type A Aortic Dissection
    Shi-Pan Wang, Yuan Xue, Hai-Yang Li, Wen-Jian Jiang, Hong-Jia Zhang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Triiodothyronine improves contractile recovery of human atrial trabeculae after hypoxia/reoxygenation
    Petra Kleinbongard, Philipp Kuthan, Chantal Eickelmann, Philipp Jakobs, Joachim Altschmied, Judith Haendeler, Arjang Ruhparwar, Matthias Thielmann, Gerd Heusch
    International Journal of Cardiology.2022; 363: 159.     CrossRef
  • Hypothyroidism Is Correlated with Ventilator Complications and Longer Hospital Days after Coronary Artery Bypass Grafting Surgery in a Relatively Young Population: A Nationwide, Population-Based Study
    Jiun-Yu Lin, Pei-Chi Kao, Yi-Ting Tsai, Chi-Hsiang Chung, Wu-Chien Chien, Chih-Yuan Lin, Chieh-Hua Lu, Chien-Sung Tsai
    Journal of Clinical Medicine.2022; 11(13): 3881.     CrossRef
  • Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—Physiological mechanisms and clinical evidence
    Patrick Müller, Melvin Khee-Shing Leow, Johannes W. Dietrich
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape
    Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2021; 36(3): 500.     CrossRef
Close layer
Case Report
A Case of Pituitary Feedback Adenoma Caused by Primary Hypothyroidism.
Soon Jib Yoo, Sang A Chang, Yoo Bae Ahn, Hyun Sik Son, Kun Ho Yoon, Moo Il Kang, Bong Yun Cha, Kwang Woo Lee, Ho Young Son, Sung Koo Kang, Myung Hee Chung
J Korean Endocr Soc. 1996;11(2):199-206.   Published online November 7, 2019
  • 1,741 View
  • 30 Download
AbstractAbstract PDF
A 14-year-old girl presented with severe headache and grand mal seizure. A magnetic resonance imaging(MRI) of brain showed a pituitary mass(1.0X1.5X1.3cm) incidentally during seizure evaluation. On physical examination, nodular goiter was detected on her anterior neck. The hormone study showed markdly increased basal thyroid stimulating hormone(TSH) level compared to thyroid hormone level, hyperprolactinemia and decreased basal growth hormone level. TSH and prolactin showed exaggerated response to thyrotropin releasing hormone(TRH) and the growth hormone showed delayed and blunted response to insulin-induced hypoglycemia. With the results of thyroid autoantibody and thyroid scan, the diagnosis of Hashimoto's thyroiditis was possible. Thyroid hormone and anticonvulsant drug were started with close observation of clinical status under the impression of pituitary feedback adenoma caused by hypothyroidism. After 3 months replacement therapy of levothyroxine sodium, she achieved euthyroid state with disappearance of headache and nodular goiter. After continuous replacement therapy for 9 months more, the pituitary mass was successfully regressed on follow up MRI with normalization of basal prolactin level. Grand mal seizure was developed after withholding anticonvulsant drug even though continuous admmistration of thyroid hormone. Because of similarity among pituitary adenoma discovered incidentally, careful hormonal study and high index of suspicion should be maintained to achieve correct diagnosis in order to avoid unnecessary pituitary surgery in these patients.
Close layer
Original Articles
Serum Insulin-like Growth Factor-1(IGF-1) and Insulin-like Growth Factor Binding Proteins in Hyperthyroidism and Hypothyroidism.
Hyun Mo Song, Sang Seok Park, Tae Seon Park, Hong Sun Baek, Dae Yeol Lee
J Korean Endocr Soc. 1996;11(1):52-60.   Published online November 7, 2019
  • 1,877 View
  • 37 Download
AbstractAbstract PDF
Background
s: Thyroid hormones play a fundamental role in the initiation and maintenance of somatic growth in mammalian species, and the insulin-like growth factors(IGFs) occupy a position of central importance in the growth of all tissues. To evaluate the changes in serum insulin-like growth factor-I(IGF-I) and insulin-like growth factor binding proteins in hyperthyroid and hypothyroid patients, sera was obtained from 19 hyperthyroid patients, 9 hypothyroid patients, and 10 healthy volunteers. Methods: IGF-I concentration was determined by radioimmunoassay, and changes in IGFBPs were assesed by Western Ligand Blotting. To evaluate the binding pattern of IGF-I & IGFBPs, autoradiographs were obtained. Results & Conclusion: IGF-I levels were increased significantly in hyperthyroid patients(mean ±SE, 267.88±9.80 ng/ml, p<0.05) and decreased significantly in hypothyroid patients(154.81±1.43 ng/ml, p<0.01) compaired to healthy control group(209.45±.60 ng/ml). Autoradiograph of serum IGFBPs from patients with hyperthyroidism and hypothyroidism did not show any change in the intensity of IGFBP-3 bands(40-45 KD) and IGFBP-1 bands, but in hyperthyroid patients, it showed increased intensity of IGFBP-2 band compared to healthy control group and hypothyroid patients.
Close layer
Changes in Serum Lipids and Apolipoproteins Levels According to the Thyroxine Treatment in The Patients with Subclinical Hypothyroidism.
Hye Young Park, Bo Youn Cho, Won Bae Kim, Hong Gyu Lee, Chang Soon Koh, Geon Sang Park, Hyung Kyu Park, Sook Kyung Kim, Chan Soo Shin, Seong Yeon Kim
J Korean Endocr Soc. 1996;11(1):41-51.   Published online November 7, 2019
  • 1,760 View
  • 21 Download
AbstractAbstract PDF
Background
Subclinical hypothyroidism(SCH) is a common biochemical abnormality which can be found in routine screening tests of thyroid function. We are increasingly faced with the question of whether its an indication for thyroxine replacement therapy. The effect of thyroxine replacement on lipid profile in SCH has aroused a great interest because of an association of overt hypothyroidism(OVH) with hyperlipidemia and increased risk of coronary artery disease. Method: We prospectively evaluated the changes in lipids and apoproteins before and after thyroxine replacement therapy in 23 patients with SCH and in 37 patients with OVH. We measured serum total cholesterol and triglyceride using autoanalyzer, high density lipoprotein(HDL) chole-sterol by dextran sulfate method, Apo A1 and Apo B by immunonephelometric assay. Results: Thyroxine replacement therapy significantly decreased total cholesterol, low density lipoprotein(LDL) cholesterol and apo B levels, but did not affect the level of triglyceride, HDL cholesterol or apo AI in patients with OVH. In SCH, thyroxine replacement therapy with the doses to normalize serum TSH concentrations also decreased significantly the level of cholesterol and LDL cholesterol albeit apo B levels did not change. Moreover, in most of patients with OVH (11 of 12) and in all of patients with SCH(5 of 5) who had had hyperchlesterolemia before treatment, thyroxine replament normalized their cholesterol and LDL cholesterol levels. Conclusion: In regard to the beneficial changes in blood lipid levels, patients with SCH should be treated, especially in cases who have other risk factors for the development of atherosclerosis. If thyroxine replacement only will reduce the incidence of coronary artery disease in SCH remains to be elucidated by long-term prospective studies.
Close layer
Spontaneous Recovery from Hypothyroidism in Autommune Thyroiditis.
Bo Youn Cho, Jae Hoon Chung, Kwang Won Kim, Kyu Jeung Ahn, Yong Ki Min, Myung Shik Lee, Moon Kyu Lee
J Korean Endocr Soc. 1996;11(1):30-40.   Published online November 7, 2019
  • 4,031 View
  • 43 Download
AbstractAbstract PDF
Background
A lifelong thyroxine therapy is indicated in all patients who have hypothyroidism as a result of autoimmune thyroiditis. However, it has been reported that some hypothyroid patients with autoimmune thyroiditis have spontaneous remission with restriction of iodine intake instead of thyroxine therapy. The purpose of study was to investigate how many hypothyroid patients with autoimmune thyroiditis can recover from hypothyroidism with restriction of iodine intake instead of thyroxine therapy and which factors predict recovery from hypothyroidism. Methods: We studied 64 patients with autoimmune thyroiditis(goitrous autoimmune thyroiditis 56, atrophic autoimmune thyroiditis 8). Thyroxine therapy was discontinued in patients with goitrous autoimmune thyroiditis on the way(group 1, n=32) or from the beginning(group 2, n=24) and atrophic autoimmune thyroiditis on the way(group 3, n-8). All patients were asked to avoid iodine-rich foods and thyroid function was monitored every one to two months for up to 35 months. Serum T3, T4, TSH concentrations, antithyroglobulin and antimicrosomal antibodies were measured by radioimmunoassay(RIA). TSH binding inhibitor immunoglobulin(TBII) was measured in serum using radioreceptor assay. Two hundred micrograms of thyrotropin releasing hormone (TRH) were given as intravenous bolus and TSH levels were measured in blood samples taken at 0, 30, and 60 minutes. All values were expressed as mean+-SEM. Statistical analysis was done with paired or non-paired t-test, ANOVA, and the Chi-square test. Statistical significance was defined as p-value below 0.05. Results: Thirteen(40.6%) of 32 patients in group 1 remained euthyroid after 12-35 months of discontinuation of thyroxine therapy. The other 19(59.4%) patients in group 1 had recurrences of hypothyroidism within 3 months after discontinuation of thyroxine therapy. In 11(45.8%) out of 24 patients in group 2, serum TSH concentrations declined below 5 mU/L within 3 months without thyroxine therapy. The other 13(54.2%) patients in group 2 remained hypothyroid till 2-16 months and the thyroxine was given. In contrast, all 8 patients in group 3 had recurrences of hypothy- roidism within 3 months after stopping thyroxine therapy. When we compared the recovered patients of goitrous autoimmune thyroiditis with the non-recovered patients of goitrous autoimmune thyroiditis, regardless of thyroxine therapy from the beginning, age at onset of disease of the 24 recovered patients was significantly younger than the 32 non-recovered patients(30.1+2.0 years vs. 40.2+ 2.4 years; p=0.004). Concl#usion: These findings suggest that 42.9% of hypothyroid patients with goitrous autoim- mune thyroiditis remain or become spontaneously euthyroid with restriction of iodine intake instead of thyroxine therapy. Young age may be a predicting factor of recovery from hypothyroidism in goitrous autoimmune thyroiditis.
Close layer
Case Report
A Case of Subclinical Hypothyroidism Associated with Turner's Syndrome.
In Kwon Han, Jung Gil Lee, Sun Wha Lee, Seong Kyu Lee, Chan Moon Pak, Ho Yeon Chung
J Korean Endocr Soc. 1994;9(1):35-38.   Published online November 6, 2019
  • 1,921 View
  • 21 Download
AbstractAbstract PDF
Recently it is known that Turner's syndrome is frequently associated with hypothyroidism. We report a case of Turner's syndrome associated with subclinical hypothyroidism. A 23-year-old female was admitted to the hospital with complaints of amenorrhea and short stature. She had a mosaicism of 45, X0/46, Xi(X_q) in the cell, cultured from the peripheral blood. The plasma thyroxine and triiodothyronine were normal and there was no clinical symptom of hypothyroidism. But the thyroid-stimulating hormone(TSH) concentration was unusually higher(184 uU/L). She has been treated with the cyclic therapy of conjugated estrogen and medroxyprogesterone, in addition to the thyroxine replacement therapy. After 2 months, the menstruation was restored and TSH was normalized.
Close layer
Review Article
Thyroid
Digital Medicine in Thyroidology: A New Era of Managing Thyroid Disease
Jae Hoon Moon, Steven R. Steinhubl
Endocrinol Metab. 2019;34(2):124-131.   Published online June 24, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.2.124
  • 10,002 View
  • 165 Download
  • 15 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   

Digital medicine has the capacity to affect all aspects of medicine, including disease prediction, prevention, diagnosis, treatment, and post-treatment management. In the field of thyroidology, researchers are also investigating potential applications of digital technology for the thyroid disease. Recent studies using artificial intelligence (AI)/machine learning (ML) have reported reasonable performance for the classification of thyroid nodules based on ultrasonographic (US) images. AI/ML-based methods have also shown good diagnostic accuracy for distinguishing between benign and malignant thyroid lesions based on cytopathologic findings. Assistance from AI/ML methods could overcome the limitations of conventional thyroid US and fine-needle aspiration cytology. A web-based database has been developed for thyroid cancer care. In addition to its role as a nationwide registry of thyroid cancer, it is expected to serve as a clinical platform to facilitate better thyroid cancer care and as a research platform providing comprehensive disease-specific big data. Evidence has been found that biosignal monitoring with wearable devices may predict thyroid dysfunction. This real-world thyroid function monitoring could aid in the management and early detection of thyroid dysfunction. In the thyroidology field, research involving the range of digital medicine technologies and their clinical applications is expected to be even more active in the future.

Citations

Citations to this article as recorded by  
  • Cost-effectiveness Analysis Comparing Conventional and Digital Software Supported Management for Hypothyroidism
    Jung Hyun Kim, Jaeyong Shin, Man S Kim, Jae Hoon Moon
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(6): 1596.     CrossRef
  • Enhancing diagnostic accuracy of thyroid nodules: integrating self-learning and artificial intelligence in clinical training
    Daham Kim, Yoon-a Hwang, Youngsook Kim, Hye Sun Lee, Eunjung Lee, Hyunju Lee, Jung Hyun Yoon, Vivian Youngjean Park, Miribi Rho, Jiyoung Yoon, Si Eun Lee, Jin Young Kwak
    Endocrine.2025; 88(3): 766.     CrossRef
  • Machine Learning for Thyroid Cancer Detection, Presence of Metastasis, and Recurrence Predictions—A Scoping Review
    Irina-Oana Lixandru-Petre, Alexandru Dima, Madalina Musat, Mihai Dascalu, Gratiela Gradisteanu Pircalabioru, Florina Silvia Iliescu, Ciprian Iliescu
    Cancers.2025; 17(8): 1308.     CrossRef
  • Thyroid Cancer Staging: Historical Evolution and Analysis From Macrocarcinoma to Microcarcinoma
    Carlos S Duque, Carlos E Builes-Montaño, Catalina Tobón-Ospina, Alejandro Velez Hoyos, Juan G Sánchez, Andres F Londoño, Miguel Agudelo, Julio A Valencia, Juan P Dueñas, Maria F Palacio, Natalia Sierra
    Cureus.2025;[Epub]     CrossRef
  • Clinical management of thyroid dysfunction in the aging population
    Bin Gao, Tongyan Yang, Guojuan Li
    Aging Research.2025; 3(3): 9340048.     CrossRef
  • An update on the safety of antithyroid drugs in pregnancy: the power of real-world data
    Stine Linding Andersen
    Expert Opinion on Drug Safety.2025; : 1.     CrossRef
  • An interpretable multimodal machine learning model for predicting malignancy of thyroid nodules in low-resource scenarios
    Fuqiang Ma, Fengchang Yu, Xinyu Gu, Lihua Zhang, Zhilin Lu, Lele Zhang, Herong Mao, Nan Xiang
    BMC Endocrine Disorders.2025;[Epub]     CrossRef
  • Understanding the factors of wearable devices among the patients with thyroid cancer: A modified UTAUT2 model
    LingLi Song, BinXian Li, HaiBo Wu, CuiCui Wu, XueQi Zhang, Zhiyuan Yu
    PLOS ONE.2024; 19(7): e0305944.     CrossRef
  • The Current Progress of Artificial Intelligence in Approach to Thyroid Nodules: A Narrative Review
    Parsa Yazdanpanahi, Farnaz Atighi, Alireza Keshtkar, Reza Hamidi, Mohamadali Rezaeimanesh, Alireza Karimi, Arzhang Naseri, Mohammad Hossein Dabbaghmanesh
    Shiraz E-Medical Journal.2024;[Epub]     CrossRef
  • AI in Thyroid Cancer Diagnosis: Techniques, Trends, and Future Directions
    Yassine Habchi, Yassine Himeur, Hamza Kheddar, Abdelkrim Boukabou, Shadi Atalla, Ammar Chouchane, Abdelmalik Ouamane, Wathiq Mansoor
    Systems.2023; 11(10): 519.     CrossRef
  • A COMPREHENSIVE INVESTIGATION INTO THE DEVELOPMENT OF A DEEP LEARNING MODEL FOR ROBUST CLASSIFICATION IN THYROID DISEASE DIAGNOSIS
    Minal Chaphekar, Omprakash Chandrakar
    ShodhKosh: Journal of Visual and Performing Arts.2023;[Epub]     CrossRef
  • [Retracted] Empirical Method for Thyroid Disease Classification Using a Machine Learning Approach
    Tahir Alyas, Muhammad Hamid, Khalid Alissa, Tauqeer Faiz, Nadia Tabassum, Aqeel Ahmad, Gulnaz Afzal
    BioMed Research International.2022;[Epub]     CrossRef
  • Deep Learning Based Classification of Wrist Cracks from X-ray Imaging
    Jahangir Jabbar, Muzammil Hussain, Hassaan Malik, Abdullah Gani, Ali Haider Khan, Muhammad Shiraz
    Computers, Materials & Continua.2022; 73(1): 1827.     CrossRef
  • Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a Region with Long History of Iodine Deficiency: A German Multicenter Trial
    Philipp Seifert, Simone Schenke, Michael Zimny, Alexander Stahl, Michael Grunert, Burkhard Klemenz, Martin Freesmeyer, Michael C. Kreissl, Ken Herrmann, Rainer Görges
    Cancers.2021; 13(17): 4467.     CrossRef
  • Association between Thyroid Function and Heart Rate Monitored by Wearable Devices in Patients with Hypothyroidism
    Ki-Hun Kim, Juhui Lee, Chang Ho Ahn, Hyeong Won Yu, June Young Choi, Ho-Young Lee, Won Woo Lee, Jae Hoon Moon
    Endocrinology and Metabolism.2021; 36(5): 1121.     CrossRef
  • Deep Learning based Classification of Thyroid Cancer using Different Medical Imaging Modalities : A Systematic Review
    Maheen Ilyas, Hassaan Malik, Muhammad Adnan, Umair Bashir, Wajahat Anwaar Bukhari, Muhammad Imran Ali Khan, Adnan Ahmad
    VFAST Transactions on Software Engineering.2021; 9(4): 1.     CrossRef
  • Ultrasound risk stratification systems for thyroid nodule: between lights and shadows, we are moving towards a new era
    Pierpaolo Trimboli, Cosimo Durante
    Endocrine.2020; 69(1): 1.     CrossRef
  • Associations of Thyroid Hormones and Resting Heart Rate in Patients Referred to Coronary Angiography
    Eva Steinberger, Stefan Pilz, Christian Trummer, Verena Theiler-Schwetz, Markus Reichhartinger, Thomas Benninger, Marlene Pandis, Oliver Malle, Martin H. Keppel, Nicolas Verheyen, Martin R. Grübler, Jakob Voelkl, Andreas Meinitzer, Winfried März
    Hormone and Metabolic Research.2020; 52(12): 850.     CrossRef
Close layer
Original Articles
Thyroid
Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country
Carmen Castillo, Nicole Lustig, Paula Margozzini, Andrea Gomez, María Paulina Rojas, Santiago Muzzo, Lorena Mosso
Endocrinol Metab. 2018;33(4):466-472.   Published online November 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.4.466
  • 10,715 View
  • 118 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Thyroid dysfunction is associated with negative neonatal and obstetric outcomes. Large differences in thyroid function reference intervals exist across different populations. These differences can be explained by population-specific factors, such as iodine status. Many countries in Latin America report iodine sufficiency, but relatively few countries have published up-to-date data on iodine levels and thyroid function in the overall population, and especially in pregnant women. We evaluated the iodine status of pregnant women in Chile and determined thyroid hormone reference ranges in this population.

Methods

This was a prospective observational study of healthy Chilean women at their first prenatal visit before week 14. Thyroid-stimulating hormone (TSH), total thyroxine (T4), free T4, antithyroid peroxidase antibody (TPOAb), and iodine levels from spot urine samples were measured. Iodine status and the reference ranges for TSH were calculated.

Results

A total of 1,022 pregnant women in the first trimester were selected. Urinary iodine levels were measured in 302 randomly-selected women. The median urinary iodine concentration was 173.45 µg/L (interquartile range, 108.11 to 249.35).The reference ranges of TSH were calculated in 670 patients selected according to the National Academy of Clinical Biochemistry guidelines. The median TSH level was 1.88 µIU/mL (2.5th percentile: 0.13 to 97.5th percentile: 5.37). Using the reference range in the 1,022 women, the prevalence of clinical hypothyroidism was 1.76%, and that of subclinical hypothyroidism was 3.92%. TPOAb positivity was more common in women with TSH levels above 3.5 µIU/mL.

Conclusion

We found adequate iodine intake and a right-shifted distribution of serum TSH levels in pregnant women in Chile. The prevalence of hypothyroidism in our sample of pregnant women was higher than has been described in the literature.

Citations

Citations to this article as recorded by  
  • Impact of Subclinical Hypothyroidism on Pregnancy and Newborn
    Kamuran Suman, Ebru Gök, Musa Büyük, Murat Suman
    Phoenix Medical Journal.2024;[Epub]     CrossRef
  • Defining Trimester-Specific Reference Intervals for Thyroid Hormones: Insights from a Bulgarian Monocenter Study
    Vesselina Yanachkova, Radiana Staynova, Emilia Krassimirova Naseva
    Medicina.2024; 60(5): 801.     CrossRef
  • Long-term impact of hypothyroidism during gestation and lactation on the mammary gland
    Fiorella Campo Verde Arboccó, Fabio A. Persia, Leila Zyla, Nicolás Bernal, Verónica C. Sasso, Flavia Santiano, Silvina Gomez, Flavia Bruna, Virginia Pistone-Creydt, Constanza Lopez-Fontana, Graciela A. Jahn, María Belén Hapon, Ruben W. Carón
    Journal of Developmental Origins of Health and Disease.2023; 14(1): 122.     CrossRef
  • Evaluation of first and second trimester maternal thyroid profile on the prediction of gestational diabetes mellitus and post load glycemia
    Daniela Mennickent, Bernel Ortega-Contreras, Sebastián Gutiérrez-Vega, Erica Castro, Andrés Rodríguez, Juan Araya, Enrique Guzmán-Gutiérrez, Surangi Nilanka Jayakody Mudiyanselage
    PLOS ONE.2023; 18(1): e0280513.     CrossRef
  • Clinical and histopathological features of follicular thyroid cancer in Chile
    René Díaz, José Miguel Domínguez, Hernán Tala, Roberto Olmos, Pedro Pineda, Daniela Olivarí, Marcela Jiménez, Ximena Mimica, Alejandra Lanas, Gerson Ocares, Jorge Sapunar
    Archives of Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • Effect of the Cut-Off Level for Thyroid-Stimulating Hormone on the Prevalence of Subclinical Hypothyroidism among Infertile Mexican Women
    Lidia Arce-Sánchez, Salvatore Giovanni Vitale, Claudia Montserrat Flores-Robles, Myrna Souraye Godines-Enriquez, Marco Noventa, Carmen Marcela Urquia-Figueroa, Nayeli Martínez-Cruz, Guadalupe Estrada-Gutierrez, Salvador Espino y Sosa, José Romo-Yañez, Ara
    Diagnostics.2021; 11(3): 417.     CrossRef
  • Subclinical hypothyroidism in pregnancy
    Freddy J.K. Toloza, Sanaz Abedzadeh-Anaraki, Spyridoula Maraka
    Current Opinion in Endocrinology, Diabetes & Obesity.2019; 26(5): 225.     CrossRef
  • Letter: Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country (Endocrinol Metab 2018;33:466-72, Carmen Castillo et al.)
    Hyemi Kwon
    Endocrinology and Metabolism.2019; 34(1): 93.     CrossRef
  • Response: Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country (Endocrinol Metab 2018;33:466–72, Carmen Castillo et al.)
    Lorena Mosso
    Endocrinology and Metabolism.2019; 34(2): 213.     CrossRef
  • Thyroid-Stimulating Hormone Reference Ranges in Early Pregnancy: Possible Influence of Iodine Status
    Tae Yong Kim
    Endocrinology and Metabolism.2018; 33(4): 445.     CrossRef
Close layer
Thyroid
Prevalence and Annual Incidence of Thyroid Disease in Korea from 2006 to 2015: A Nationwide Population-Based Cohort Study
Hyemi Kwon, Jin-hyung Jung, Kyung-Do Han, Yong-Gyu Park, Jung-Hwan Cho, Da Young Lee, Ji Min Han, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
Endocrinol Metab. 2018;33(2):260-267.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.260
  • 11,028 View
  • 157 Download
  • 50 Web of Science
  • 49 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The incidence of thyroid nodules has increased worldwide in recent years. Thyroid dysfunction is a potential risk factor for hypercholesterolemia, cardiovascular disease, osteoporosis, arrhythmia, and neuropsychiatric disease. This study investigated the prevalence and annual incidence of thyroid nodules, hypothyroidism, and hyperthyroidism in Koreans.

Methods

In this nationwide population-based cohort study, 51,834,660 subjects were included using the National Health Information database from 2006 to 2015, after the exclusion of subjects with thyroid cancer.

Results

The prevalence in Korea in 2015 of thyroid nodules, hypothyroidism in patients taking thyroid hormone, and hyperthyroidism in patients undergoing treatment was 15.82/1,000 population, 15.94/1,000 population, and 2.76/1,000 population, respectively. All these diseases were more prevalent among women than among men. The number of incident cases of these three thyroid diseases steadily increased from 2006 to 2012, and then decreased through 2015. The incidence of thyroid nodules, hypothyroidism treated with thyroid hormone, and treated hyperthyroidism was 6.79/1,000 population, 1.76/1,000 population, and 0.55/1,000 population, respectively, in Korea in 2015. The use of methimazole continuously increased, from 33% of total antithyroid drug prescriptions in 2006 to 74.4% in 2015, and it became the most frequently prescribed antithyroid drug in Korea. In contrast, the use of propylthiouracil continuously decreased.

Conclusion

This was the first nationwide study of the prevalence and annual incidence of thyroid nodules, hypothyroidism, and hyperthyroidism to take into account recent changes and to include the current status of patients receiving treatment.

Citations

Citations to this article as recorded by  
  • Association between Benign Thyroid Disorders and Breast Cancer Risk in Korean Women
    Boyoung Park, Thi Xuan Mai Tran
    Cancer Research and Treatment.2026; 58(1): 141.     CrossRef
  • Risk of non-thyroidal autoimmune diseases in patients with Graves’ disease: a nationwide retrospective cohort study
    Seo Young Sohn, Jiyeon Ahn, Min Kyung Lee, Jae Hyuk Lee, Ji-Won Kwon, Ji-Min Kweon, Ju-Yeun Lee
    Rheumatology.2025; 64(1): 303.     CrossRef
  • Graves’ Disease and the Risk of Type 2 Diabetes: A Korean Population-Based Study
    Yoon Young Cho, Bongseong Kim, Sang-Man Jin, Chan-Hee Jung, Ji Oh Mok, Sun Wook Kim, Jae Hoon Chung, Kyung-Do Han, Tae Hyuk Kim
    Thyroid®.2025; 35(1): 60.     CrossRef
  • Incidence and Risk Factors for Amiodarone-Induced Thyroid Dysfunction: A Nationwide Retrospective Cohort Study
    Seo Young Sohn, Yun Jin Kim, Sungsoo Cho, Sung Woo Cho
    American Journal of Cardiovascular Drugs.2025; 25(3): 419.     CrossRef
  • Risk of psychiatric disorders in patients with graves' disease: A nationwide population-based analysis
    Ju-Yeun Lee, Minha Hong, Young Hee Jung, Seo Young Sohn
    Journal of Affective Disorders.2025; 385: 119386.     CrossRef
  • New Onset of Hair Loss Disorders During the Coronavirus Disease 2019 Pandemic: A Korean Nationwide Population-Based Study
    Youngjoo Cho, Ji Won Lim, Yi Na Yoon, Chang Yong Kim, Yang Won Lee, Yong Beom Choe, Da-Ae Yu
    Annals of Dermatology.2025; 37(4): 250.     CrossRef
  • Development of a Machine Learning-based Model for Methimazole Dosage Adjustment in Youth With Hyperthyroidism
    Joon Young Kim, Kanghyuck Lee, Eunsik Choi, Jun Suk Oh, Eun Byoul Lee, Hyun Wook Chae, Taehoon Ko, Kyungchul Song
    The Journal of Clinical Endocrinology & Metabolism.2025;[Epub]     CrossRef
  • New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment
    Hyung Woo Kim, Minkyung Han, Inkyung Jung, Sung Soo Ahn
    Rheumatology.2024; 63(3): 630.     CrossRef
  • Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea
    Hyemi Kwon, Kyung-Do Han, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1095.     CrossRef
  • Endocrine and metabolic comorbidities in primary cicatricial alopecia: A nationwide population‐based study
    Da‐Ae Yu, Seong Rae Kim, Soo Ick Cho, Ohsang Kwon
    The Journal of Dermatology.2024; 51(3): 429.     CrossRef
  • Cancer Risk in Graves Disease with Radioactive131I Treatment: A Nationwide Cohort Study
    Kyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim
    Journal of Nuclear Medicine.2024; 65(5): 693.     CrossRef
  • Long-term Effect of Thyrotropin-binding Inhibitor Immunoglobulin on Atrial Fibrillation in Euthyroid Patients
    Jung-Chi Hsu, Kang-Chih Fan, Ting-Chuan Wang, Shu-Lin Chuang, Ying-Ting Chao, Ting-Tse Lin, Kuan-Chih Huang, Lian-Yu Lin, Lung-Chun Lin
    Endocrine Practice.2024; 30(6): 537.     CrossRef
  • Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks
    Incheol Seo, Jin-Mo Park
    Neurological Sciences.2024; 45(9): 4573.     CrossRef
  • The relationship between dietary total flavonoids and thyroid function in U.S.adults, NHANES 2007–2010
    Jie Wu, Chuyu Jia, Zirui Zhang, Zebin Hou, Yanhua Cui, Yuyan Wang
    PLOS ONE.2024; 19(5): e0303169.     CrossRef
  • Epidemiology of Carpal Tunnel Syndrome and Trigger Finger in South Korea: A Nationwide Population-Based Study
    Min-Seo Kim, Jae Kwang Kim, Ye-Jee Kim, Young Ho Shin
    Clinics in Orthopedic Surgery.2024; 16(5): 774.     CrossRef
  • Cancer Risks of Patients with Graves’ Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis
    Ju-Yeun Lee, Min Kyung Lee, Jae Hyuk Lee, Kyungsik Kim, Kunho Bae, Seo Young Sohn
    Thyroid®.2024; 34(10): 1271.     CrossRef
  • National trends in thyroid disease and COVID-19 pandemic-related factors, 1998–2021: A nationwide representative study in South Korea
    Kyeongmin Lee, Jaeyu Park, Myeongcheol Lee, Hojae Lee, Yejun Son, Hyejun Kim, Jiseung Kang, Yujin Choi, Sang Youl Rhee, Masoud Rahmati, Ai Koyanagi, Lee Smith, Guillermo F. López Sánchez, Elena Dragioti, Selin Woo, Dong Keon Yon
    Heliyon.2024; 10(20): e39401.     CrossRef
  • Rising Incidence and Comorbidities of Endogenous Hypothyroidism in Republic of Korea from 2004 to 2018: A Nationwide Population Study
    Chae Won Chung, Hwa Young Ahn, Sun Wook Cho, Ka Hee Yi
    Endocrinology and Metabolism.2024; 39(6): 891.     CrossRef
  • Association of ITM2A rs1751094 polymorphism on X chromosome in Korean pediatric patients with autoimmune thyroid disease
    Won K. Cho, In‐Cheol Baek, Sung E. Kim, Mirae Kim, Tai‐Gyu Kim, Byung‐Kyu Suh
    Immunity, Inflammation and Disease.2023;[Epub]     CrossRef
  • Preoperative Risk Stratification of Follicular-patterned Thyroid Lesions on Core Needle Biopsy by Histologic Subtyping and RAS Variant-specific Immunohistochemistry
    Meejeong Kim, Sora Jeon, Chan Kwon Jung
    Endocrine Pathology.2023; 34(2): 247.     CrossRef
  • Cancer and Mortality Risks of Graves’ Disease in South Korea Based on National Data from 2010 to 2019
    Young Ju Choi, Kyungdo Han, Won Kyoung Cho, Min Ho Jung, Byung-Kyu Suh
    Clinical Epidemiology.2023; Volume 15: 535.     CrossRef
  • Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study
    Hyemi Kwon, Kyung-Do Han, Bong-Sung Kim, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Osteoporosis International.2023; 34(9): 1591.     CrossRef
  • Association of Thyroid Hormone Medication Adherence With Risk of Dementia
    Saemi Han, Seogsong Jeong, Seulggie Choi, Sun Jae Park, Kyae Hyung Kim, Gyeongsil Lee, Yoosun Cho, Joung Sik Son, Sang Min Park
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e225.     CrossRef
  • Increased risk of incident gout in patients with hyperthyroidism: a nationwide retrospective cohort study
    Ju-Yeun Lee, So-Yeon Park, Seo Young Sohn
    Rheumatology International.2023; 44(3): 451.     CrossRef
  • The Current Status of Hyperthyroidism in Korea
    Hyemi Kwon
    Endocrinology and Metabolism.2023; 38(4): 392.     CrossRef
  • Prevalence, Treatment Status, and Comorbidities of Hyperthyroidism in Korea from 2003 to 2018: A Nationwide Population Study
    Hwa Young Ahn, Sun Wook Cho, Mi Young Lee, Young Joo Park, Bon Seok Koo, Hang-Seok Chang, Ka Hee Yi
    Endocrinology and Metabolism.2023; 38(4): 436.     CrossRef
  • Comprehensive analysis of chemokine gene polymorphisms in Korean children with autoimmune thyroid disease
    Chungwoo Shin, In-Cheol Baek, Won Kyoung Cho, Tai-Gyu Kim, Byung-Kyu Suh
    Scientific Reports.2023;[Epub]     CrossRef
  • Analysis of the status of treatment of benign thyroid diseases — a public health problem aggravated in the COVID-19 pandemic era
    Giulianno Molina Melo, Antonio José Gonçalves, Fernando Walder, Carolina Ferraz, Murilo Catafesta Neves, Marcio Abrahão, Onivaldo Cervantes
    Brazilian Journal of Otorhinolaryngology.2022; 88(6): 982.     CrossRef
  • Graves’ disease and the risk of Parkinson’s disease: a Korean population-based study
    Yoon Young Cho, Bongseong Kim, Dong Wook Shin, Jinyoung Youn, Ji Oh Mok, Chul-Hee Kim, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han, Tae Hyuk Kim
    Brain Communications.2022;[Epub]     CrossRef
  • Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
    Yoon Young Cho, Bongseong Kim, Dong Wook Shin, Hye Ryoun Jang, Bo-Yeon Kim, Chan-Hee Jung, Jae Hyeon Kim, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han, Tae Hyuk Kim
    Endocrinology and Metabolism.2022; 37(2): 281.     CrossRef
  • Incidence of hypothyroidism after treatment for breast cancer: A Korean population-based study
    Jongmoo Park, Choongrak Kim, Yongkan Ki, Wontaek Kim, Jiho Nam, Donghyun Kim, Dahl Park, Hosang Jeon, Dong Woon Kim, Ji Hyeon Joo, Claudio Andaloro
    PLOS ONE.2022; 17(6): e0269893.     CrossRef
  • Genome-wide association study of hyperthyroidism based on electronic medical record from Taiwan
    Ting-Yuan Liu, Wen-Ling Liao, Tzu-Yuan Wang, Chia-Jung Chan, Jan-Gowth Chang, Yu-Chia Chen, Hsing-Fang Lu, Hsien-Hui Yang, Shih-Yin Chen, Fuu-Jen Tsai
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Graves’ disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study
    Yoon Young Cho, Bongseong Kim, Dughyun Choi, Chul-Hee Kim, Dong Wook Shin, Jee Soo Kim, Seung-Jung Park, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han, Tae Hyuk Kim
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Análise da situação do tratamento das doenças benignas da tireoide – Um problema de saúde pública agravado pela pandemia de Covid‐19
    Giulianno Molina Melo, Antonio José Gonçalves, Fernando Walder, Carolina Ferraz, Murilo Catafesta Neves, Marcio Abrahão, Onivaldo Cervantes
    Brazilian Journal of Otorhinolaryngology (Versão em Português).2022; 88(6): 982.     CrossRef
  • Risk of autoimmune diseases in recurrent aphthous ulcer patients: A nationwide population study
    Young Chan Lee, Su Jin Jeong, Young‐Gyu Eun, Ran Song, In‐Hwan Oh
    Oral Diseases.2021; 27(6): 1443.     CrossRef
  • Hyperthyroidism Prevalence in China After Universal Salt Iodization
    Chuyuan Wang, Yongze Li, Di Teng, Xiaoguang Shi, Jianming Ba, Bing Chen, Jianling Du, Lanjie He, Xiaoyang Lai, Yanbo Li, Haiyi Chi, Eryuan Liao, Chao Liu, Libin Liu, Guijun Qin, Yingfen Qin, Huibiao Quan, Bingyin Shi, Hui Sun, Xulei Tang, Nanwei Tong, Gui
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Comorbidity network analysis related to obesity in middle-aged and older adults: findings from Korean population-based survey data
    Hye Ah Lee, Hyesook Park
    Epidemiology and Health.2021; 43: e2021018.     CrossRef
  • Prevalence of Hyperthyroidism and Hypothyroidism and its Correlation with Serum Antithyroglobulin among patients in Kirkuk-Iraq ‎
    Sabah Mohammed Salih, Wijdan Abdullameer Kamel, Mohammed Talat Abbas, Kasim Sakran Abass
    Journal Of Advanced Pharmacy Education And Research.2021; 11(2): 57.     CrossRef
  • A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea
    Ka-Won Kang, Ji Eun Song, Byung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Yong Park, Byung Soo Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • Incidence and Mortality of Myocardial Infarction and Stroke in Patients with Hyperthyroidism: A Nationwide Cohort Study in Korea
    Hyun Jung Kim, Taeuk Kang, Min Ji Kang, Hyeong Sik Ahn, Seo Young Sohn
    Thyroid.2020; 30(7): 955.     CrossRef
  • Vitamin D supplementation does not prevent the recurrence of Graves’ disease
    Yoon Young Cho, Yun Jae Chung
    Scientific Reports.2020;[Epub]     CrossRef
  • Binding and Activity of Tetrabromobisphenol A Mono-Ether Structural Analogs to Thyroid Hormone Transport Proteins and Receptors
    Xiao-Min Ren, Linlin Yao, Qiao Xue, Jianbo Shi, Qinghua Zhang, Pu Wang, Jianjie Fu, Aiqian Zhang, Guangbo Qu, Guibin Jiang
    Environmental Health Perspectives.2020;[Epub]     CrossRef
  • Epidemiology of metabolic syndrome and its components in Chinese patients with a range of thyroid-stimulating hormone concentrations
    Kun Tang, Qiao Zhang, Nian-chun Peng, Miao Zhang, Shu-jing Xu, Hong Li, Ying Hu, Chun-ju Xue, Li-xin Shi
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • The Association of Overt and Subclinical Hyperthyroidism with the Risk of Cardiovascular Events and Cardiovascular Mortality: Meta-Analysis and Systematic Review of Cohort Studies
    Seo Young Sohn, Eunyoung Lee, Min Kyung Lee, Jae Hyuk Lee
    Endocrinology and Metabolism.2020; 35(4): 786.     CrossRef
  • Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
    Daham Kim, Yongin Cho, Cheol Ryong Ku, Hyein Jung, Ju Hyung Moon, Eui Hyun Kim, Dong Yeob Shin, Sun Ho Kim, Eun Jig Lee
    Journal of Clinical Medicine.2019; 8(8): 1142.     CrossRef
  • Association of Thyroid-Stimulating Hormone and Thyroid Hormones with Cardiometabolic Risk Factors in Euthyroid Children and Adolescents Aged 10–18 Years: A Population-Based Study
    Cheol Gyu Ma, Young Suk Shim
    Scientific Reports.2019;[Epub]     CrossRef
  • Weight change is significantly associated with risk of thyroid cancer: A nationwide population-based cohort study
    Hyemi Kwon, Kyung-Do Han, Cheol-Young Park
    Scientific Reports.2019;[Epub]     CrossRef
  • Evaluation of the relationship of subclinical hypothyroidism with metabolic syndrome and its components in adolescents: a population-based study
    Min-Kyung Lee, Yoo Mee Kim, Seo-Young Sohn, Jae-Hyuk Lee, Young Jun Won, Se Hwa Kim
    Endocrine.2019; 65(3): 608.     CrossRef
  • Autoimmune thyroiditis and central serous chorioretinopathy may have a relation
    Brijesh Takkar, Harsha Saxena, Anubha Rathi, Rekha Singh
    Medical Hypotheses.2018; 121: 180.     CrossRef
Close layer
The Effects of Altered Membrane Cholesterol Levels on Sodium Pump Activity in Subclinical Hypothyroidism
Suparna Roy, Anindya Dasgupta
Endocrinol Metab. 2017;32(1):129-139.   Published online February 28, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.129
  • 5,517 View
  • 44 Download
  • 2 Web of Science
AbstractAbstract PDFPubReader   
Background

Metabolic dysfunctions characteristic of overt hypothyroidism (OH) start at the early stage of subclinical hypothyroidism (SCH). Na+/K+-ATPase (the sodium pump) is a transmembrane enzyme that plays a vital role in cellular activities in combination with membrane lipids. We evaluated the effects of early changes in thyroid hormone and membrane cholesterol on sodium pump activity in SCH and OH patients.

Methods

In 32 SCH patients, 35 OH patients, and 34 euthyroid patients, sodium pump activity and cholesterol levels in red blood cell membranes were measured. Serum thyroxine (T4) and thyroid stimulating hormone (TSH) levels were measured using enzyme-linked immunosorbent assays. Differences in their mean values were analysed using post hoc analysis of variance. We assessed the dependence of the sodium pump on other metabolites by multiple regression analysis.

Results

Sodium pump activity and membrane cholesterol were lower in both hypothyroid groups than in control group, OH group exhibiting lower values than SCH group. In SCH group, sodium pump activity showed a significant direct dependence on membrane cholesterol with an inverse relationship with serum TSH levels. In OH group, sodium pump activity depended directly on membrane cholesterol and serum T4 levels. No dependence on serum cholesterol was observed in either case.

Conclusion

Despite the presence of elevated serum cholesterol in hypothyroidism, membrane cholesterol contributed significantly to maintain sodium pump activity in the cells. A critical reduction in membrane cholesterol levels heralds compromised enzyme activity, even in the early stage of hypothyroidism, and this can be predicted by elevated TSH levels alone, without any evident clinical manifestations.

Close layer
Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015
Won Gu Kim, Won Bae Kim, Gyeongji Woo, Hyejin Kim, Yumi Cho, Tae Yong Kim, Sun Wook Kim, Myung-Hee Shin, Jin Woo Park, Hai-Lin Park, Kyungwon Oh, Jae Hoon Chung
Endocrinol Metab. 2017;32(1):106-114.   Published online January 23, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.106
Correction in: Endocrinol Metab 2023;38(3):357
  • 13,527 View
  • 243 Download
  • 83 Web of Science
  • 89 Crossref
AbstractAbstract PDFPubReader   
Background

No nationwide epidemiological study evaluating the prevalence of subclinical and overt forms of hypothyroidism and hyperthyroidism has yet been conducted in Korea. This study aimed to evaluate the reference range of serum thyroid stimulating hormone (TSH) and the national prevalence of thyroid dysfunctions in Korea.

Methods

Nation-wide cross-sectional data were analyzed from a representative sample of the civilian, non-institutionalized Korean population (n=6,564) who underwent blood testing for thyroid function and anti-thyroid peroxidase antibody (TPOAb) as part of the Korea National Health and Nutrition Examination Survey VI (2013 to 2015).

Results

The reference interval of serum TSH in the Korean reference population was 0.62 to 6.68 mIU/L. Based on this reference interval, the prevalence of overt and subclinical hypothyroidism was 0.73% (males 0.40%, females 1.10%) and 3.10% (males 2.26%, females 4.04%), respectively. The prevalence of hypothyroidism increased with age until the age group between 50 to 59 years. Positive TPOAb were found in 7.30% of subjects (males 4.33%, females 10.62%). The prevalence of overt and subclinical hypothyroidism TPOAb-positive subjects was 5.16% and 10.88%, respectively. The prevalence of overt and subclinical hyperthyroidism was 0.54% (males 0.30%, females 0.81%) and 2.98% (males 2.43%, females, 3.59%), respectively.

Conclusion

The Serum TSH reference levels in the Korean population were higher than the corresponding levels in Western countries. Differences were found in the prevalence of hypothyroidism and hyperthyroidism according to age, sex, and TPOAb positivity. This study provides important baseline information for understanding patterns of thyroid dysfunction and diseases in Korea.

Citations

Citations to this article as recorded by  
  • Lifetime Atopic Dermatitis is Associated With Risk of Autoimmune Thyroid Disease: Evidence From a Nationwide Study
    Taehun Kim, Haeun Kim, Wonjin Lee, Jinhee Kim, Hyungryul Lim, Seri Hong, Young-Min Ye
    Allergy, Asthma & Immunology Research.2026; 18(1): 145.     CrossRef
  • The Impact of Physical Activity on Thyroid Health: Insights From Representative Data in Korea
    Jeongmin Lee, Han-Sang Baek, Kwanhoon Jo, Min-Hee Kim, Jung Min Lee, Sang Ah Chang, Dong-Jun Lim
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(3): e717.     CrossRef
  • Metabolic and Endocrine Correlates of Subclinical Hypothyroidism in Young Adults With First-Episode and Drug-Naive Major Depressive Disorder
    ZhaoXuan Shang, ChunQing Fang, XiaoE. Lang, Xiangyang Zhang
    Journal of the Academy of Consultation-Liaison Psychiatry.2025; 66(1): 13.     CrossRef
  • The Role of the Parametric Thyroid Feedback Quantile Index in Cardiovascular Risk Evaluation Among Euthyroid Koreans
    Hun Jee Choe, Yun Mi Choi, Yeonjung Ha, Jinseob Kim, Minhyuk Kim, Ho Jin Cha, Jiwoo Lee, Mi Kyung Kwak, Eun-Gyoung Hong
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(10): e3401.     CrossRef
  • Low Thyrotropin Levels Are Associated With an Increased Risk of Atherosclerotic Cardiovascular Disease in Euthyroid Individuals: The Korea National Health and Nutrition Examination Survey 2013–2015
    Jin-Woo Kim, Han-Joon Bae, Jun Sung Moon, Sung-Woo Kim
    Journal of Lipid and Atherosclerosis.2025; 14(2): 236.     CrossRef
  • Non-linear associations between exposure to a mixture of per- and polyfluoroalkyl substances and thyroid hormone levels in Korean adults
    Seung Min Chung, Ji-Hyeon Cha, Young-Heun Jung, Ju-Hyun Kim, Jun Sung Moon, Kyu Chang Won
    Environment International.2025; 201: 109585.     CrossRef
  • Prevalence of Subclinical Hypothyroidism in Information Technology Professionals With High Screen Exposure
    Subha Lakshmanan, Mohamed Nasrul Ariffin, Siiriin Shahul Hameed Sahib, Thirumeni Aravazhi, Thosit Krishnaa Arunagiri Adikesavan, Nancy Elizabeth Samuel
    Cureus.2025;[Epub]     CrossRef
  • Role of thyroid autoimmunity independent of thyroid hormone levels in pulmonary function decline: A population-based study in euthyroid adults
    Kyung-Hun Sung, Jeongeun Kwak, Mee Kyung Kim, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Jeongmin Lee, Aamir Ijaz
    PLOS One.2025; 20(12): e0336920.     CrossRef
  • Iodine Intake and Risk of Mortality: Evidence from a Nationally Representative Korean Cohort
    Jung-Hwan Cho, Jun Young Kim, Nak Gyeong Ko, Hanaro Park, Byung Soo Kwan, Ji Min Han, Sunghwan Suh, Ji Cheol Bae, Tae Hyuk Kim, Sun Wook Kim, Jae Hoon Chung, Hye Rang Bak, Hye In Kim
    Nutrients.2025; 17(24): 3859.     CrossRef
  • Deciphering the roles of triiodothyronine (T3) and thyroid-stimulating hormone (TSH) on cardiac electrical remodeling in clinical and experimental hypothyroidism
    Oscar Casis, Leire Echeazarra, Beatriz Sáenz-Díez, Mónica Gallego
    Journal of Physiology and Biochemistry.2024; 80(1): 1.     CrossRef
  • Associations between short-term exposure to air pollution and thyroid function in a representative sample of the Korean population
    Kyoung-Nam Kim, SoHyun Park, Junseo Choi, Il-Ung Hwang
    Environmental Research.2024; 252: 119018.     CrossRef
  • Association between ambient temperature and thyroid-stimulating hormone and free thyroxine levels in Korean euthyroid adults
    Jisun Sung, Jong-Hun Kim
    Environmental Research.2024; 262: 119918.     CrossRef
  • Subclinical thyroid dysfunction and chronic kidney disease: a nationwide population-based study
    Hye Jeong Kim, Sang Joon Park, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo
    BMC Nephrology.2023;[Epub]     CrossRef
  • Association between iodine intake and metabolic syndrome in euthyroid adult in an iodine-replete area: a nationwide population-based study
    Hye Jeong Kim, Suyeon Park, Sang Joon Park, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo
    Endocrine Journal.2023; 70(4): 393.     CrossRef
  • 2023 Korean Thyroid Association Management Guidelines for Patients with Subclinical Hypothyroidism
    Hyun Kyung Chung, Eu Jeong Ku, Won Sang Yoo, Yea Eun Kang, Kyeong Jin Kim, Bo Hyun Kim, Tae-Yong Kim, Young Joo Park, Chang Ho Ahn, Jee Hee Yoon, Eun Kyung Lee, Jong Min Lee, Eui Dal Jung, Jae Hoon Chung, Yun Jae Chung, Won Bae Kim, Ka Hee Yi, Ho-Cheol Ka
    International Journal of Thyroidology.2023; 16(1): 32.     CrossRef
  • The Current Status of Hyperthyroidism in Korea
    Hyemi Kwon
    Endocrinology and Metabolism.2023; 38(4): 392.     CrossRef
  • Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines
    Eu Jeong Ku, Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2023; 38(4): 381.     CrossRef
  • Association between shift work and the risk of hypothyroidism in adult male workers in Korea: a cohort study
    Seonghyeon Kwon, Yesung Lee, Eunhye Seo, Daehoon Kim, Jaehong Lee, Youshik Jeong, Jihoon Kim, Jinsook Jeong, Woncheol Lee
    Annals of Occupational and Environmental Medicine.2023;[Epub]     CrossRef
  • Depressão e hipotireoidismo: Uma revisão sistemática
    Eduarda Silva Souza, Rosangela Soares Chriguer, Maria Cristina Mazzaia
    Revista Portuguesa de Investigação Comportamental e Social.2023;[Epub]     CrossRef
  • Comparison of Thyroid-Stimulating Hormone Results from Eight Different Reagents and Assay-Specific Korean Reference Interval for Subclinical Hypothyroidism Treatment
    Won Sang Yoo, Sollip Kim, Young Joo Park, Sang Hoon Song, Kyunghoon Lee, Eun Kyung Lee, Jehoon Lee, Ho-Young Lee, Yun Jae Chung, Hyun Kyung Chung, Jin Chul Paeng, Minje Han, Ho-Cheol Kang
    International Journal of Thyroidology.2023; 16(2): 166.     CrossRef
  • Comparison of Five Different Criteria for Diagnosis of Subclinical Hypothyroidism in a Large-Scale Chinese Population
    Yan-song Zheng, Sheng-yong Dong, Yan Gong, Jia-hong Wang, Fei Wang, Qiang Zeng
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Association of thyroid autoimmunity with nonalcoholic fatty liver disease in euthyroid middle‐aged subjects: A population‐based study
    Hye Jeong Kim, Sang Joon Park, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo
    Journal of Gastroenterology and Hepatology.2022; 37(8): 1617.     CrossRef
  • Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis
    Wook Yi, Bo Hyun Kim, Mijin Kim, Jinmi Kim, Myungsoo Im, Soree Ryang, Eun Heui Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim
    Thyroid.2022; 32(7): 764.     CrossRef
  • Association of free thyroxine with obstructive lung pattern in euthyroid middle-aged subjects: A population-based study
    Hye Jeong Kim, Sang Joon Park, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo, Dong Keon Yon
    PLOS ONE.2022; 17(7): e0270126.     CrossRef
  • Long working hours and the risk of hypothyroidism in healthy Korean workers: a cohort study
    Yesung Lee, Woncheol Lee, Hyoung-Ryoul Kim
    Epidemiology and Health.2022; 44: e2022104.     CrossRef
  • Association of breastfeeding with thyroid function and autoimmunity in postmenopausal women
    Sung-Woo Kim, Ji-Hyun Lee, Ho-Sang Shon, Eonju Jeon, Tae-Yong Kim
    Endocrine.2021; 71(1): 130.     CrossRef
  • Distributions of serum thyroid-stimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China
    B. Ren, S. Wan, L. Liu, M. Qu, H. Wu, H. Shen
    Journal of Endocrinological Investigation.2021; 44(5): 1001.     CrossRef
  • Low Thyroid-stimulating Hormone Levels Are Associated With Annoying Tinnitus in Adult Women: Korea National Health and Nutrition Examination Surveys
    So Young Kim, Chanyang Min, Hyung-Jong Kim, Hyo Geun Choi
    Otology & Neurotology.2021; 42(4): e408.     CrossRef
  • Risk of All-Cause Mortality in Levothyroxine-Treated Hypothyroid Patients: A Nationwide Korean Cohort Study
    Seo Young Sohn, Gi Hyeon Seo, Jae Hoon Chung
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Decreased Expression of Ileal Thyroid Hormone Transporters in a Hypothyroid Patient: A Case Report
    Chae Won Chung, Eun Young Mo, Gyung Seo Jung, Yoo Hyung Kim, Sun Wook Cho, Do Joon Park, Jeong Mo Bae, Young Joo Park
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Korea National Health and Nutrition Examination Survey, 20th anniversary: accomplishments and future directions
    Kyungwon Oh, Yoonjung Kim, Sanghui Kweon, Soyeon Kim, Sungha Yun, Suyeon Park, Yeon-Kyeng Lee, Youngtaek Kim, Ok Park, Eun Kyeong Jeong
    Epidemiology and Health.2021; 43: e2021025.     CrossRef
  • Association between triglyceride-glucose index and thyroid function in euthyroid adults: The Korea National Health and Nutritional Examination Survey 2015
    Wonsuk Choi, Ji Yong Park, A. Ram Hong, Jee Hee Yoon, Hee Kyung Kim, Ho-Cheol Kang, Sun Young Lee
    PLOS ONE.2021; 16(7): e0254630.     CrossRef
  • Association between Subclinical Hypothyroidism and Incident Hypertension in Women: A Systematic Review and Meta-Analysis
    Jean Kim, Narut Prasitlumkum, Sandeep Randhawa, Dipanjan Banerjee
    Journal of Clinical Medicine.2021; 10(15): 3318.     CrossRef
  • Sex Difference in the Association between Sleep Duration and Thyroid Disease among South Korean Adults
    Jeong Hyun Ahn, Jin Young Nam, Soojin Park
    Journal of Health Informatics and Statistics.2021; 46(3): 337.     CrossRef
  • The Association between the Dietary Inflammatory Index and Thyroid Function in U.S. Adult Males
    Nuozhou Liu, Fang Ma, Ying Feng, Xue Ma
    Nutrients.2021; 13(10): 3330.     CrossRef
  • T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
    Wilmar M. Wiersinga
    Endocrinology and Metabolism.2021; 36(5): 938.     CrossRef
  • Association between thyroid hormones and insulin resistance indices based on the Korean National Health and Nutrition Examination Survey
    Yun Mi Choi, Min Kyung Kim, Mi Kyung Kwak, Dooman Kim, Eun-Gyoung Hong
    Scientific Reports.2021;[Epub]     CrossRef
  • Implication of thyroid function in periodontitis: a nationwide population-based study
    Eyun Song, Min Jeong Park, Jung A. Kim, Eun Roh, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
    Scientific Reports.2021;[Epub]     CrossRef
  • Association between thyroid hormone and components of metabolic syndrome in euthyroid Korean adults
    Kyung A. Shin, Eun Jae Kim
    Medicine.2021; 100(51): e28409.     CrossRef
  • Association between Serum Free Thyroxine and Anemia in Euthyroid Adults: A Nationwide Study
    Mijin Kim, Bo Hyun Kim, Hyungi Lee, Min Hee Jang, Jeong Mi Kim, Eun Heui Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim
    Endocrinology and Metabolism.2020; 35(1): 106.     CrossRef
  • Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
    Won Bae Kim, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong
    Endocrinology and Metabolism.2020; 35(1): 14.     CrossRef
  • Long Work Hours Are Associated with Hypothyroidism: A Cross-Sectional Study with Population-Representative Data
    Young Ki Lee, Dong-eun Lee, Yul Hwangbo, You Jin Lee, Hyeon Chang Kim, Eun Kyung Lee
    Thyroid.2020; 30(10): 1432.     CrossRef
  • Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population
    K. Lee, S. Lim, H. Park, H.Y. Woo, Y. Chang, E. Sung, H.S. Jung, K.E. Yun, C.W. Kim, S. Ryu, M.J. Kwon
    Osteoporosis International.2020; 31(3): 547.     CrossRef
  • Update on Thyroid Hormone Levels and Thyroid Dysfunction in the Korean Population Based on Data from the Korea National Health and Nutrition Examination Survey VI (2013 to 2015)
    Jae Hoon Chung
    Endocrinology and Metabolism.2020; 35(1): 7.     CrossRef
  • Assessment of the relationship between knee ultrasound and clinical symptoms in patients with thyroid dysfunction
    Bo Young Kim, Sung-Soo Kim, Hyeong Kyu Park, Hyun-Sook Kim
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • Association between urinary sodium levels and iodine status in Korea
    Jonghwa Ahn, Jang Ho Lee, Jiwoo Lee, Ji Yeon Baek, Eyun Song, Hye-Seon Oh, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Won Gu Kim
    The Korean Journal of Internal Medicine.2020; 35(2): 392.     CrossRef
  • Association of Thyroid Status with Health-Related Quality of Life in Korean Older Adults
    Minjung Han, Seulggie Choi, Sarang Kim, Ahryoung Ko, Joung Sik Son, Sang Min Park
    Korean Journal of Family Medicine.2020; 41(1): 38.     CrossRef
  • High neutrophil-to-lymphocyte ratio is associated with relapse in Graves’ disease after antithyroid drug therapy
    Mijin Kim, Bo Hyun Kim, Min Hee Jang, Jeong Mi Kim, Eun Heui Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim
    Endocrine.2020; 67(2): 406.     CrossRef
  • Sex differences in subclinical hypothyroidism and associations with metabolic risk factors: a health examination-based study in mainland China
    Li Jiang, Jinman Du, Weizhu Wu, Jianjiang Fang, Jufang Wang, Jinhua Ding
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Association between Serum Free Thyroxine and Anemia in Euthyroid Adults: A Nationwide Study (Endocrinol Metab 2020;35:106-14, Mijin Kim et al.)
    Mijin Kim, Bo Hyun Kim
    Endocrinology and Metabolism.2020; 35(3): 669.     CrossRef
  • Urinary Iodine Concentration and Thyroid Peroxidase Antibodies in the Korean Population Using Korea National Health and Nutrition Examination Survey VI
    Myung-Chul Chang
    International Journal of Thyroidology.2020; 13(2): 155.     CrossRef
  • Recent Issues Related to Thyroid Disease in Pregnancy
    Jae Hoon Chung
    International Journal of Thyroidology.2020; 13(2): 85.     CrossRef
  • Epidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands)
    Hanneke J. C. M. Wouters, Sandra N. Slagter, Anneke C. Muller Kobold, Melanie M. van der Klauw, Bruce H. R. Wolffenbuttel, Silvia Naitza
    PLOS ONE.2020; 15(11): e0242795.     CrossRef
  • Hipertiroidi Hastalarında Tedavi Öncesi ve Sonrası Trombosit/Lenfosit ve Nötrofil/Lenfosit Oranlarının Değerlendirilmesi
    Çiğdem CİNDOĞLU, Mehmet GÜLER, Mehmet Ali EREN, Tevfik SABUNCU
    Harran Üniversitesi Tıp Fakültesi Dergisi.2020; 17(1): 104.     CrossRef
  • Association between Sleep Duration and Subclinical Thyroid Dysfunction Based on Nationally Representative Data
    Woojun Kim, Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Min-Hee Kim
    Journal of Clinical Medicine.2019; 8(11): 2010.     CrossRef
  • High Normal Range of Free Thyroxine is Associated with Decreased Triglycerides and with Increased High-Density Lipoprotein Cholesterol Based on Population Representative Data
    Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Min-Hee Kim
    Journal of Clinical Medicine.2019; 8(6): 758.     CrossRef
  • Association High-Iodine-Containing Seaweed Soup Consumption after Birth and Subclinical Hypothyroidism in Korean Women: Korea National Health and Nutrition Examination Survey IV (2013–2015)
    Hyunsam Kim, Ha Ni Lee, Jeonghoon Ha
    International Journal of Thyroidology.2019; 12(2): 105.     CrossRef
  • Reference Range and Sociodemographic Characteristics of TSH among Reproductive Age Women in Rural China
    Qiang Su, Shikun Zhang, Mei Hu, Qiaomei Wang, Na Liu, Haiping Shen, Yiping Zhang, Man Zhang
    Biological Trace Element Research.2019; 189(2): 336.     CrossRef
  • Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
    Daham Kim, Yongin Cho, Cheol Ryong Ku, Hyein Jung, Ju Hyung Moon, Eui Hyun Kim, Dong Yeob Shin, Sun Ho Kim, Eun Jig Lee
    Journal of Clinical Medicine.2019; 8(8): 1142.     CrossRef
  • Thyroid Dysfunction in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: A Monocentric Retrospective Study
    JAE YEON KIM, YONG-BEOM PARK, SANG-WON LEE
    The Journal of Rheumatology.2019; 46(9): 1248.     CrossRef
  • Thyroid dysfunction in patients with suspected or documented supraventricular tachyarrhythmia
    Hye Bin Gwag, Ji Eun Jun, Youngjun Park, Seong Soo Lee, Seung-Jung Park, June Soo Kim, Kyoung-Min Park, Young Keun On
    International Journal of Arrhythmia.2019;[Epub]     CrossRef
  • Association between Iodine Nutrition Status and Thyroid Disease-Related Hormone in Korean Adults: Korean National Health and Nutrition Examination Survey VI (2013–2015)
    Sohye Kim, Yong Seok Kwon, Ju Young Kim, Kyung Hee Hong, Yoo Kyoung Park
    Nutrients.2019; 11(11): 2757.     CrossRef
  • Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus
    T. I. de Vries, L. J. Kappelle, Y. van der Graaf, H. W. de Valk, G. J. de Borst, H. M. Nathoe, F. L. J. Visseren, Jan Westerink
    Acta Diabetologica.2019; 56(4): 431.     CrossRef
  • The Association between Low Vitamin D Status and Autoimmune Thyroid Disease in Korean Premenopausal Women: The 6th Korea National Health and Nutrition Examination Survey, 2013–2014
    Choon-Young Kim, Yeon Ji Lee, Ji-Ho Choi, Soo Yeon Lee, Hye Young Lee, Da Hye Jeong, Yeon Jun Choi
    Korean Journal of Family Medicine.2019; 40(5): 323.     CrossRef
  • Associations between urine iodine and allergic diseases in the Korean National Health and Nutrition Examination Survey 2013–2015: A STROBE-compliant article
    Young Bok Lee, Ji hyun Lee, Min Ji Kang, Dong Soo Yu, Kyung Do Han, Yong Gyu Park
    Phytomedicine.2019; 62: 152937.     CrossRef
  • The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults
    Jeong Mi Kim, Bo Hyun Kim, Hyungi Lee, Eun Heui Kim, Mijin Kim, Jong Ho Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim, Yong Ki Kim
    Diabetes & Metabolism Journal.2019; 43(6): 867.     CrossRef
  • Sex-Dependent Association between Weight Change and Thyroid Dysfunction: Population-Level Analysis Using the Korean National Health and Nutrition Examination Survey
    Eyun Song, Jonghwa Ahn, Hye-Seon Oh, Min Ji Jeon, Won Gu Kim, Won Bae Kim, Young Kee Shong, Tae Yong Kim
    European Thyroid Journal.2019; 8(4): 202.     CrossRef
  • Subclinical Hypothyroidism: is it Really Subclinical with Aging?
    Robin Gourmelon, Sandrine Donadio-Andréi, Karim Chikh, Muriel Rabilloud, Elisabetta Kuczewski, Anne-Sophie Gauchez, Anne Charrié, Pierre-Yves Brard, Raphaëlle Andréani, Jean-Cyril Bourre, Christine Waterlot, Domitille Guédel, Anne Mayer, Emmanuel Disse, C
    Aging and disease.2019; 10(3): 520.     CrossRef
  • Serum thyroid‐stimulating hormone levels and smoking status: Data from the Korean National Health and Nutrition Examination Survey VI
    Suyeon Park, Won Gu Kim, Min Ji Jeon, Mijin Kim, Hye‐Seon Oh, Minkyu Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Clinical Endocrinology.2018; 88(6): 969.     CrossRef
  • Sex-specific genetic influence on thyroid-stimulating hormone and free thyroxine levels, and interactions between measurements: KNHANES 2013–2015
    Young Ki Lee, Dong Yeob Shin, Hyejung Shin, Eun Jig Lee, Silvia Naitza
    PLOS ONE.2018; 13(11): e0207446.     CrossRef
  • Ten Years of the Korean Thyroid Association: Achievement and Future
    Young Joo Park, Young Shin Song, Ka Hee Yi
    International Journal of Thyroidology.2018; 11(1): 1.     CrossRef
  • Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAFV600E mutation
    Young Ki Lee, Kyeong Hye Park, Se Hee Park, Kwang Joon Kim, Dong Yeob Shin, Kee Hyun Nam, Woong Youn Chung, Eun Jig Lee
    Head & Neck.2018; 40(10): 2271.     CrossRef
  • Prevalence and Annual Incidence of Thyroid Disease in Korea from 2006 to 2015: A Nationwide Population-Based Cohort Study
    Hyemi Kwon, Jin-hyung Jung, Kyung-Do Han, Yong-Gyu Park, Jung-Hwan Cho, Da Young Lee, Ji Min Han, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Endocrinology and Metabolism.2018; 33(2): 260.     CrossRef
  • Evaluation of Thyroid Hormone Levels and Urinary Iodine Concentrations in Koreans Based on the Data from Korea National Health and Nutrition Examination Survey VI (2013 to 2015)
    Jae Hoon Chung
    Endocrinology and Metabolism.2018; 33(2): 160.     CrossRef
  • Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country
    Carmen Castillo, Nicole Lustig, Paula Margozzini, Andrea Gomez, María Paulina Rojas, Santiago Muzzo, Lorena Mosso
    Endocrinology and Metabolism.2018; 33(4): 466.     CrossRef
  • Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015
    Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Bong-Yun Cha, Min-Hee Kim
    Scientific Reports.2018;[Epub]     CrossRef
  • Sex differences in risk factors for subclinical hypothyroidism
    Jeonghoon Ha, Jeongmin Lee, Kwanhoon Jo, Dong-Jun Lim, Moo Il Kang, Bong Yun Cha, Min-Hee Kim
    Endocrine Connections.2018; 7(4): 511.     CrossRef
  • Associations of Urinary Cotinine-Verified Active and Passive Smoking with Thyroid Function: Analysis of Population-Based Nationally Representative Data
    Jihun Kang, Eunhee Kong, Jongsoon Choi
    Thyroid.2018; 28(5): 583.     CrossRef
  • Establishment of Korean Thyroid Association-10 Years of Development in Internal Medicine
    Jae Hoon Chung
    International Journal of Thyroidology.2018; 11(1): 7.     CrossRef
  • Association between subclinical thyroid dysfunction and depressive symptoms in the Korean adult population: The 2014 Korea National Health and Nutrition Examination Survey
    Jae Won Hong, Jung Hyun Noh, Dong-Jun Kim, Osama Ali Abulseoud
    PLOS ONE.2018; 13(8): e0202258.     CrossRef
  • Association Between Thyroid Dysfunction and Lipid Profiles Differs According to Age and Sex: Results from the Korean National Health and Nutrition Examination Survey
    Hye-Seon Oh, Hyemi Kwon, Jonghwa Ahn, Eyun Song, Suyeon Park, Mijin Kim, Minkyu Han, Min Ji Jeon, Won Gu Kim, Won Bae Kim, Young Kee Shong, Eun-Jung Rhee, Tae Yong Kim
    Thyroid.2018; 28(7): 849.     CrossRef
  • The Relationship between Subclinical Thyroid Disease and Cardiovascular Disease Risk Score in Koreans
    Hee Joong Lim, Seong Hee Ahn, Seongbin Hong, Young Ju Suh
    Journal of Korean Medical Science.2017; 32(10): 1626.     CrossRef
  • Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data
    Yun Mi Choi, Won Gu Kim, Hyemi Kwon, Min Ji Jeon, Minkyu Han, Tae Yong Kim, Young Kee Shong, Sang Mo Hong, Eun‐Gyoung Hong, Won Bae Kim
    Cancer.2017; 123(24): 4808.     CrossRef
  • Response: Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015 (Endocrinol Metab 2017;32:106-14, Won Gu Kim et al.)
    Won Gu Kim, Jae Hoon Chung
    Endocrinology and Metabolism.2017; 32(2): 304.     CrossRef
  • Excessive Iodine Intake and Thyrotropin Reference Interval: Data from the Korean National Health and Nutrition Examination Survey
    Min Ji Jeon, Won Gu Kim, Hyemi Kwon, Mijin Kim, Suyeon Park, Hye-Seon Oh, Minkyu Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(7): 967.     CrossRef
  • Subclinical thyroid dysfunction and risk of carotid atherosclerosis
    Hosu Kim, Tae Hyuk Kim, Hye In Kim, So Young Park, Young Nam Kim, Seonwoo Kim, Min-Ji Kim, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee, Yong-Ki Min, Jae Hoon Chung, Mira Kang, Sun Wook Kim, Tatsuo Shimosawa
    PLOS ONE.2017; 12(7): e0182090.     CrossRef
  • Letter: Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015 (Endocrinol Metab 2017;32:106-14, Won Gu Kim et al.)
    Young Ki Lee, Dong Yeob Shin
    Endocrinology and Metabolism.2017; 32(2): 302.     CrossRef
  • Vitamin D deficiency affects thyroid autoimmunity and dysfunction in iodine-replete area: Korea national health and nutrition examination survey
    Mijin Kim, Eyun Song, Hye-Seon Oh, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Won Bae Kim, Young Kee Shong, Tae Yong Kim
    Endocrine.2017; 58(2): 332.     CrossRef
  • Viral Hepatitis in South Korea
    Stella C Pak, Yaseen Alastal, Zubair Khan, Umar Darr
    Euroasian Journal of Hepato-Gastroenterology.2017; 7(2): 163.     CrossRef
Close layer
Clinical Study
Prevalence of Hyponatremia in Hypothyroid Patients during Radioactive 131I Ablation for Differentiated Thyroid Cancer: Single Institution Experience
Juan Carlo P. Dayrit, Elaine C. Cunanan, Sjoberg A. Kho
Endocrinol Metab. 2016;31(3):410-415.   Published online August 17, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.3.410
  • 7,430 View
  • 39 Download
  • 4 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   
Background

Hyponatremia developing in hypothyroid patients has been encountered in clinical practice; however, its prevalence has not been well established.

Methods

Thirty patients diagnosed with differentiated thyroid cancer, rendered hypothyroid after surgery and levothyroxine withdrawal, and who are for radioactive iodine (RAI) ablation were included. Serum sodium concentrations were measured twice, at the time of admission for RAI ablation, and before discharge after increased oral fluid intake. The outcome measures were to determine the prevalence of hyponatremia among hypothyroid patients prior to RAI ablation and after oral hydration post-RAI, and to correlate the serum sodium levels pre-RAI and post-RAI with thyroid-stimulating hormone (TSH) concentration and age.

Results

Thirty patients were included, with ages from 23 to 65 years old (median, 40). Two patients (6.7%) were hyponatremic prior to RAI ablation, and eight patients (26.7%) had mild hyponatremia (130 to 134 mEq/L) after RAI and hydration. There was no significant correlation between TSH levels and serum sodium levels prior to or after RAI. There was also no significant correlation between pre- and post-RAI sodium concentration and age.

Conclusions

The prevalence of hyponatremia pre-RAI was 6.7%, and 26.7% post-RAI. No significant correlation was noted between TSH concentration and age on pre- or post-RAI sodium concentrations. Routine measurement of serum sodium post-RAI/isolation is still not advised. Measurement of sodium post-RAI may be considered in patients who are elderly, with comorbid conditions or on medications.

Citations

Citations to this article as recorded by  
  • Epidemiology, Diagnosis, and Management of Thyroid Cancer in the Philippines
    Karol Ann T. Baldo, Ruby Anne N. King, Florence Giannina F. San Juan, Cecile C. Dungog, Jea Giezl N. Solidum, Jeremy A. Ceriales, Ma. Carmela P. dela Cruz, Frances Dominique V. Ho, Nicole Picart, Aldrin Nico R. Plantado, Jessica Perez, Jervy P. Garcia, Jo
    Indian Journal of Surgical Oncology.2025;[Epub]     CrossRef
  • Is there a causal relationship between hypothyroidism and hyponatremia?
    Julie Chen
    Therapeutic Advances in Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • Endocrinopathy-induced euvolemic hyponatremia
    Talia Diker-Cohen, Benaya Rozen-Zvi, Dana Yelin, Amit Akirov, Eyal Robenshtok, Anat Gafter-Gvili, Daniel Shepshelovich
    Internal and Emergency Medicine.2018; 13(5): 679.     CrossRef
Close layer
Review Article
Thyroid
Update on the Management of Thyroid Disease during Pregnancy
Chang Hoon Yim
Endocrinol Metab. 2016;31(3):386-391.   Published online August 16, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.3.386
  • 8,857 View
  • 94 Download
  • 16 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   

Thyroid dysfunction during pregnancy can result in serious complications for both the mother and infant; however, these complications can be prevented by optimal treatment of maternal overt thyroid dysfunction. Although several studies have demonstrated that maternal subclinical hypothyroidism is associated with obstetric complications and neurocognitive impairments in offspring, there is limited evidence that levothyroxine treatment can improve these complications. Therefore, most professional societies do not recommend universal screening for thyroid dysfunction during pregnancy, and instead recommend a case-finding approach in which only high-risk women are tested. However, recent studies have estimated that targeted thyroid function testing misses approximately 30% to 55% of hypothyroidism cases in pregnant women, and some associations and researchers have recommended universal screening of pregnant women to facilitate the early detection and treatment of overt hypothyroidism. This review summarizes recent data on thyroid function test changes, thyroid functional disorder management, and thyroid screening during pregnancy.

Citations

Citations to this article as recorded by  
  • Prevalence of congenital hypothyroidism in infants of mothers with hypothyroidism: a meta-analysis
    Shree Dheera Yarlagadda, Dhananjaya Melkunte Shanthaiah, Shruthi Ravindra, Vijaya Sarathi
    Journal of Pediatric Endocrinology and Metabolism.2026; 39(1): 1.     CrossRef
  • The association of back pain with physical inactivity and hypothyroidism in pregnant women
    Chencui Shi, Qiangdong Zou, Hong Wei
    Journal of Back and Musculoskeletal Rehabilitation.2024; 37(6): 1663.     CrossRef
  • The Effect of Inflammatory Markers in the Hemogram Parameters of Pregnant Women with Thyroid Disease on Obstetric and Neonatal Outcomes
    Funda DEMİREL, Ünal TURKAY
    Düzce Tıp Fakültesi Dergisi.2023; 25(3): 231.     CrossRef
  • Enfermedades tiroideas y embarazo en una unidad de cuidados intensivos. Experiencia 2014-2019
    J.G. Vázquez-Rodríguez, A.C. Andrade-Rodríguez
    Clínica e Investigación en Ginecología y Obstetricia.2021; 48(3): 100662.     CrossRef
  • Decreased Expression of Ileal Thyroid Hormone Transporters in a Hypothyroid Patient: A Case Report
    Chae Won Chung, Eun Young Mo, Gyung Seo Jung, Yoo Hyung Kim, Sun Wook Cho, Do Joon Park, Jeong Mo Bae, Young Joo Park
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Tiroidectomía en paciente embarazada con enfermedad de Graves sin respuesta a tratamiento médico: reporte de caso
    Elly Morros González, Leonardo Javier Rojas Melo, Viviana Cruz Ramírez, Angélica Imitola
    Universitas Médica.2020;[Epub]     CrossRef
  • Thyroid disorders in subfertility and early pregnancy
    Samantha Anandappa, Mamta Joshi, Lukasz Polanski, Paul V. Carroll
    Therapeutic Advances in Endocrinology and Metabolism.2020;[Epub]     CrossRef
  • Addressing thyroid dysfunction in pregnancy
    Teodora Onciu, Remus Şipoş
    Medic.ro.2020; 3(135): 48.     CrossRef
  • Antenatal/early postnatal hypothyroidism increases the contribution of Rho-kinase to contractile responses of mesenteric and skeletal muscle arteries in adult rats
    Dina K. Gaynullina, Svetlana I. Sofronova, Anastasia A. Shvetsova, Ekaterina K. Selivanova, Anna P. Sharova, Andrey A. Martyanov, Olga S. Tarasova
    Pediatric Research.2018; 84(1): 112.     CrossRef
  • Voluntary exercise training restores anticontractile effect of NO in coronary arteries of adult rats with antenatal/early postnatal hypothyroidism
    D.K. Gaynullina, A.A. Borzykh, S.I. Sofronova, E.K. Selivanova, A.A. Shvetsova, A.A. Martyanov, I.V. Kuzmin, O.S. Tarasova
    Nitric Oxide.2018; 74: 10.     CrossRef
  • Impact of positive thyroid autoimmunity on pregnant women with subclinical hypothyroidism
    Cristina López-Tinoco, Amparo Rodríguez-Mengual, Almudena Lara-Barea, Julia Barcala, Laura Larrán, Ana Saez-Benito, Manuel Aguilar-Diosdado
    Endocrinología, Diabetes y Nutrición (English ed.).2018; 65(3): 150.     CrossRef
  • Impacto de la autoinmunidad antitiroidea positiva en gestantes con hipotiroidismo subclínico
    Cristina López-Tinoco, Amparo Rodríguez-Mengual, Almudena Lara-Barea, Julia Barcala, Laura Larrán, Ana Saez-Benito, Manuel Aguilar-Diosdado
    Endocrinología, Diabetes y Nutrición.2018; 65(3): 150.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Maternal hypothyroidism: An overview of current experimental models
    Mahboubeh Ghanbari, Asghar Ghasemi
    Life Sciences.2017; 187: 1.     CrossRef
Close layer
Case Report
Thyroid
A Rare Manifestation of Hypothyroid Myopathy: Hoffmann's Syndrome
Kang Won Lee, Sun Hwa Kim, Kyoung Jin Kim, Sang Hyun Kim, Hee Young Kim, Byung-Jo Kim, Sin Gon Kim, Dong Seop Choi
Endocrinol Metab. 2015;30(4):626-630.   Published online December 31, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.4.626
  • 12,931 View
  • 141 Download
  • 13 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   

Hypothyroid myopathy is observed frequently and the resolution of the clinical manifestations of myopathy following thyroid hormone replacement is well known. However, a specific subtype of hypothyroid myopathy, Hoffmann's syndrome, characterized by increased muscular mass (pseudohypertrophy), proximal muscle weakness, muscle stiffness and cramps, is rarely reported. Herein, we describe a 34-year-old male who presented with proximal muscle weakness and non-pitting edema of the lower extremities. He initially visited the neurology department where he was suspected of having polymyositis. Additional laboratory evaluation revealed profound autoimmune hypothyroidism and elevated muscle enzymes including creatine kinase. The patient was started on levothyroxine treatment and, subsequently, clinical symptoms and biochemical parameters resolved with the treatment. The present case highlights that hypothyroidism should be considered in the differential diagnosis of musculoskeletal symptoms even in the absence of overt manifestations of hypothyroidism. To our knowledge, this is the first case reported in Korea.

Citations

Citations to this article as recorded by  
  • Suspected muscular pseudohypertrophy in a dog: An atypical presentation of hypothyroidism
    Florian Bedel, Maud Girod, Alexis Lecoindre
    Veterinary Record Case Reports.2025;[Epub]     CrossRef
  • Muscle pseudohypertrophy as the presenting manifestation of autoimmune hypothyroidism: Hoffmann’s syndrome
    Atanu Chandra, Moni Sankar Bhattacharjee, Purbasha Biswas, Parthasarathi Karmakar
    BMJ Case Reports.2025; 18(1): e262110.     CrossRef
  • Hoffmann's syndrome: delayed onset and progression in the elderly - a case report
    Dhakchinamoorthi Krishna Kumar, Murugan Sridhar, Nethaji Priyadharshini, Balaji Yogesh, Navaneethakrishnan Manoj
    International Journal of Research in Medical Sciences.2025; 13(8): 3508.     CrossRef
  • Stiff-person syndrome mimic secondary to hypopituitarism: a case report and literature review
    Menghan Zheng, Bo Cui, Junqi Liu, Huanli Duan, Wei Wang, Haifeng Li, Lu Lu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The association of back pain with physical inactivity and hypothyroidism in pregnant women
    Chencui Shi, Qiangdong Zou, Hong Wei
    Journal of Back and Musculoskeletal Rehabilitation.2024; 37(6): 1663.     CrossRef
  • Hoffmann’s Syndrome as a Rare Manifestation of Hypothyroidism: Current Views on Mechanisms of Development and Diagnosis
    T.I. Mamedova, K.A. Reznichenko, E.V. Timofeev
    Juvenis Scientia.2024; 10(6): 19.     CrossRef
  • Hoffmann’s syndrome in the differential work-up of myopathic complaints: a case report
    Sabine Winter, Bianka Heiling, Niklas Eckardt, Christof Kloos, Hubertus Axer
    Journal of Medical Case Reports.2023;[Epub]     CrossRef
  • Hypothyroidism: A Peculiar Presentation
    Rita V Nogueira, Rui Lima, Carina Parente, Pedro Liberal, Lucia Santos
    Cureus.2023;[Epub]     CrossRef
  • Hoffman's syndrome as the presenting manifestation of non-primary hypothyroidism in a case of Prader-Willi Syndrome
    R. Ghosh, A. Ray, D. Roy, J. Benito-Leon
    Neurología.2022; 37(9): 824.     CrossRef
  • Hoffman's syndrome as the presenting manifestation of non-primary hypothyroidism in a case of Prader-Willi Syndrome
    R. Ghosh, A. Ray, D. Roy, J. Benito-Leon
    Neurología (English Edition).2022; 37(9): 824.     CrossRef
  • Hoffmann’s syndrome necessitating forearm fasciotomy: a case report
    Erling Aarsæther, Ragnar Joakimsen, Hanne Halvorsen, Trude Sildnes, Olav Sivertsen, Jan Due
    Journal of Medical Case Reports.2020;[Epub]     CrossRef
  • Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature
    Alessandro Sindoni, Carmelo Rodolico, Maria Angela Pappalardo, Simona Portaro, Salvatore Benvenga
    Reviews in Endocrine and Metabolic Disorders.2016; 17(4): 499.     CrossRef
Close layer
Review Article
Thyroid
Subclinical Hypothyroidism and Cardiovascular Disease
Sunghwan Suh, Duk Kyu Kim
Endocrinol Metab. 2015;30(3):246-251.   Published online August 4, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.3.246
  • 12,125 View
  • 133 Download
  • 33 Web of Science
  • 34 Crossref
AbstractAbstract PDFPubReader   

Subclinical hypothyroidism (SCH) is a common disorder that is characterized by elevated thyroid-stimulating hormone levels in conjunction with free thyroxine concentrations within the normal reference range. Thyroid hormones are known to affect the heart and vasculature and, as a result, the impact of SCH on the cardiovascular (CV) system has recently become an important topic of research. Strong evidence points to a link between SCH and CV risk factors such as alterations in blood pressure, lipid levels, and atherosclerosis. Additionally, accumulating evidence indicates that SCH is associated with metabolic syndrome and heart failure. The present review proposes that SCH may be a potentially modifiable risk factor of CV disease and mortality. However, large-scale clinical trials with appropriate power investigating the risks and benefits of SCH treatment are required to determine whether these benefits can be achieved with levothyroxine therapy.

Citations

Citations to this article as recorded by  
  • Long-Term Impact of Subclinical Hypothyroidism on Cardiovascular Outcomes in Adults: A Meta-Analysis of Cohort and Observational Studies
    Abali Wandala, Nana Akuoko- Frimpong, Marium Nadeem Khan, Hussein Khalid Mamdooh, Abdullah Ghaith Alshaharli, Sufyan Mustafa, Muhammad Bilal Akbar
    Indus Journal of Bioscience Research.2025; 3(4): 21.     CrossRef
  • The impact of weight loss interventions on thyroid function: a systematic review and meta-analysis
    Sandeep Samethadka Nayak, Seyyed Mohammad Hashemi, Masum Patel, Nimra Shafi, Pubali Biswas, Sepide Javankiani, Padmavathi Jaladi, Sanjana B. Patil, Rahiq Rashid, Ehsan Amini-Salehi, Daniyal Ameen, Khushbu Viresh Janani, Anil Kumar Jonnalagadda, Kwame Boat
    Annals of Medicine & Surgery.2025; 87(7): 4484.     CrossRef
  • Association Between Vitamin D Deficiency and Subclinical Cardiovascular Symptoms Among Young Adults in Pakistan
    Sandhya Sahani, Adu Yiadom Boakye, Maherullah Kasi, Hafsa Ahmed, Naveen Shaikh, Ayesha Mansoor, Syed Saif Ali, Faheem Ashraf, Bushra Kaynat, Muhammad Imran Sharif, Haider Alam
    Cureus.2025;[Epub]     CrossRef
  • Prognostic implications of thyroid disease in patients with atrial fibrillation
    Anthi Vasilopoulou, Vasiliki Patsiou, Alexandra Bekiaridou, Andreas S. Papazoglou, Dimitrios V. Moysidis, Marina Spaho, Martha Zergioti, Dimitrios Kostakakis, Maria-Eirini Kyriakideli, Chrysanthi-Ioanna Lampropoulou, Anastasios Kartas, Athanasios Samaras,
    Heart and Vessels.2024; 39(2): 185.     CrossRef
  • A Comparative Study of Iron Status in Subclinical Hypothyroid and Euthyroid Subjects in a Tertiary Care Hospital
    Thokati G Swapnika, S S Sabitha Rani, Satish Dipankar, Afreen Begum H Itagi, Immadi S Vamshidhar
    Cureus.2024;[Epub]     CrossRef
  • Impact of Subclinical Hypothyroidism on Lipid Profile in Jeddah: A Retrospective Cohort Study
    Mahmoud A Alzahrani, Fatemah S Baqar, Basil A Alzahrani, Ziyad A Badri, Rayan Alshamrani, Jamal Aljuhani
    Cureus.2024;[Epub]     CrossRef
  • Lipid Profile Pitfalls in Subclinical Hypothyroidism Pathophysiology and Treatment
    Marina Nicolaou, Meropi Toumba
    Lipidology.2024; 1(2): 105.     CrossRef
  • The influence of hypothyroidism on the course of coronary artery disease in patients with reduced left ventricular ejection fraction
    M.V. Kucheriava, G.B. Mankovskyi
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(3): 161.     CrossRef
  • Correlation between Subclinical Hypothyroidism and Metabolic Syndrome: A Retrospective Study
    Salhah Saleh Alsulami, Mukhtiar Baig, Atheer Hameed Albeladi, Shahad Bandar Alyoubi, Shahad Alhumaidi Alsubaie, Samah Abdulsalam Albeladi, Kholoud Alawi Ghamri, Abeer Mohammed Saeed Alraiqi, Safa Mobarak Alyoubi, Wesam Aied Almutairi
    Saudi Journal of Medicine & Medical Sciences.2023; 11(3): 250.     CrossRef
  • Low awareness and under-diagnosis of hypothyroidism
    Ulrike Gottwald-Hostalek, Barbara Schulte
    Current Medical Research and Opinion.2022; 38(1): 59.     CrossRef
  • Mean platelet volume (MPV) levels in subclinical hypothyroidism and its relation to serum lipid levels
    Zafer ERCAN, Mehmet Emin DEMİR
    Anatolian Current Medical Journal.2022; 4(3): 234.     CrossRef
  • The impact of subclinical hypothyroidism on long-term outcomes in older patients undergoing percutaneous coronary intervention
    Yong-Sheng Liu, Mei Wei, Le Wang, Gang Liu, Guo-Ping Ma, Katsushige Ono, Ze-Long Cao, Man Yang, Ming-Qi Zheng
    BMC Endocrine Disorders.2021;[Epub]     CrossRef
  • Subclinical Hypothyroidism in Geriatric Population and Its Association With Heart Failure
    Priyanka Panday, Ana P Arcia Franchini, Beshoy Iskander, Fatima Anwer, Federico Oliveri, Fotios Kakargias , Pousette Hamid
    Cureus.2021;[Epub]     CrossRef
  • The Effect of Thyroxine Therapy on Cardiovascular Risk Factors in Patients with Subclinical Hypothyroidism
    Selvihan BEYSEL, Mahmut APAYDIN, Mustafa ÇALIŞKAN, Mustafa ÖZBEK, Erman ÇAKAL
    Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi.2021;[Epub]     CrossRef
  • Pathophysiological aspects of development myocardial infarction type 2 in subclinical hypothyroidism
    A. A. Ivannikov, A. A. Kanibolotsky, Kh. G. Alidzhanova, I. V. Bratischev
    Medical alphabet.2021; (42): 34.     CrossRef
  • Unknown Subclinical Hypothyroidism and In-Hospital Outcomes and Short- and Long-Term All-Cause Mortality among ST Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
    Elena Izkhakov, David Zahler, Keren-Lee Rozenfeld, Dor Ravid, Shmuel Banai, Yan Topilsky, Naftali Stern, Yona Greenman, Yacov Shacham
    Journal of Clinical Medicine.2020; 9(12): 3829.     CrossRef
  • Evaluation of left atrial volume and functions by real time three‐dimensional echocardiography in patients with subclinical hypothyroidism before and after levothyroxine therapy
    Seçkin Dereli, Adil Bayramoğlu, Nurtaç Özer, Ahmet Kaya, Muhammet Özbilen
    Echocardiography.2019; 36(5): 916.     CrossRef
  • The impact of thyroid hormone dysfunction on ischemic heart disease
    Madalena von Hafe, João Sergio Neves, Catarina Vale, Marta Borges-Canha, Adelino Leite-Moreira
    Endocrine Connections.2019; 8(5): R76.     CrossRef
  • Association High-Iodine-Containing Seaweed Soup Consumption after Birth and Subclinical Hypothyroidism in Korean Women: Korea National Health and Nutrition Examination Survey IV (2013–2015)
    Hyunsam Kim, Ha Ni Lee, Jeonghoon Ha
    International Journal of Thyroidology.2019; 12(2): 105.     CrossRef
  • Association between subclinical hypothyroidism and metabolic disorders: A retrospective chart review study in an emerging university hospital
    Khaled Aldossari, Sameer Al‐Ghamdi, Jamaan Al‐Zahrani, Anwar Al Jammah, Bader Alanazi, Abdulilah Al‐Briek, Mohammad Alanazi
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study
    Rasiah Thayakaran, Nicola J Adderley, Christopher Sainsbury, Barbara Torlinska, Kristien Boelaert, Dana Šumilo, Malcolm Price, G Neil Thomas, Konstantinos A Toulis, Krishnarajah Nirantharakumar
    BMJ.2019; : l4892.     CrossRef
  • Visceral Adiposity Index Levels in Patients with Hypothyroidism
    Selma Pekgor, Cevdet Duran, Ruhuşen Kutlu, Ibrahim Solak, Ahmet Pekgor, Mehmet Ali Eryilmaz
    Journal of the National Medical Association.2018; 110(6): 606.     CrossRef
  • Diagnosis and Management of Hypothyroidism: Addressing the Knowledge–Action Gaps
    Sanjay Kalra, A. K. Das, Sarita Bajaj, Banshi Saboo, Deepak Khandelwal, Mangesh Tiwaskar, Navneet Agarwal, Pritam Gupta, Rakesh Sahay, Sameer Aggarwal, Sujoy Ghosh, Vijay Negalur, A. G. Unnikrishnan, Ganapathi Bantwal, Rashmi Aggarwal, Harshal Chaudhari,
    Advances in Therapy.2018; 35(10): 1519.     CrossRef
  • DYNAMICS OF EXCHANGE PARAMETERS OF ULTRASONIC HEART RESEARCH IN PATIENTS WITH CLIMACTERIC SYNDROME ASSOCIATED WITH HYPOTHYROIDISM UNDER THE INFLUENCE OF COMPLEX THERAPY
    M. O. Pavlovska, V. P. Vakaluk, E. I. Deltsova
    World of Medicine and Biology.2018; 14(63): 056.     CrossRef
  • Risk factors for cardiovascular disease in subclinical hypothyroidism
    F. Decandia
    Irish Journal of Medical Science (1971 -).2018; 187(1): 39.     CrossRef
  • New levothyroxine formulation meeting 95–105% specification over the whole shelf-life: results from two pharmacokinetic trials
    Ulrike Gottwald-Hostalek, Wolfgang Uhl, Peter Wolna, George J. Kahaly
    Current Medical Research and Opinion.2017; 33(2): 169.     CrossRef
  • Subclinical thyroid dysfunction and risk of carotid atherosclerosis
    Hosu Kim, Tae Hyuk Kim, Hye In Kim, So Young Park, Young Nam Kim, Seonwoo Kim, Min-Ji Kim, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee, Yong-Ki Min, Jae Hoon Chung, Mira Kang, Sun Wook Kim, Tatsuo Shimosawa
    PLOS ONE.2017; 12(7): e0182090.     CrossRef
  • Effect of Marijuana Use on Thyroid Function and Autoimmunity
    Sonali Malhotra, Rubina A. Heptulla, Peter Homel, Roja Motaghedi
    Thyroid.2017; 27(2): 167.     CrossRef
  • Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury
    Viswanathan Rajagopalan, Youhua Zhang, Christine Pol, Clifford Costello, Samantha Seitter, Ann Lehto, Olga V. Savinova, Yue-feng Chen, A. Martin Gerdes
    Frontiers in Physiology.2017;[Epub]     CrossRef
  • Myocardial Performance Index for Patients with Overt and Subclinical Hypothyroidism
    Aziz Karabulut, Abdullah Doğan, Alpaslan Kemal Tuzcu
    Medical Science Monitor.2017; 23: 2519.     CrossRef
  • CARDIOVASCULAR MANIFESTATIONS IN PATIENTS OF HYPOTHYROIDISM- RESULTS OF A SINGLE CENTRE STUDY
    Rohit Vasant Deshpande, Swati Harish Sharma, Swapnil Sahebrao Walke, Mayur Ramakrishnarao Hedau, Bharat Sing Rathod, Amol Raghunath Bhore, Hitesh Lotan Mahale
    Journal of Evolution of Medical and Dental Sciences.2017; 6(45): 3514.     CrossRef
  • The Association of Thyroid Hormones and Tsh with the Metabolic Syndrome in Euthyroid Taiwanese Individuals
    Chun-Yuan Huang, Lee-Ching Hwang
    Endocrine Practice.2016; 22(11): 1303.     CrossRef
  • Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism
    Xuejie Dong, Zhi Yao, Yanjin Hu, Ning Yang, Xia Gao, Yuan Xu, Guang Wang
    Medicine.2016; 95(29): e4291.     CrossRef
  • Impaired Hemorheological Parameters and Increased Carotid Intima-Media Thickness in Children with Subclinical Hypothyroidism
    Yasemin Isik-Balci, Sebahat Agladioglu, Kadir Agladioglu, Emine Kilic-Toprak, Ozgen Kilic-Erkek, Bayram Ozhan, Aziz Polat, Melek Bor-Kucukatay
    Hormone Research in Paediatrics.2016; 85(4): 250.     CrossRef
Close layer
Original Articles
Thyroid
Incidence and Prevalence of Overt Hypothyroidism and Causative Diseases in Korea as Determined Using Claims Data Provided by the Health Insurance Review and Assessment Service
Gi Hyeon Seo, Jae Hoon Chung
Endocrinol Metab. 2015;30(3):288-296.   Published online January 5, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.3.288
  • 7,031 View
  • 60 Download
  • 18 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   
Background

The incidence and prevalence of overt hypothyroidism have been reported to be 2 to 4/1,000 population/year and 8 to 13/1,000 population, respectively, in foreign countries. As there has been no nationwide survey to obtain data in Korea, the present study investigated the incidence and prevalence of overt hypothyroidism in Korea using claims data provided by the Health Insurance Review and Assessment Service. The proportions of causative diseases for hypothyroidism were also analyzed.

Methods

This study was retrospectively performed with 541,969 Korean patients (92,832 men and 449,137 women), with overt hypothyroidism, treated with thyroid hormone between 2008 and 2012.

Results

The incidence of overt hypothyroidism in Korea was 2.26/1,000 population/year (0.78 in men and 3.72 in women), and the prevalence was 14.28/1,000 population (4.40 in men and 24.03 in women). When patients with thyroid cancer were excluded, the incidence was 1.56/1,000 population/year (0.54 in men and 2.57 in women). The incidence increased with age, with peaks in and after the late 60s in men and in the early 50s in women. The prevalence peaked in the early 70s in men and in the late 50s in women.

Conclusion

This is a report of the first nationwide investigation of the incidence and prevalence of overt hypothyroidism in Korea, although it is limited to patients treated with thyroid hormone.

Citations

Citations to this article as recorded by  
  • Long-term forecasting and evaluation of medicine consumption for the ATC class H with a focus on thyroid hormones in OECD countries using ARIMA models
    Lilly Josephine Bindel, Roland Seifert
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(8): 10691.     CrossRef
  • A Review of Herbal Medicine Treatments on Aftereffects of Thyroidectomy
    Soo-duk Kim, Min-jo Seo, Su-na Park, Hye-ri Jo, So-hyeon Ryu, Geon-sik Kong, Yo-sup Choi
    The Journal of Internal Korean Medicine.2024; 45(4): 615.     CrossRef
  • Rising Incidence and Comorbidities of Endogenous Hypothyroidism in Republic of Korea from 2004 to 2018: A Nationwide Population Study
    Chae Won Chung, Hwa Young Ahn, Sun Wook Cho, Ka Hee Yi
    Endocrinology and Metabolism.2024; 39(6): 891.     CrossRef
  • Association of Thyroid Hormone Medication Adherence With Risk of Dementia
    Saemi Han, Seogsong Jeong, Seulggie Choi, Sun Jae Park, Kyae Hyung Kim, Gyeongsil Lee, Yoosun Cho, Joung Sik Son, Sang Min Park
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e225.     CrossRef
  • The impact of the micronutrient iodine in health and diseases
    Ma. Cecilia Opazo, Irenice Coronado-Arrázola, Omar P. Vallejos, Rodrigo Moreno-Reyes, Carlos Fardella, Lorena Mosso, Alexis M. Kalergis, Susan M. Bueno, Claudia A. Riedel
    Critical Reviews in Food Science and Nutrition.2022; 62(6): 1466.     CrossRef
  • Hypothyroidism risk associated with rheumatoid arthritis
    Chung-Ming Huang, Fung-Chang Sung, Hsuan-Ju Chen, Che-Chen Lin, Cheng-Li Lin, Po-Hao Huang
    Medicine.2022; 101(1): e28487.     CrossRef
  • Risk of All-Cause Mortality in Levothyroxine-Treated Hypothyroid Patients: A Nationwide Korean Cohort Study
    Seo Young Sohn, Gi Hyeon Seo, Jae Hoon Chung
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Update on Thyroid Hormone Levels and Thyroid Dysfunction in the Korean Population Based on Data from the Korea National Health and Nutrition Examination Survey VI (2013 to 2015)
    Jae Hoon Chung
    Endocrinology and Metabolism.2020; 35(1): 7.     CrossRef
  • Treatment of hypothyroidism using Korean medicine: 2 case reports
    Hyongjun Kim, Sun-Young Moon, Kyungsun Han, Jun-Hwan Lee, Jong Hwan Im, Sungha Kim, Jeong-Eun Yoo
    Medicine.2020; 99(18): e19737.     CrossRef
  • Genotype association of IP6K3 gene with Hashimoto’s thyroiditis in Algerian population (Aures region)
    Warda Kherrour, Dean Kalicanin, Luka Brčić, Leila Hambaba, Mouloud Yahia, Souheyla Benbia, Vesna Boraska Perica
    Egyptian Journal of Medical Human Genetics.2020;[Epub]     CrossRef
  • Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
    Daham Kim, Yongin Cho, Cheol Ryong Ku, Hyein Jung, Ju Hyung Moon, Eui Hyun Kim, Dong Yeob Shin, Sun Ho Kim, Eun Jig Lee
    Journal of Clinical Medicine.2019; 8(8): 1142.     CrossRef
  • Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration
    Hun-Sung Kim, Dai-Jin Kim, Kun-Ho Yoon
    Endocrinology and Metabolism.2019; 34(4): 349.     CrossRef
  • Evaluation of Thyroid Hormone Levels and Urinary Iodine Concentrations in Koreans Based on the Data from Korea National Health and Nutrition Examination Survey VI (2013 to 2015)
    Jae Hoon Chung
    Endocrinology and Metabolism.2018; 33(2): 160.     CrossRef
  • Prevalence and Annual Incidence of Thyroid Disease in Korea from 2006 to 2015: A Nationwide Population-Based Cohort Study
    Hyemi Kwon, Jin-hyung Jung, Kyung-Do Han, Yong-Gyu Park, Jung-Hwan Cho, Da Young Lee, Ji Min Han, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Endocrinology and Metabolism.2018; 33(2): 260.     CrossRef
  • Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015
    Won Gu Kim, Won Bae Kim, Gyeongji Woo, Hyejin Kim, Yumi Cho, Tae Yong Kim, Sun Wook Kim, Myung-Hee Shin, Jin Woo Park, Hai-Lin Park, Kyungwon Oh, Jae Hoon Chung
    Endocrinology and Metabolism.2017; 32(1): 106.     CrossRef
  • The relationship of 19 functional polymorphisms in iodothyronine deiodinase and psychological well-being in hypothyroid patients
    Yoon Young Cho, Hye Jeong Kim, Hye Won Jang, Tae Hyuk Kim, Chang-Seok Ki, Sun Wook Kim, Jae Hoon Chung
    Endocrine.2017; 57(1): 115.     CrossRef
  • Concomitant Thyroid Disorders and Inflammatory Bowel Disease: A Literature Review
    Toru Shizuma
    BioMed Research International.2016; 2016: 1.     CrossRef
  • Hypothyroidism among SLE patients: Case–control study
    Abdulla Watad, Naim Mahroum, Aaron Whitby, Smadar Gertel, Doron Comaneshter, Arnon D. Cohen, Howard Amital
    Autoimmunity Reviews.2016; 15(5): 484.     CrossRef
Close layer
Thyroid
The Biochemical Prognostic Factors of Subclinical Hypothyroidism
Myung Won Lee, Dong Yeob Shin, Kwang Joon Kim, Sena Hwang, Eun Jig Lee
Endocrinol Metab. 2014;29(2):154-162.   Published online June 26, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.2.154
  • 6,624 View
  • 61 Download
  • 14 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   
Background

Patients with subclinical hypothyroidism (SHT) are common in clinical practice. However, the clinical significance of SHT, including prognosis, has not been established. Further clarifying SHT will be critical in devising a management plan and treatment guidelines for SHT patients. Thus, the aim of this study was to investigate the prognostic factors of SHT.

Methods

We reviewed the medical records of Korean patients who visited the endocrinology outpatient clinic of Severance Hospital from January 2008 to September 2012. Newly-diagnosed patients with SHT were selected and reviewed retrospectively. We compared two groups: the SHT maintenance group and the spontaneous improvement group.

Results

The SHT maintenance group and the spontaneous improvement group had initial thyroid-stimulating hormone (TSH) levels that were significantly different (P=0.035). In subanalysis for subjects with TSH levels between 5 to 10 µIU/mL, the spontaneous improvement group showed significantly lower antithyroid peroxidase antibody (anti-TPO-Ab) titer than the SHT maintenance group (P=0.039). Regarding lipid profiles, only triglyceride level, unlike total cholesterol and low density lipoprotein cholesterol, was related to TSH level, which is correlated with the severity of SHT. Diffuse thyroiditis on ultrasonography only contributed to the severity of SHT, not to the prognosis. High sensitivity C-reactive protein and urine iodine excretion, generally regarded as possible prognostic factors, did not show any significant relation with the prognosis and severity of SHT.

Conclusion

Only initial TSH level was a definite prognostic factor of SHT. TPO-Ab titer was also a helpful prognostic factor for SHT in cases with mildly elevated TSH. Other than TSH and TPO-Ab, we were unable to validate biochemical prognostic factors in this retrospective study for Korean SHT patients.

Citations

Citations to this article as recorded by  
  • Exploring Serum Anti-thyroid Peroxidase Antibodies and High-Sensitivity C-reactive Protein as Inflammatory Markers in Subclinical Hypothyroidism: A Comprehensive Study
    Anantha Priya, Barani Sri, Ganesh Bala, Suganya Kannan
    Cureus.2025;[Epub]     CrossRef
  • Determinants of Levothyroxine Treatment in Patients with Hypothyroidism
    Savaş Karataş, Yalçın Hacıoğlu
    Cyprus Journal of Medical Sciences.2022; 7(5): 593.     CrossRef
  • Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape
    Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2021; 36(3): 500.     CrossRef
  • Thyroid disorders in Brazil: the contribution of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
    I.M. Bensenor
    Brazilian Journal of Medical and Biological Research.2019;[Epub]     CrossRef
  • Risk factors for hypothyroidism in euthyroid thyroid nodule patients with lymphocytic thyroiditis on fine needle aspiration cytology
    Jeong-Min Lee, Jeonghoon Ha, Kwanhoon Jo, Yejee Lim, Min-Hee Kim, Chan-Kwan Jung, So-Lyung Jung, Moo-Il Kang, Bong-Yun Cha, Dong-Jun Lim
    The Korean Journal of Internal Medicine.2019; 34(6): 1287.     CrossRef
  • Analysis of the factors affecting the evolution over time of subclinical hypothyroidism in children
    Mariella Valenzise, Tommaso Aversa, Giuseppina Zirilli, Giuseppina Salzano, Domenico Corica, Simona Santucci, Filippo De Luca
    Italian Journal of Pediatrics.2017;[Epub]     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Reference interval for thyrotropin in a ultrasonography screened Korean population
    Mijin Kim, Tae Yong Kim, Soo Han Kim, Yunkyoung Lee, Su-yeon Park, Hyung-don Kim, Hyemi Kwon, Yun Mi Choi, Eun Kyung Jang, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
    The Korean Journal of Internal Medicine.2015; 30(3): 335.     CrossRef
  • Subclinical hypothyroidism: a historical view and shifting prevalence
    J. V. Hennessey, R. Espaillat
    International Journal of Clinical Practice.2015; 69(7): 771.     CrossRef
  • Letter: The Biochemical Prognostic Factors of Subclinical Hypothyroidism (Endocrinol Metab2014;29:154-62, Myung Won Lee et al.)
    Hwa Young Ahn, Yun Jae Chung
    Endocrinology and Metabolism.2014; 29(3): 400.     CrossRef
  • The Biochemical Prognostic Factors of Subclinical Hypothyroidism
    You Jin Lee
    Endocrinology and Metabolism.2014; 29(2): 144.     CrossRef
Close layer
Case Reports
Thyroid
Hypoparathyroidism and Subclinical Hypothyroidism with Secondary Hemochromatosis
Hyung Ki Jeong, Joon Hwan An, Hyoung Sang Kim, Eun Ae Cho, Min Gui Han, Jung Sik Moon, Hee Kyung Kim, Ho-Cheol Kang
Endocrinol Metab. 2014;29(1):91-95.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.91
  • 7,926 View
  • 49 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   

Hemochromatosis is an inherited genetic disorder of iron metabolism which can also occur as a secondary result of iron-overload. It leads to organ damage such as cardiomyopathy, liver cirrhosis, hypogonadism, and diabetes. This paper discusses a case of secondary hemochromatosis associated with repeated transfusions, presenting as asymptomatic hypoparathyroidism and subclinical hypothyroidism with multiple organ involvement. The 29-year-old female, who had severe aplastic anemia, received multiple transfusions totaling approximately 1,400 units of red blood cells over 15 years. During her routine laboratory examination, hypocalcemia was detected with decreased intact parathyroid hormone and increased thyroid stimulating hormone. Serum ferritin, iron, and total iron binding capacity had increased to 27,583.03 ng/mL, 291 µg/dL, and 389 µg/dL, respectively. She had unusually bronze skin and computed tomography revealed iron deposition in the thyroid, liver, and heart. Multiorgan involvement as seen in this case is rare in hemochromatosis associated with secondary transfusions. To the best of the author's knowledge, this is the first case report in Korea of hypoparathyroidism and subclinical hypothyroidism due to iron deposition in the parathyroid and thyroid gland.

Citations

Citations to this article as recorded by  
  • Severe Hypocalcemia During JAK1/2 Inhibitor Therapy for Myelofibrosis in a Patient with Liver Cirrhosis
    Mayuna Kurumazaki, Noriko Ogawa, Mariko Kobayashi, Fumiyoshi Ikejiri, Keizo Kanasaki
    Internal Medicine.2025; 64(15): 2338.     CrossRef
  • Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease
    Annita Kolnagou, Marios Kleanthous, George J. Kontoghiorghes
    Frontiers in Bioscience-Elite.2022;[Epub]     CrossRef
  • Hypocalcaemic Cardiomyopathy: A Description of Two Cases and a Literature Review
    Martin Válek, Lenka Roblová, Ivan Raška, Dita Schaffelhoferová, Tomáš Paleček
    ESC Heart Failure.2020; 7(3): 1291.     CrossRef
  • Differential effects of Fe2+ and Fe3+ on osteoblasts and the effects of 1,25(OH)2D3, deferiprone and extracellular calcium on osteoblast viability under iron-overloaded conditions
    Kornkamon Lertsuwan, Ketsaraporn Nammultriputtar, Supanan Nanthawuttiphan, Natnicha Tannop, Jarinthorn Teerapornpuntakit, Jirawan Thongbunchoo, Narattaphol Charoenphandhu, Gianpaolo Papaccio
    PLOS ONE.2020; 15(5): e0234009.     CrossRef
  • Apparent Resolution of Canine Primary Hypoparathyroidism with Immunosuppressive Treatment
    J. Warland, B. Skelly, C. Knudsen, M. Herrtage
    Journal of Veterinary Internal Medicine.2015; 29(1): 400.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Thyroid
Hyponatremia after Thyroid Hormone Withdrawal in a Patient with Papillary Thyroid Carcinoma
Hyo Jin Jo, Yong Hyun Kim, Dong Hyun Shin, Mi Jeoung Kim, Sang Jin Lee, Dong Ok Jeon, Sung Gyu Im, Sun Kyung Jang, Jin Young Choi
Endocrinol Metab. 2014;29(1):77-82.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.77
  • 7,794 View
  • 48 Download
  • 4 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   

Hyponatremia is an electrolyte abnormality commonly found in clinical practice. It is important to diagnose the underlying etiology of the hyponatremia and correct it appropriately because severe hyponatremia can cause serious complications and substantially increase the risk of mortality. Although hypothyroidism is known to be a cause of hyponatremia, it is rare that hyponatremia occurs in relation to hypothyroidism induced by thyroid hormone withdrawal in patients with differentiated thyroid cancer. We report a case of a 76-year-old woman with papillary thyroid carcinoma presenting with severe hyponatremia related to hypothyroidism induced by thyroid hormone withdrawal for radio-active iodine whole-body scanning, who was treated by thyroid hormone replacement and hydration. Considering that the incidence of differentiated thyroid cancer is rapidly increasing, physicians should be aware that, although uncommon, hyponatremia can occur in patients undergoing radioiodine therapy or diagnostic testing.

Citations

Citations to this article as recorded by  
  • Study of Hyponatremia in Hypothyroidism Patients
    Vishva J Ahya, Sarvatnida N Shaikh, Twinkal D Varsani, Simbita A Marwah, Karan N Shah
    Indian Journal of Medical Biochemistry.2025; 30(1): 120.     CrossRef
  • Effect of preparation method for radioactive iodine therapy on serum electrolytes
    Noriko Takata, Masao Miyagawa, Tomohisa Okada, Naoto Kawaguchi, Yutaka Fujimoto, Yoshihiro Kouchi, Shintaro Tsuruoka, Kotaro Uwatsu, Teruhito Kido
    Japanese Journal of Radiology.2023; 41(11): 1247.     CrossRef
  • MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment
    G Liamis, T D Filippatos, A Liontos, M S Elisaf
    European Journal of Endocrinology.2017; 176(1): R15.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma
    Zhongjing Lv, Xiangbing Wu, Wei Cao, ZongZe Shen, Lizhen Wang, FuRong Xie, JianJun Zhang, Tong Ji, Ming Yan, WanTao Chen
    Journal of Experimental & Clinical Cancer Research.2014;[Epub]     CrossRef
  • Hyponatremia and the Thyroid: Causality or Association?
    Kevin Pantalone, Betul Hatipoglu
    Journal of Clinical Medicine.2014; 4(1): 32.     CrossRef
Close layer
Review Article
Thyroid
Prevalence and Risk Factors of Subclinical Thyroid Disease
Ye An Kim, Young Joo Park
Endocrinol Metab. 2014;29(1):20-29.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.20
  • 15,596 View
  • 171 Download
  • 76 Web of Science
  • 78 Crossref
AbstractAbstract PDFPubReader   

Subclinical thyroid disease is defined biochemically by an abnormal thyrotropin (TSH) level and normal serum-free thyroxine level. The prevalence of this condition varies according to the reference range for TSH and geographic or demographic factors. Recently, several studies, including our community-based cohort studies, have reported on the incidence of subclinical thyroid disease in Korea. Using these studies, we reviewed the prevalence and risk factors of subclinical thyroid disease, focusing on subclinical hypothyroidism.

Citations

Citations to this article as recorded by  
  • Hyperthyroidism: a review of the African American population
    Chibuzor Joseph Onwughalu, Irebami Kolapo-Raheem, Toluwalase Emmanuel Akinfisoye, Olamide Olayinka, Kelsey Danielle Rodrigues, Inemesit Imoh Ekanem, Olawale Gabriel Ajibola
    Discover Medicine.2025;[Epub]     CrossRef
  • Radiological, cytological and histopathological correlation in patients undergoing thyroid surgery at a tertiary care hospital in western Gujarat: a cross-sectional study
    Rashmi Sorathiya, Sharvil Nimavat, Narendra Hirani, Ajeet Kumar Khilnani, Ayush Tank, Mansi Patel
    International Journal of Otorhinolaryngology and Head and Neck Surgery.2025; 11(1): 28.     CrossRef
  • Mechanistic insights into TSH-mediated macrophage mitochondrial dysfunction via TSHR signaling in metabolic disorders
    Yuhan Zhang, Hanyu Wang, Mengfei Fu, Liu Yang, Xiao Chen, Zixuan Wang, Jiaqi Liu, Hui Sun
    Free Radical Biology and Medicine.2025; 240: 783.     CrossRef
  • Subclinical hyperthyroidism
    Alasdair Cooper, Prakash Abraham
    Current Opinion in Endocrinology, Diabetes & Obesity.2025; 32(5): 175.     CrossRef
  • Heart rate variability and left atrial stiffness index by 2D speckle-tracking echocardiography in subclinical thyroid dysfunction
    Asmaa A. Hassan, Eman Samy El Shehawy, Mona S. Esmail, Gehan E. Hossam-Eldin, Radwa M. Fath Allah, Hanaa Elasayed Abozeid, Doaa Sayed Mohammed, Marwa Abdelaziz Abo Seree Yassien, Sally Abdelaziz Ahmed, Doaa Mohamed Salama, Esraa M. Aslah, Fatma M. Kotb, E
    Egyptian Journal of Radiology and Nuclear Medicine.2025;[Epub]     CrossRef
  • Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study
    Ivan Nicolas Ayala, Cristian Soto Jacome, David Toro-Tobon, Elizabeth Golembiewski, Andrea Garcia-Bautista, Jessica Hidalgo, Sandra Cordova-Madera, Raghda Al Anbari, Jessica Sohn R, Naykky Singh Ospina, Spyridoula Maraka, Marina Joseph, Juan P Brito
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e765.     CrossRef
  • Changes in thyroid function and evolution of subclinical thyroid disease in older men
    Stephanie Y. Tan, S. A. Paul Chubb, Leon Flicker, Osvaldo P. Almeida, Jonathan Golledge, Graeme J. Hankey, Bu B. Yeap
    Clinical Endocrinology.2024; 100(2): 170.     CrossRef
  • Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis
    Hasveer Singh, Mariam Z. Shahid, Stephanie L. Harrison, Deirdre A. Lane, Gregory Y. H. Lip, Sunil Jit R. J. Logantha, Gaetano Santulli
    PLOS ONE.2024; 19(1): e0296413.     CrossRef
  • EMAS position statement: Thyroid disease and menopause
    Gesthimani Mintziori, Stavroula Veneti, Kris Poppe, Dimitrios G. Goulis, Eleni Armeni, C. Tamer Erel, Ivan Fistonić, Timothy Hillard, Angelica Lindén Hirschberg, Blazej Meczekalski, Nicolás Mendoza, Alfred O. Mueck, Tommaso Simoncini, Petra Stute, Dorenda
    Maturitas.2024; 185: 107991.     CrossRef
  • A Clinical Study of Thyroid Abnormalities and Autoantibodies in Patients Diagnosed With Anti-nuclear Antibody Positive Autoimmune Connective Tissue Disorders: An Observational Cross-Sectional Study
    Saimounika Adapa, Varsha R Bhatt, Govind Shiddapur, Nilesh Jagdale, Vutukuru Kalyan Kumar Reddy, Mohith Prakash Kondapalli, Sonali Agarwal, Diksha Sabharwal, Advait Jha
    Cureus.2024;[Epub]     CrossRef
  • Efficacy of Standardized Yoga Asanas as Add-on Therapy in the Management of Hypothyroidism: A Randomized, Open-label, Controlled Clinical Study
    Tanu Sharma, Bhavy Goyal, Khan Afreen Mustaq Ahmed, Guru Deo, Ishita Kaushik, Rohit Malik, Vineet Jain, Dharmander Singh, Sunil Kohli, Kailash Chandra
    International Journal of Yoga.2024; 17(2): 124.     CrossRef
  • Subclinical Hypothyroidism and Clinical Outcomes After Percutaneous Coronary Intervention: A Meta-Analysis
    Song Peng Ang, Jia Ee Chia, Vikash Jaiswal, Dhrubajyoti Bandyopadhyay, Jose Iglesias, Gautham Varun Krishna Mohan, Sudarshan Gautam, Thazin Win, Tushar Kumar, Abbas Iqbal, Tong Hong Chia, Wilbert Aronow
    Current Problems in Cardiology.2023; 48(8): 101719.     CrossRef
  • Preliminary observation of thyroid function changes in subclinical thyroid diseases
    Hua-Xin Wang, Wen-Yu Gao, Yang Yang, Yun-Feng Li, Yan Zhang, Xin-Yi Zhang, Yu-Xia Li
    Technology and Health Care.2023; 31(5): 1715.     CrossRef
  • Cardiovascular outcomes in subclinical thyroid disease: an update
    Matthew D. Ettleson
    Current Opinion in Endocrinology, Diabetes & Obesity.2023; 30(5): 218.     CrossRef
  • Effects of whole seaweed consumption on humans: current evidence from randomized-controlled intervention trials, knowledge gaps, and limitations
    João P. Trigo, Marie Palmnäs-Bédard, Mar Vall-Llosera Juanola, Ingrid Undeland
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • The correlation of lipid profile with subclinical and overt hypothyroidism: A cross-sectional study from Syria
    Fatima Tarboush, Mohammad Alsultan, Zaynab Alourfi
    Medicine.2023; 102(37): e34959.     CrossRef
  • Autoimmune thyroid status in subclinical thyroid disorders in patients attending a tertiary care center in Nepal: a hospital-based cross-sectional study
    Vijay Kumar Sharma, Apeksha Niraula, Eans Tara Tuladhar, Aseem Bhattarai, Mithileshwer Raut, Raju Kumar Dubey, Sujata Baidya, Naresh Parajuli
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • The effect of low dose thyroid replacement therapy in patients with episodic migraine and subclinical hypothyroidism: A randomised placebo-controlled trial
    Priya Dev, T.T. Favas, Rishab Jaiswal, Mareena Cyriac, Vijaya Nath Mishra, Abhishek Pathak
    Cephalalgia.2023;[Epub]     CrossRef
  • The Role of Global Longitudinal Strain in Subclinical Hypothyroid Patients With Heart Failure
    Nismat Javed, Vibha Hayagreev, Angel DeLaCruz, Muhammad Saad, Amandeep Singh, Timothy Vittorio
    Cureus.2023;[Epub]     CrossRef
  • Relationship Between Thyroid Hormonal Status in Patients with a Hypothyroid Form of Hashimoto’s Thyroiditis and Iodine Concentrations in Drinking Water
    Olha Kasiyan, Halyna Tkachenko, Natalia Kurhaluk, Svitlana Yurchenko, Alek Manenko
    Biological Trace Element Research.2022; 200(1): 59.     CrossRef
  • Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases
    Jui‐Ming Liu, Yu‐Tang Chen, Chun‐Te Wu, Wen‐Lin Hsu, Ren‐Jun Hsu
    The Prostate.2022; 82(7): 809.     CrossRef
  • Subclinical hypothyroidism in women’s health: from pre- to post-menopause
    Anna Capozzi, Giovanni Scambia, Stefano Lello
    Gynecological Endocrinology.2022; 38(5): 357.     CrossRef
  • Subclinical Hypothyroidism and Cognitive Impairment
    Jung-Min Pyun, Young Ho Park, SangYun Kim
    Journal of Alzheimer's Disease.2022; 88(2): 757.     CrossRef
  • Rosuvastatin potentiates the thyrotropin‐lowering effect of metformin in men with non‐autoimmune subclinical hypothyroidism and prediabetes
    Robert Krysiak, Karolina Kowalcze, Bogusław Okopień
    Journal of Clinical Pharmacy and Therapeutics.2022; 47(12): 2030.     CrossRef
  • Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS)
    A. Amouzegar, M. Dehghani, H. Abdi, L. Mehran, S. Masoumi, F. Azizi
    Journal of Endocrinological Investigation.2022; 45(12): 2353.     CrossRef
  • Interplay between cardiovascular and thyroid dysfunctions: A review of clinical implications and management strategies
    Sanyal Debmalya, Ray Saumitra, Malhi Harshveer Singh
    Endocrine Regulations.2022; 56(4): 311.     CrossRef
  • Routine Measurement of Thyroid Stimulating Hormone in Patients Presenting With Third-Degree Atrioventricular Block: Do We Really Need It?
    Muhammad Faisal, Zubair Mumtaz, Abdul Mueed, Sajid Ali, Haseeb H Raza, Samra Khan, Sayeda Salma, Mustajab Mujtaba, Musa Karim, Faisal Qadir
    Cureus.2021;[Epub]     CrossRef
  • Update of hypothyroidism and its management in Unani medicine
    Md. Anzar Alam, Mohd Aleemuddin Quamri, Ghulamuddin Sofi, Shabnam Ansari
    Journal of Basic and Clinical Physiology and Pharmacology.2021; 32(2): 1.     CrossRef
  • Endemik guatrın dünü, bugünü ve yarını
    Yılmaz SEZGİN
    Turkish Journal of Family Medicine and Primary Care.2021; 15(1): 1.     CrossRef
  • Prognosis of papillary thyroid carcinoma in relation to preoperative subclinical hypothyroidism
    SY Kang, HR Ahn, HJ Youn, SH Jung
    The Annals of The Royal College of Surgeons of England.2021; 103(5): 367.     CrossRef
  • Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology
    Saeideh Aghayari Sheikh Neshin, Shima Shahjouei, Eric Koza, Isabel Friedenberg, Faezeh Khodadadi, Mirna Sabra, Firas Kobeissy, Saeed Ansari, Georgios Tsivgoulis, Jiang Li, Vida Abedi, Donna M. Wolk, Ramin Zand
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • Higher hepatic sterol-binding protein-2 gene expression and serum triglyceride level in methimazole induced subclinical hypothyroid animal model
    Marie Saghaeian Jazi, Mohammad Mostakhdem Hashemi, Abbas Nezhadebrahimi, Azadreza Mansourian
    Comparative Clinical Pathology.2021; 30(4): 627.     CrossRef
  • Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape
    Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2021; 36(3): 500.     CrossRef
  • Thyroid Function and Nutrient Status in the Athlete
    D. Enette Larson-Meyer, Demetre E. Gostas
    Current Sports Medicine Reports.2020; 19(2): 84.     CrossRef
  • Seasonal effects on resting energy expenditure are dependent on age and percent body fat
    Duong Duc Pham, Jeong Hun Lee, Ki Hwan Hong, Youn Joo Jung, Sung Jin Kim, Chae Hun Leem
    Clinical Nutrition.2020; 39(4): 1276.     CrossRef
  • Subclinical hypothyroidism
    Chelsea Simon, Emily Weidman-Evans, Sarah Allen
    JAAPA.2020; 33(5): 21.     CrossRef
  • Clinical and subclinical maternal hypothyroidism and their effects on neurodevelopment, behavior and cognition
    Alice Batistuzzo, Miriam Oliveira Ribeiro
    Archives of Endocrinology and Metabolism.2020; 64(1): 89.     CrossRef
  • Protective effect of a polyherbal bioactive fraction in propylthiouracil-induced thyroid toxicity in ratsby modulation of the hypothalamic–pituitary–thyroid and hypothalamic–pituitary–adrenal axes
    Sneha Singh, Vandana Panda, Sudhamani S., Payal Dande
    Toxicology Reports.2020; 7: 730.     CrossRef
  • Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery
    Hana Kim, Sung Hye Kong, Jae Hoon Moon, Sang Yoon Kim, Kay-Hyun Park, Jun Sung Kim, Joong Haeng Choh, Young Joo Park, Cheong Lim
    Endocrinology and Metabolism.2020; 35(2): 308.     CrossRef
  • Serum FT4 / FT3 Ratio, a Predictive Biochemical Marker for Subclinical Hypothyroidism in Patients with Chronic Kidney Disease
    Venkat Siddarth Chagamreddy, Malligai Elancheran, Murugavel K
    Journal of Evolution of Medical and Dental Sciences.2020; 9(33): 2319.     CrossRef
  • Importance of thyroid-stimulating hormone levels in liver disease
    Hyun Jin Kim
    Journal of Pediatric Endocrinology and Metabolism.2020; 33(9): 1133.     CrossRef
  • Does Hypothyroidism Increase Complications, Lengths of Stay, Readmissions, and Costs Following Primary 1- to 2-Level Lumbar Fusion?
    Rushabh M. Vakharia, Joseph O. Ehiorobo, Bilal Mahmood, Martin W. Roche, Michael A. Mont, Afshin E. Razi
    Clinical Spine Surgery: A Spine Publication.2020; 33(10): E559.     CrossRef
  • Acute psychosis in patients with subclinical hyperthyroidism
    Sohei Kimoto, Kazuhiko Yamamuro, Toshifumi Kishimoto
    Psychiatry and Clinical Neurosciences.2019; 73(6): 348.     CrossRef
  • Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review
    Francesca Reyes Domingo, Marc T. Avey, Marion Doull
    Systematic Reviews.2019;[Epub]     CrossRef
  • Association between subclinical hypothyroidism and metabolic disorders: A retrospective chart review study in an emerging university hospital
    Khaled Aldossari, Sameer Al‐Ghamdi, Jamaan Al‐Zahrani, Anwar Al Jammah, Bader Alanazi, Abdulilah Al‐Briek, Mohammad Alanazi
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • Investigation of Vitamin D Levels and Metabolic Parameters in Patients With Subclinical Hyperthyroidism
    Müge Keskin, Esra Ademoğlu, Arzu Or Koca, Derun Taner Ertugrul
    Ankara Medical Journal.2019;[Epub]     CrossRef
  • Reference Range and Sociodemographic Characteristics of TSH among Reproductive Age Women in Rural China
    Qiang Su, Shikun Zhang, Mei Hu, Qiaomei Wang, Na Liu, Haiping Shen, Yiping Zhang, Man Zhang
    Biological Trace Element Research.2019; 189(2): 336.     CrossRef
  • Subklinik Hipotiroiditli Çocuklarda Ağız Sağlığı Durumunun Değerlendirilmesi
    Nuray TÜLOĞLU, Tuğçe KALİÇOĞLU, Birgül KIREL
    Journal of Biotechnology and Strategic Health Research.2019; 3(3): 237.     CrossRef
  • Association High-Iodine-Containing Seaweed Soup Consumption after Birth and Subclinical Hypothyroidism in Korean Women: Korea National Health and Nutrition Examination Survey IV (2013–2015)
    Hyunsam Kim, Ha Ni Lee, Jeonghoon Ha
    International Journal of Thyroidology.2019; 12(2): 105.     CrossRef
  • Graves Disease in Central Ghana: Clinical Characteristics and Associated Factors
    Osei Sarfo-Kantanka, Fred Stephen Sarfo, Eunice Oparebea Ansah, Ishmael Kyei
    Clinical Medicine Insights: Endocrinology and Diabetes.2018;[Epub]     CrossRef
  • Sex differences in risk factors for subclinical hypothyroidism
    Jeonghoon Ha, Jeongmin Lee, Kwanhoon Jo, Dong-Jun Lim, Moo Il Kang, Bong Yun Cha, Min-Hee Kim
    Endocrine Connections.2018; 7(4): 511.     CrossRef
  • Age-sex disparities and sub-clinical hypothyroidism among patients in Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia
    Habtamu Azene Tekle, Tesfahun Molla Bobe, Efrata Girma Tufa, Fithamlak Bisetegen Solomon
    Journal of Health, Population and Nutrition.2018;[Epub]     CrossRef
  • Subclinical Hypothyroidism and the Risk of Cardiovascular Disease and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies
    Shinje Moon, Min Joo Kim, Jae Myung Yu, Hyung Joon Yoo, Young Joo Park
    Thyroid.2018; 28(9): 1101.     CrossRef
  • Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013–2015)
    So Young Park, Hae In Kim, Hyun-Kyung Oh, Tae Hyuk Kim, Hye Won Jang, Jae Hoon Chung, Myung-Hee Shin, Sun Wook Kim, Sun Y Lee
    PLOS ONE.2018; 13(2): e0190738.     CrossRef
  • Helicobacter pylori-induced autoimmune thyroiditis: is the pathogenic link concluded or still a hypothesis?
    Santhanamari Thiyagarajan, Anil M.R. Saini, Jamal Alruwaili
    Reviews in Medical Microbiology.2018; 29(2): 64.     CrossRef
  • Evaluation of Thyroid Hormone Levels and Urinary Iodine Concentrations in Koreans Based on the Data from Korea National Health and Nutrition Examination Survey VI (2013 to 2015)
    Jae Hoon Chung
    Endocrinology and Metabolism.2018; 33(2): 160.     CrossRef
  • Transcriptome Network Analysis Reveals Aging-Related Mitochondrial and Proteasomal Dysfunction and Immune Activation in Human Thyroid
    Byuri Angela Cho, Seong-Keun Yoo, Young Shin Song, Su-jin Kim, Kyu Eun Lee, Minho Shong, Young Joo Park, Jeong-Sun Seo
    Thyroid.2018; 28(5): 656.     CrossRef
  • Relation of Subclinical Hypothyroidism is Associated With Cardiovascular Events and All-Cause Mortality in Adults With High Cardiovascular Risk
    Shinje Moon, Sung Hye Kong, Hoon Sung Choi, Yul Hwangbo, Moon-Kyu Lee, Jae Hoon Moon, Hak Chul Jang, Nam Han Cho, Young Joo Park
    The American Journal of Cardiology.2018; 122(4): 571.     CrossRef
  • Subclinical Hypothyroidism and Coronary Revascularization After Coronary Artery Bypass Grafting
    Sung Hye Kong, Ji Won Yoon, Sang Yoon Kim, Tae Jung Oh, Kay-Hyun Park, Joong Haeng Choh, Young Joo Park, Cheong Lim
    The American Journal of Cardiology.2018; 122(11): 1862.     CrossRef
  • A Case of Subclinical Hyperthyroidism Treatment with Herbal Medicine
    Dong-eun Jin, Seok-woo Kim, Hyeon-cheo Shin
    The Journal of Internal Korean Medicine.2018; 39(4): 831.     CrossRef
  • Cardiovascular Risk in Subclinical Hypothyroidism
    Mariana Dobrescu, Diana Păun, Daniel Grigorie, Cătălina Poiană
    Internal Medicine.2018; 15(3): 51.     CrossRef
  • Association between thyroid autoimmunity and Helicobacter pylori infection
    Yun Mi Choi, Tae Yong Kim, Eui Young Kim, Eun Kyung Jang, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
    The Korean Journal of Internal Medicine.2017; 32(2): 309.     CrossRef
  • Effect of Marijuana Use on Thyroid Function and Autoimmunity
    Sonali Malhotra, Rubina A. Heptulla, Peter Homel, Roja Motaghedi
    Thyroid.2017; 27(2): 167.     CrossRef
  • Insidious danger in childhood era's: subclinical hypothyroidism
    Ayşegül Alpcan, Ayça Törel Ergür, Serkan Tursun
    Ortadoğu Tıp Dergisi.2017; 9(1): 34.     CrossRef
  • Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015
    Won Gu Kim, Won Bae Kim, Gyeongji Woo, Hyejin Kim, Yumi Cho, Tae Yong Kim, Sun Wook Kim, Myung-Hee Shin, Jin Woo Park, Hai-Lin Park, Kyungwon Oh, Jae Hoon Chung
    Endocrinology and Metabolism.2017; 32(1): 106.     CrossRef
  • Thyroid diseases and risk of non-thyroidal pathology
    R I Glushakov, E V Kozyrko, I V Sobolev, S A Ermolova, O V Vlaseva, A A Kuzin, N I Tapilskaya
    Kazan medical journal.2017; 98(1): 77.     CrossRef
  • Hipertiroidismo
    M. Toni, J. Pineda, E. Anda, J.C. Galofré
    Medicine - Programa de Formación Médica Continuada Acreditado.2016; 12(13): 731.     CrossRef
  • Subclinical Hypothyroidism in Childhood Cancer Survivors
    Hyun Joo Lee, Seung Min Hahn, Song Lee Jin, Yoon Jung Shin, Sun Hee Kim, Yoon Sun Lee, Hyo Sun Kim, Chuhl Joo Lyu, Jung Woo Han
    Yonsei Medical Journal.2016; 57(4): 915.     CrossRef
  • Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders
    Sima Nazarpour, Fahimeh Ramezani Tehrani, Masoumeh Simbar, Maryam Tohidi, Hamid AlaviMajd, Fereidoun Azizi
    European Journal of Endocrinology.2016; 174(1): 77.     CrossRef
  • Association of low baseline free thyroxin levels with progression of coronary artery calcification over 4 years in euthyroid subjects: the Kangbuk Samsung Health Study
    Hye‐Jeong Park, Jihyun Kim, Eun Jin Han, Se Eun Park, Cheol‐Young Park, Won‐Young Lee, Ki‐Won Oh, Sung‐Woo Park, Eun‐Jung Rhee
    Clinical Endocrinology.2016; 84(6): 889.     CrossRef
  • Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases
    Woo Kyung Lee, Sena Hwang, Daham Kim, Seul Gi Lee, Seonhyang Jeong, Mi-Youn Seol, Hyunji Kim, Cheol Ryong Ku, Dong Yeop Shin, Woong Youn Chung, Eun Jig Lee, Jandee Lee, Young Suk Jo
    Medicine.2016; 95(14): e3346.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Reference interval for thyrotropin in a ultrasonography screened Korean population
    Mijin Kim, Tae Yong Kim, Soo Han Kim, Yunkyoung Lee, Su-yeon Park, Hyung-don Kim, Hyemi Kwon, Yun Mi Choi, Eun Kyung Jang, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
    The Korean Journal of Internal Medicine.2015; 30(3): 335.     CrossRef
  • Incidence and Prevalence of Overt Hypothyroidism and Causative Diseases in Korea as Determined Using Claims Data Provided by the Health Insurance Review and Assessment Service
    Gi Hyeon Seo, Jae Hoon Chung
    Endocrinology and Metabolism.2015; 30(3): 288.     CrossRef
  • Subclinical Hypothyroidism and Cardiovascular Disease
    Sunghwan Suh, Duk Kyu Kim
    Endocrinology and Metabolism.2015; 30(3): 246.     CrossRef
  • Bone Health and Clinical Results after Hip Fracture Surgery in Patients with Subclinical Hypothyroidism
    Ki-Choul Kim, Young-Kyun Lee, You Jin Lee, Yong-Chan Ha, Kyung-Hoi Koo
    Journal of Bone Metabolism.2014; 21(3): 213.     CrossRef
  • Subclinical Thyroid Dysfunction in the Elderly
    Ki Dong Ko
    Journal of the Korean Geriatrics Society.2014; 18(3): 111.     CrossRef
  • Subclinical hypothyroidism in addition to common risk scores for prediction of cardiovascular disease: a 10-year community-based cohort study
    Tae Hyuk Kim, Hoon Sung Choi, Ji Cheol Bae, Jae Hoon Moon, Hyung-Kwan Kim, Sung Hee Choi, Soo Lim, Do Joon Park, Kyong Soo Park, Hak Chul Jang, Moon-Kyu Lee, Nam H Cho, Young Joo Park
    European Journal of Endocrinology.2014; 171(5): 649.     CrossRef
Close layer
Case Reports
Thyroid
Rhabdomyolysis and Acute Kidney Injury Associated with Hypothyroidism and Statin Therapy
Pyoung Ahn, Hyun-Jun Min, Sang-Hyun Park, Byoung-Mu Lee, Myung-Jin Choi, Jong-Woo Yoon, Ja-Ryong Koo
Endocrinol Metab. 2013;28(4):331-334.   Published online December 12, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.4.331
  • 7,852 View
  • 52 Download
  • 15 Crossref
AbstractAbstract PDFPubReader   

Rhabdomyolysis is a syndrome involving the breakdown of skeletal muscle that causes myoglobin and other intracellular proteins to leak into the circulatory system, resulting in organ injury including acute kidney injury. We report a case of statin-induced rhabdomyolysis and acute kidney injury that developed in a 63-year-old woman with previously undiagnosed hypothyroidism. Untreated hypothyroidism may have caused her hypercholesterolemia requiring statin treatment, and it is postulated that statin-induced muscle injury was aggravated by hypothyroidism resulting in her full-blown rhabdomyolysis. Although this patient was successfully treated with continuous venovenous hemofiltration and L-thyroxin replacement, rhabdomyolysis with acute kidney injury is a potentially life-threatening disorder. Physicians must pay special attention to the possible presence of subclinical hypothyroidism when administering statins in patients with hypercholesterolemia.

Citations

Citations to this article as recorded by  
  • Hypothyreoïdie en statine-geïnduceerde rhabdomyolyse: case report en literatuurstudie
    T. ENGELEN, A.H. VAN CRAENENBROECK
    Tijdschrift voor Geneeskunde.2025;[Epub]     CrossRef
  • The Hidden Hazard of Hypothyroidism: Statin-Associated Rhabdomyolysis With Life-Threatening Complications
    George Bechir, Angelina Bechir
    Cureus.2025;[Epub]     CrossRef
  • Effects of statin use on serum creatinine phosphokinase levels in normal thyroid function
    Jeonghoon Ha, Joonyub Lee, Jin Yu, Hakyoung Park, Jiwon Shinn, Seung-Hwan Lee, Jae-Hyoung Cho, Hun-Sung Kim
    The Korean Journal of Internal Medicine.2024; 39(4): 650.     CrossRef
  • Is Kidney Stone Associated with Thyroid Disease? The United States National Health and Nutrition Examination Survey 2007-2018
    Wenya Xue, Zihan Xue, Yanbing Liu, Pan Yin, Luyu Liu, Shen’ao Qu, Shaobo Wu, Chuance Yang
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2024; 24(11): 1323.     CrossRef
  • Systematic Review on Efficacy, Effectiveness, and Safety of Pitavastatin in Dyslipidemia in Asia
    Nam Xuan Vo, Huong Lai Pham, Tan Trong Bui, Tien Thuy Bui
    Healthcare.2024; 13(1): 59.     CrossRef
  • Dyslipidémies secondaires
    S. Chalopin, A. Gallo
    EMC - Endocrinologie - Nutrition.2024; 35(1): 1.     CrossRef
  • Case report: Rhabdomyolysis and kidney injury in a statin-treated hypothyroid patient–kill two birds with one stone
    Wen-Fang Chiang, Jenq-Shyong Chan, Po-Jen Hsiao, Shih-Hua Lin
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Secondary dyslipidemia: its treatments and association with atherosclerosis
    Hidekatsu Yanai, Hiroshi Yoshida
    Global Health & Medicine.2021; 3(1): 15.     CrossRef
  • Hypothyroidism-associated rhabdomyolysis
    Fahmi Yousef Khan, Theeb Osama Sulaiman, Raza Ali Akbar
    Imam Journal of Applied Sciences.2021; 6(2): 31.     CrossRef
  • Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization
    Jingyun Choi, Yejin Kim, Hun-Sung Kim, In Young Choi, Hwanjo Yu, Katriina Aalto-Setala
    PLOS ONE.2018; 13(6): e0197518.     CrossRef
  • Discovery of potential novel microsomal triglyceride transfer protein inhibitors via virtual screening of pharmacophore modelling and molecular docking
    Ludi Jiang, Yusu He, Ganggang Luo, Yongqiang Yang, Gongyu Li, Yanling Zhang
    Molecular Simulation.2016; 42(15): 1223.     CrossRef
  • Statin‐related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea
    H.‐S. Kim, S. H. Lee, H. Kim, S.‐H. Lee, J. H. Cho, H. Lee, H. W. Yim, S.‐H. Kim, I.‐Y. Choi, K.‐H. Yoon, J. H. Kim
    Journal of Clinical Pharmacy and Therapeutics.2016; 41(3): 266.     CrossRef
  • Creatinine as predictor value of mortality and acute kidney injury in rhabdomyolysis
    R. Baeza‐Trinidad, A. Brea‐Hernando, S. Morera‐Rodriguez, Y. Brito‐Diaz, S. Sanchez‐Hernandez, L. El Bikri, E. Ramalle‐Gomara, J. L. Garcia‐Alvarez
    Internal Medicine Journal.2015; 45(11): 1173.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!
    Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis, Dimitri P. Mikhailidis
    Current Medical Research and Opinion.2014; 30(9): 1701.     CrossRef
Close layer
A Case of Lingual Thyroid Treated by 131I Ablation.
Myeong Ho Yeon, Yong Hyeok Choi, Young Rak Choi, Woo Ri Park, Hyung Jin Choi, Tae Keun Oh, Hyun Jeong Jeon
Endocrinol Metab. 2012;27(4):303-307.   Published online December 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.4.303
  • 2,715 View
  • 27 Download
AbstractAbstract PDF
A lingual thyroid is a rare developmental anomaly caused by the failure of the descent of the thyroid gland anlage early in the course of embryogenesis. The incidence of lingual thyroid has been reported to be 1/100,000. Lingual thyroid is often asymptomatic but may cause dysphagia, dysphonia, upper airway obstruction and hemorrhage. In this report, we described the case of a 50-year-old women experiencing lingual thyroid who had subclinical hypothyroidism. She underwent successful 131I ablation and has done well on thyroid hormone replacement therapy.
Close layer
A Case of Hypothyroidism in Remission during Pregnancy.
Ha Do Song, Eun Jin Han, Sung Ja Lee, Ji Hoon Yang, So Young Park, Sung Hoon Kim, Ki Ok Han, Hyun Koo Yoon, Chang Hoon Yim
Endocrinol Metab. 2012;27(4):295-298.   Published online December 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.4.295
  • 3,728 View
  • 84 Download
AbstractAbstract PDF
Hypothyroidism should be treated in pregnancy, because it has been associated with an increased risk of adverse pregnancy complications, as well as detrimental effects upon fetal neurocognitive development. The goal of L-thyroxine (LT4) treatment is to normalize maternal serum TSH values within the trimester-specific pregnancy reference range. 50% to 85% of hypothyroid women being treated with exogenous LT4 need to increase the dose during pregnancy. In this study, we report a case of a 29-year-old woman with hypothyroidism who had been in remission and discontinued LT4 treatment during her pregnancy. Three months after delivery she had a relapse of hypothyroidism and was retreated with LT4. Many factors can influence the gestational requirement for LT4, therefore maternal serum TSH should be monitored and the LT4 dose should be adjusted in pregnant patients with treated hypothyroidism.
Close layer
Original Article
Thyroid Dysfunction of North Korean Women Living in South Korea, Focusing on Subclinical Hypothyroidism.
Joo Hyung Kim, Sol Ah Park, Nam Hoon Kim, Jae Hee Ahn, Yoon Jung Kim, Myongjin Cho, Yoon Jung Lee, Hye Jin Yoo, Hee Young Kim, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Sin Gon Kim
Endocrinol Metab. 2012;27(3):200-207.   Published online September 19, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.3.200
  • 4,917 View
  • 32 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Thyroid function depends on ethnic and environmental factors. North Korean refugees have the same genetic background as South Koreans, but they have been exposed to different environments. This study examines the prevalence and pattern of thyroid disorders in North Korean women living in South Korea, focusing on subclinical hypothyroidism (SCH). METHODS: The intended sample was a total of 327 North Korean women residing in Seoul. Health questionnaires and medical examinations, including serum thyrotropin (thyroid stimulating hormone, TSH), free thyroxine, and thyroid autoantibodies, were conducted. RESULTS: The prevalence of SCH was 9.4%. In logistic regression analysis, smoking, menopause, length of stay in South Korea, body mass index, history of thyroid disease, and metabolic syndrome were not associated with the risk of SCH. Whereas, the positivity of autoantibodies were associated with a high risk for SCH (odds ratio [OR], 4.840; 95% confidence interval [CI], 1.80-13.017; P = 0.002), and age was associated with a low risk for SCH (OR, 0.94; 95% CI, 0.888-0.994; P = 0.031). The serum TSH levels also decreased with increasing age, and in particular, there was significant difference between 30-39 years, and over 60 years (2.33 +/- 1.51 microIU/mL vs. 1.54 +/- 0.73 microIU/mL, P = 0.028). CONCLUSION: In North Korean women, the positivity of autoantibodies was associated with a high risk for SCH. But interestingly, a younger age was associated with a high risk for SCH. Considering that they suffered from severe famine at the period of growth, and this led to malnutrition, their thyroid dysfunction might be associated with the peculiar environment that they experienced.

Citations

Citations to this article as recorded by  
  • Systematic review of evidence on public health in the Democratic People’s Republic of Korea
    John J Park, Ah-Young Lim, Hyung-Soon Ahn, Andrew I Kim, Soyoung Choi, David HW Oh, Owen Lee-Park, Sharon Y Kim, Sun Jae Jung, Jesse B Bump, Rifat Atun, Hee Young Shin, Kee B Park
    BMJ Global Health.2019; 4(2): e001133.     CrossRef
  • Environmental Factors and Thyroid Dysfunction
    Hyun-Kyung Chung
    Endocrinology and Metabolism.2012; 27(3): 191.     CrossRef
Close layer
Case Reports
Thyroid Dysfunction Induced by Metastatic Thyroid Cancer: Report of Two Cases.
Kang Hee Ahn, Bo Kyung Choi, Won Jin Kim, Bo Gwang Choi, Yun Kyung Jeon, Sang Soo Kim, Soo Hyung Lee, Bo Hyun Kim, Yong Ki Kim, In Ju Kim
Endocrinol Metab. 2010;25(4):370-373.   Published online December 1, 2010
DOI: https://doi.org/10.3803/EnM.2010.25.4.370
  • 2,628 View
  • 24 Download
  • 1 Crossref
AbstractAbstract PDF
Metastases to the thyroid gland are not frequently observed in clinical practice, although an overall incidence of secondary thyroid malignant tumors has been reported to range from 1.25% to 24% in autopsy series. Generally, patients with metastatic thyroid cancer present with euthyroidism and they do not develop thyroid dysfunction. Thyroid dysfunctions, including hypothyroidism and hyperthyroidism, rarely occur in patients with metastatic thyroid cancer. We describe here a case of hypothyroidism induced by thyroid metastasis from cancer of an unknown primary site in a 53-year-old man and another case of thyrotoxicosis induced by thyroid metastasis from lung cancer in a 65-year-old man.

Citations

Citations to this article as recorded by  
  • Thyroid metastases from breast cancer: a case report and brief literature review
    Siqi He, Jicheng Li, Donglai Wang, Qiaohong Nong, Guangxin Li, Ying Yin, Xiaoling Liu
    Frontiers in Oncology.2025;[Epub]     CrossRef
Close layer
Secondary Pituitary Hyperplasia Induced by Hashimoto's Thyroiditis Related Hypothyroidism: A Case Report.
Kwang Joon Kim, Hyun min Kim, Obin Kwon, Eun Young Park, Yong ho Lee, Jae Won Hong, Jin Wi, Eun Jig Lee
J Korean Endocr Soc. 2010;25(1):72-77.   Published online March 1, 2010
DOI: https://doi.org/10.3803/jkes.2010.25.1.72
  • 3,445 View
  • 37 Download
  • 2 Crossref
AbstractAbstract PDF
Pituitary hyperplasia associated with untreated primary hypothyroidism in children is a rare condition. There are only a few reports on this condition in children, and especially when pituitary hyperplasia is accompanied with Hashimoto thyroiditis and growth arrest. Here, we describe an unusual association of pituitary hyperplasia with hypothyroidism and growth retardation, and this was all caused by Hashimoto thyroiditis. Hormonal testing showed a low thyroxine level and a high thyroid stimulating hormone level, elevated anti-thyroglobulin, low growth hormone levels and prepubertal levels of gonadotropins. A large intrasellar mass expanding beyond the sella turcica was detected on magnetic resonance imaging (MRI). Homogeneous contrast enhancement of mass highly suggested that it was a pituitary hyperplasia rather than a pituitary tumor. Therapy with L-thyroxine resulted in rapid improvement of the clinical signs, including renewed growth, normalization of the hormone levels and resolution of the pituitary hyperplasia on MRI within 90 days. In children, prolonged unrecognized primary hypothyroidism might be accompanied by growth deficiency and pubertal disharmony. Physicians must be aware of pituitary hyperplasia in these cases.

Citations

Citations to this article as recorded by  
  • Pituitary macroadenoma secondary to Hashimoto’s thyroiditis: inadvertent diagnosis in a pre-pubertal girl
    Deepanjan Bhattacharya, Rakesh Kumar, Jaivinder Yadav
    Tropical Doctor.2020; 50(3): 240.     CrossRef
  • Pituitary Hyperplasia Secondary to Hypothyroidism Caused by Hashimoto's Thyroiditis in a Female Adolescent
    Jeoung Suk Kim, Min Sun Kim, Sun Jun Kim, Gyung Ho Chung, Pyoung Han Hwang, Dae-Yeol Lee
    Journal of Korean Society of Pediatric Endocrinology.2011; 16(3): 185.     CrossRef
Close layer
Autoimmune Thyroiditis during Antiviral Therapy with Peginterferon.
Jung Min Roh, Jeong Seon Yoo, Yoon Bum Lee, Hye Rim An, Hong Kyu Choi, Kyo Tae Jung, Jong Suk Park, Kwan Sik Lee, Kyung Rae Kim
J Korean Endocr Soc. 2010;25(1):68-71.   Published online March 1, 2010
DOI: https://doi.org/10.3803/jkes.2010.25.1.68
  • 2,400 View
  • 25 Download
AbstractAbstract PDF
Combination treatment with pegylated interferon and ribavirin has been established as a standard therapy for chronic hepatitis C. Although interferon therapy is relatively safe, an important side effect is the induction of autoantibodies and autoimmune disease, especially autoimmune thyroid disease. Interferon associated autoimmune thyroid disease can consist of autoimmune hypothyroidism, Graves' disease, and destructive thyroiditis. Thyroid disease may lead to dose reduction or discontinuation of therapy.
Close layer
Original Articles
Association between Cigarette Smoking and Thyroid Function in Adults without Previous History of Thyroid Disease.
Bo Hyun Kim, Won Bae Kim, Tae Yong Kim, Hong Kyu Kim, Seong Hoon Jeon, Chang Won Lee, Young Kee Shong
J Korean Endocr Soc. 2008;23(2):123-128.   Published online April 1, 2008
DOI: https://doi.org/10.3803/jkes.2008.23.2.123
  • 3,810 View
  • 34 Download
  • 4 Crossref
AbstractAbstract PDF
BACKGROUND
Cigarette smoking has a significant impact on thyroid function. However, the association between smoking and thyroid function is incompletely understood. METHODS: We conducted a cross-sectional study that included 90,970 adults (age range: 20 to 79) who had visited the health promotion center at Asan Medical Center between January 1, 2001, and December 31, 2003. Those subjects with previous known thyroid disease, a history of thyroid operation, a history of thyroid function altering medication (herb, estrogen or digestive) or a family history of thyroid disease were excluded. Finally, 47,577 subjects (males: 30,726, females: 16,851) were included in this study. We calculated the age-adjusted geometric mean of the serum TSH and the age-adjusted mean of the serum free T4 among the current, former and never smokers. We also analyzed the age-adjusted prevalence of hypothyroidism and hyperthyroidism among each group. RESULTS: Among men, the geometric mean TSH level was significantly low in the current (1.40 mIU/L, 95% confidence interval [CI]: 1.38-1.41) and former smokers (1.59 mIU/L, 95% CI: 1.57-1.61) compared with the never smokers (1.65 mIU/L, 95% CI: 1.63-1.68). The mean free T4 level was high in the current smokers (1.236 ng/dL, 95% CI: 1.234-1.239) compared with the never smokers (1.234 ng/dL, 95% CI: 1.230-1.238). Similarly, among women, the geometric mean TSH level was low in the current smokers (1.75 mIU/L, 95% CI: 1.67-1.87) compared with the never smokers (1.85 mIU/L, 95% CI: 1.83-1.87). The mean free T4 level was high in the current smokers (1.149 ng/dL, 95% CI: 1.139-1.159) compared with the never smokers (1.138 ng/dL, 95% CI: 1.135-1.140). Among the current male smokers, heavy daily smoking (over 2 packs per day) was more associated with low TSH levels than moderate smoking (less than 1 pack per day). In men, the prevalence of subclinical hypothyroidism was low in the current smokers compared with the never smokers (odds ratio: 0.53, 95% CI: 0.43-0.66). CONCLUSION: We found that current smokers had lower TSH levels and higher free T4 levels than never smokers in both men and women and smoking was associated with a low prevalence of subclinical hypothyroidism in men, which may be of importance when evaluating subjects with subclinical hypothyroidism in Korea.

Citations

Citations to this article as recorded by  
  • Evaluation of Serum Biochemical Parameters Primarily Liver Functions in Smokers: A Case-control Study
    Yılmaz Sezgin, Sinan Becel, Abdurrahman Polat
    Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi.2024; 13(3): 1125.     CrossRef
  • Reference interval for thyrotropin in a ultrasonography screened Korean population
    Mijin Kim, Tae Yong Kim, Soo Han Kim, Yunkyoung Lee, Su-yeon Park, Hyung-don Kim, Hyemi Kwon, Yun Mi Choi, Eun Kyung Jang, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
    The Korean Journal of Internal Medicine.2015; 30(3): 335.     CrossRef
  • Clinical Review of Thyroid Dysfunction in the Subjects for Health Check-up
    Ji Eun Park, Ho Chan Cho
    Journal of Korean Thyroid Association.2012; 5(1): 52.     CrossRef
  • Thyroid Dysfunction of North Korean Women Living in South Korea, Focusing on Subclinical Hypothyroidism
    Joo Hyung Kim, Sol Ah Park, Nam Hoon Kim, Jae Hee Ahn, Yoon Jung Kim, Myongjin Cho, Yoon Jung Lee, Hye Jin Yoo, Hee Young Kim, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Sin Gon Kim
    Endocrinology and Metabolism.2012; 27(3): 200.     CrossRef
Close layer
Comparison of Common Carotid Artery Intima-Media Thickness between Subclinical Hypothyroidism and Euthyroidism.
Kyung Sun Park, Jung Im Rue, Soo Kyung Kim, In Jae Kim, Sang Wook Lim, Seok Won Park, Yu Lee Kim, Dong Hoon Cha, Yong Wook Cho, Young Kil Choi, Sang Jong Lee
J Korean Endocr Soc. 2006;21(6):490-496.   Published online December 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.6.490
  • 3,432 View
  • 22 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Common carotid artery intima-media thickness (IMT), which is increased in patients with overt hypothyroidism, is an independent risk factor of the atherosclerosis-related disease. This study was performed to compare serum lipid level and common carotid artery IMT among patients with overt hypothyroidism, subclinical hypothyroidism and euthyroidism. METHODS: Patients with newly-diagnosed subclinical (n=32) and overt (n=32) hypothyroidism were selected for this study. All of the patients and an age- and sex-matched euthyroidism cohort were checked for clinical characteristics and serum lipid levels. Common carotid artery IMT was also measured using high resolution B-mode ultrasonography. RESULTS: Statistically significant differences were observed between the total cholesterol levels of patients with subclinical hypothyroidism and those with euthyroidism. When common carotid artery IMT measured by ultrasonography, subclinical (0.67 +/- 0.11 mm) and overt (0.71 +/- 0.12 mm)) hypothyroidism showed significantly increased mean IMT compared to that of euthyroidism (0.58 +/- 0.07 mm, P < 0.05, respectively), but no differences were found between subclinical and overt hypothyroidism. CONCLUSION: We concluded that subclinical hypothyroidism is related to increased common carotid artery IMT as well as dyslipidemia. Therefore, we recommend that treatment principle of subclinical hypothyroidism be established through large-scale, prospective studies performed to determine the effect of thyroid hormone replacement on the reduction of common carotid artery IMT.

Citations

Citations to this article as recorded by  
  • The Effect of Brief Thyroid Functional Changes on Arterial Stiffness in Patients Who Preparing Radioactive Iodine Administration
    Ho-Su Kim, Jae-Hoon Jung, Jung Hwa Jung, Soo Kyoung Kim, Sungsu Kim, Jeong Rang Park, Rock Bum Kim, Jong Ryeal Hahm
    International Journal of Thyroidology.2015; 8(2): 161.     CrossRef
  • Changes of Body Composition, Blood Concentrations of Lipid Profiles and Thyroid Hormone After Exercise Training in Hypothyroid-induced Rat
    Kijin Kim
    The Korean Journal of Obesity.2012; 21(1): 65.     CrossRef
Close layer
Case Reports
A Case of Primary Hypothyroidism with Anti-Triiodothyronine Autoantibody.
Jae Ho Park, Ji Hoon Ahn, Mi Hee Kang, Jong Chul Won, Kyung Wook Lee, Yeo Joo Kim, Ji Oh Mok, Hyeong Kyu Park, Chul Hee Kim, Sang Jin Kim, Dong Won Byun, Kyo Il Suh, Myung Hi Yoo
J Korean Endocr Soc. 2006;21(5):428-432.   Published online October 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.5.428
  • 3,164 View
  • 26 Download
  • 1 Crossref
AbstractAbstract PDF
Antithyroid hormone autoantibodies can be present in the sera of patients with thyroid and non-thyroid disorders. Antithyroid hormone autoantibodies in a patient's serum interfere with radioimmunoassay of thyroid hormones. Clinically, this interference can result in discordance between the serum thyroid hormone levels and the clinical features of the patient, which can lead to misdiagnosis or inappropriate treatment. We experienced a woman who had primary hypothyroidism with unexpectedly high concentrations of serum total triiodothyronine (T(3)) and free T(3), and she had been treated for Graves' disease in the past. Through the use of a polyethylene glycol precipitation method, we detected the anti-triiodothyronine autoantibodies in her serum. We report on this case along with a review of the related literature.

Citations

Citations to this article as recorded by  
  • Thyroxine (T4) Autoantibody Interference of Free T4 Concentration Measurement in a Patient With Hashimoto’s Thyroiditis
    Mi-Na Lee, Soo-Youn Lee, Kyu Yeon Hur, Hyung-Doo Park
    Annals of Laboratory Medicine.2017; 37(2): 169.     CrossRef
Close layer
A Case of Hashimoto's Thyroiditis Associated with Multiple Sclerosis.
Beom Ju Lee, Jong Chan Oh, Sang Yong Kim, Dong Hyun Choi, Jung In Kim, Gyung Nam Kim, Jin Hwa Kim, Hak Yeon Bae
J Korean Endocr Soc. 2004;19(4):426-432.   Published online August 1, 2004
  • 1,694 View
  • 27 Download
AbstractAbstract PDF
Multiple sclerosis is an autoimmune disorder, which may be associated with other rheumatologic or endocrine diseases induced by autoantibodies. Hashimoto's thyroiditis is also an organ-specific autoimmune disorder, and its association with multiple sclerosis during interferon therapy has been reported. Cases of Hashimoto's thyroiditis with multiple sclerosis are very rare. Herein is reported our experience of a 27 year-old woman who presented with general weakness, cold intolerance and progressive muscle weakness. She had been treated with levothyroxine due to subclinical hypothyroidism, which rather aggravated the symptom. In a CSF analysis, the myelin basic protein level was above 10 ng/dL and that of the IgG and the IgG index were 135 mg/dL and 7.8, respectively. In a brain MRI, demyelinating lesions in the left middle pontocerebellar junction and right subcortex were shown. She was diagnosed with multiple sclerosis, and the symptom improved after glucocorticoid and levothyroxine therapy. Herein is reported the first Korean case of Hashimoto's thyroiditis associated with multiple sclerosis
Close layer
A Case of Acute Rhabdomyolysis as a first Manifestation of Primary Hypothyroidism.
Jung Min Lee, Hyun Shik Son, Hye Jung Lee, Sook Hee Hong, Jong Min Lee, Bong Yun Cha, Kwang Woo Lee, Ho Young Son, Sung Koo Kang
J Korean Endocr Soc. 2003;18(1):79-84.   Published online February 1, 2003
  • 1,677 View
  • 22 Download
AbstractAbstract PDF
Various symptoms, such as bradycardia, hypotension, fatigue, constipation, myalgia, muscle weakness, delayed tendon reflex, and so forth, presented in hypothyroidism. Of these symptoms, muscle weakness, myalgia, and delayed tendon reflex are common features of hypothyroid myopathy. Acute rhabdomyolysis, a very severe form of myopathy, but is a rare manifestation of primary hypothyrodism. A 29-year-old man developed acute rhabdomyolysis, associated with primary hypothyroidism as a first manifestation. After thyroxine replacement therapy, he exhibited some improvement in muscle weakness and in non-pitting edema. We report a case of primary hypothyroidism presenting with spontaneous rhabdomyolysis as a first manifestation.
Close layer
Original Articles
Changes in Plasma Leptin Levels Relating to Short-Term Thyroid Manipulation in Rats.
Min Seon Kim, Cho Ya Yoon, Young Min Cho, Hye Seung Jung, Chan Soo Shin, Kyong Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee, Stephen R Bloom
J Korean Endocr Soc. 2002;17(2):197-205.   Published online April 1, 2002
  • 1,650 View
  • 21 Download
AbstractAbstract PDF
BACKGROUND
Leptin, an adipocyte derived hormone, and thyroid hormone have similar effects on energy homeostasis, such that a shortage of both hormones is associated with decreased energy expenditure and increased body weight. Therefore, for the maintenance of energy homeostasis may require a close interaction between leptin and thyroid hormone. This study was performed to investigate the change in plasma leptin levels relating to short-term thyroid manipulation causing no significant change in body weight. METHODS: Hypothyroidism was induced by surgical thyroidectomy and hyperthyroidism by subcutaneous injection of 50 g of L-T3/100 g body weight/day, for 5 days, in 6~8 weeks old male Wistar rats. Body weights and food intakes were monitored daily until sacrifice. Plasma samples were collected, and the thyroid stimulating hormone (TSH), free triiodothyronine (T3) and leptin levels measured. The plasma leptin levels in rats with hypothyroidism and hyperthyroidism were compared with those of body weights at death and food intakes during the study, atched controls. RESULTS: The rats treated with L-T3 consumed equal amount of food as freely fed, rats but their final body weights were significantly lower (L-T3 treated 220.0 +/- 1.8 vs. freely fed 226.0 +/- 2.0 g, p<0.05). There was no difference in food intake during study, and final body weight, between the thyroidectomised rats and their paired controls (thyroidectomised 220.4 +/- 1.7 vs. paired 223.9 +/- 4.7 g, P=NS). Plasma leptin levels in the L-T3 treated rats were significantly lower than those in freely fed rats (L-T3 treated 1.7 +/- 0.1 vs. freely fed 4.8 +/- 0.2 ng/ml, p<0.005). Conversely, the thyroidectomised rats had higher plasma leptin levels, compared to those of their paired controls (thyroidectomised 4.8 +/- 0.3 vs. paired 1.7 +/- 0.1 ng/ml, p<0.005). CONCLUSION: The Plasma leptin levels in the rats were decreased by short term hyperthyroidism, while they were increased by short term hypothyroidism. These findings suggest that thyroid hormones may affect the production or secretion of leptin
Close layer
A Frequency of Hypothyroidism in a Population of Hypercholesterolemin Subjects.
Jae Hoon Chung, Kwang Won Kim, Byoung Joon Kim, Sung Hoon Kim, Kyung Ah Kim, Myung Sik Lee, Moon Gyu Lee, Yong Ki Min, Yun Ho Choi, Myung Hee Shin
J Korean Endocr Soc. 1998;13(3):351-358.   Published online January 1, 2001
  • 1,817 View
  • 22 Download
AbstractAbstract PDF
BACKGROUND
Hypothyroidism is a treatable cause of secondary hyperlipidemia. The lipid profile usually seen is an increased total and low density lipoprotein(LDL) cholesterol, and the plasma triglyceride may also be increased. Hypercholesterolemia associated with hypothyroidism is an important factor in the pathogenesis of coronary artery disease(CAD). And the hyperchole-sterolemia caused by hypothyroidism is potentially reversible by thyroid hormone replacement therapy. Hypothyroidism should be ruled out by routine laboratory screening as a treatable cause of secondary hyperlipidemia and increased CAD risk. We carried out this study aimed at evaluating the frequency of hypothyroidism and its relationship with serum cholesterol concentration in Koreans. METHODS: We investigated 15028(men 8273, women 6755) Korean subjects who visited our hospital center for health promotion during an one year period(from January 1, 1996, to December 31, 1996). Among them, we analyzed 6756 hypercholesterolemic subjects whose serum cholesterol levels were greater than 200 mg/dL. They performed thyroid function tests(total T, T4, and TSH) and lipid profiles(total cholesterol, triglyceride and HDL-cholesterol) were measured by enzyme assay. We defined hypothyroidism by serum thyrotropin values greater than 5 U/mL. RESULTS: The observed prevalence of hypothyroidism was 2.4%(163/6756). Among those with high TSH levels, 17(10.4%) had overt hypothyroidism with a low T4 (below 6 g/dL) level. As we analyzed the frequency of hypothyroidism according to cholesterol range by 20 mg/dL, the frequency was significantly increased in the group whose serum cholesterol levels were greater than 300 mg/dL, especially in women over 50 years of age. Analysis of lipid parameters showed that hypertriglyceridemia was frequent and hyperHDLaemia was observed in hypothyroidic populations. CONCLUSION: Screening for hypothyroidism by measurement of thyrotropin values is of particular importance in patients with hypercholesterolemia. And the frequency of hypothyroidism was more significantly increased in whose serum cholesterol levels were greater than 300 mg/dL, especially in the group of women over 50 years of age.
Close layer
Case Reports
A Case of Polygrandular Automune type II syndrome associated empty sella.
Jin Soo Kim, Mi Duk Lee, Hong Seung Kim, Choon Hee Chung
J Korean Endocr Soc. 1998;13(2):295-300.   Published online January 1, 2001
  • 1,275 View
  • 19 Download
AbstractAbstract PDF
The polyglandular autoimmune(PGA) syndrome designate as the dysfimction of endocrine and nonendocrine systems involving two or more organs on the basis of an autoimmune mechanism. There are 3 types of PGA syndrome and their etiology or pathogenesis is still not complete by understood. Type I PGA is present in the patients who have at least two of the triad of Addison's disease, hypopacathyroidism, and chronic mucocutaneous candidiasis. Type II PGA is present in the those who have Addisons disease with autoimmune thyroid disease and/or insulin dependent diabetes mellitus, but who do not have hypoparathyroidism or candidiasis. Type III PGA is present in the one who have autoimmune thyroid disease, without Addisons disease, but with another autoimmune disease report a case of autoimmune polyglandular syndrome type II in a seventy-three years old female patient who had primary adrenal insufficiency, primary hypothyroidism, and empty sella, pulmonary tuberculosis.
Close layer
A Case of Turner's Syndrome with Hypothyroidism and Pericardial Effusion.
Sung Kil Lim, Young Duk Song, Hyun Chul Lee, Kap Bum Huh, Jin Seok Kim, Yong Suk Yoon, Suk Ho Kwon, Jae Hyun Nam
J Korean Endocr Soc. 1997;12(4):661-666.   Published online January 1, 2001
  • 1,714 View
  • 37 Download
AbstractAbstract PDF
Clinical manifestations of hypothyroidism are very various and these degree are related to the severity and duration of the disease. Pericardial effusions, one of the manifestations of hypothy-roidism, were relatively common in the past. However, recently they may not be so frequent representative of hypothyroid subjects. The higher frequency of Hashimotos thyroiditis in Turners syndrome, especially those with an X-isochromosome, compared with the general population is well known. The pathophysiological process of autoimmunity is thought to be linked with the presence of an abnormal X-chromosome. Recently we experienced a case of X-isochromosome Turners syndrome with hypothyroidism and pericardial effusion and report it with reviews of the literatures.
Close layer
Four Cases of Newly Developing Goiter During Lithium Carbonate Therapy.
Kwan Woo Lee, Young Goo Shin, Sung Keun Lee, Sung Kyu Lee, Yun Suk Chung, Hyun Man Kim
J Korean Endocr Soc. 1997;12(4):621-626.   Published online January 1, 2001
  • 1,419 View
  • 20 Download
AbstractAbstract PDF
Since 1949, lithium has been widely used for treatment of manic depressive disorder. It has also been used for agranulocytosis after anticaneer chemotherapy and partially for hyperthyroidism. But it is well known that the long term administration of this drug is associated wih various antithyroid effects such as hypothyroidism, simple goiter, nodules and even thyrotoxicosis. Although the exact mechanism for leading hypothyroidism or goiter is still unknown, the incidence of lithium-induced hypothyroidism is 1-37% during lithium atment. We had an experience of newly developing goiter with or without hypothyroidism during lithium treatment in 4 MDP patients. Among our patients, the duration of lithium administration was from 0.7 months to 11 years, and the development of thyroid abnormality was impossible to predict. They were treated with thyroxine while lithium was discontinued causing favorable outcome. We suggest that routine thyroid function test include thyroid autoimmune antibody screening in patients planning to undergo lithium treatment.
Close layer
A Case of Piouitary Hyperplasia with Retardation due to Primary Hypothyroidism.
Hong Seung Kim, Choon Hee Chung, Young Goo Shin, Bong Ki Lee
J Korean Endocr Soc. 1997;12(4):589-595.   Published online January 1, 2001
  • 1,491 View
  • 18 Download
AbstractAbstract PDF
Primary hypothyroidism can result in reactive enlargement of the pituitary gland which is indistinguishable from primary pituitary lesions in clinical presentation and on magnetic resonance imaging. A 17-year-old girl came to the hospital due to short stature, general weakness and galac-torrhea. The magnetic resonance imaging (MRI) study showed pitutary enlargement. The hormone study showed hyperprolactinemia, decreased basal growth hormone level and primary hypothyroi-dism. By thyroid replacement therapy only, mass was successfully regressed on follow up MRI after 4 months, and growth acceleration could be achieved.
Close layer
Original Article
Changes in Properties of Thyrotropin Receptor Antibodies Following Radioiodine Treatment in Patients with Graves' Disease.
Won Bae Kim, Hyun Kyung Chung, Bo Youn Cho, Hong Kyu Lee, Chang Soon Koh, Do Joon Park, Yeon Sahng Oh
J Korean Endocr Soc. 1997;12(2):194-206.   Published online January 1, 2001
  • 1,637 View
  • 17 Download
AbstractAbstract PDF
BACKGROUND
It has been suggested that thyroid stimulation blocking antibody (TSBAb) is involved in the development of early hypothyroidism after radioiodine treatment in patient with Graves disease. However, previous studies have reported the effect of radioiodine treatment on overall changes of TSH receptor antibodies without detailed observation of changes in properties of TSH receptor antibodies. The aim of this study is to evaluate the effect of radioiodine treatment on thyroid stimulation antibody (TSAb) or on thyroid stimulation blocking antibody (TSBAb) activities and to see whether the appearance of TSBAb after radioiodine treatment is involved in the development of early hypothyroidism in patients with Graves disease. METHODS: The activities of TSAb, TSBAb were measured serially with human TSH receptor transfected Chinese hamster ovary (CHO) cells in 36 patients with Graves disease who received 131I treatment. In addition to the wild type TSH receptor-expressing cells, we used a chimeric receptor that 90-165 amino acid residues were substituted by those of rat LH/CG receptor (Mc2) for measurement of TSBAb without interference by the presence of TSAb and for evaluation of TSAb epitope spreading. We evaluated the association of early hypothyroidism after 131I treatment with changes of various immunologic parameters. RESULTS: In 14 (39%) of 36 patients, TSBAb activities were present in their sera before or after 131I treatment. Four of them had TSBAb activities before 131 treatment, and 12 newly acquired TSBAb activities after 131I treatment. The existence of TSBAb was not associated with the development of early hypothyroidism after 131I treatment but with low TSAb activities before 131 treatment, high thyroidal uptake of 131I given and with old age. The phenomena of epitope spreading measured by TSAb with Mc2 mutant clone before and after 131I treatment was not infrequent, but it had no clinical relevance. CONCLUSION: These results suggest that the existence of TSBAb may be not a major factor in the development of early hypothyroidism after radioiodine treatment in Graves disease. Other factors such as TSAb activities before radioiodine treatment, the efficiency of thyroidal uptake of 131I or old age are associated with the development of early hypothyroidism.
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP